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Abstract
A beneficial immune response must hold a balance between activation against inter-
nal/external disturbances and suppression to avoid damage to healthy tissues. Deviation from
this balance results in autoimmunity/graft rejection at one side or cancer/chronic infection
at the other side. Among numerous factors that control the immune balance, conventional T
cells (Tconv), natural regulatory T cells (nTreg) and their interplay are the key factors. Tconvs
and nTregs are selected from precursor cells which express randomly generated T cell recep-
tors (TCR). Upon activation by antigen presenting cells (APC), Tconvs boost the immune
response via the production of pro-inflammatory signals (cytokines), while nTregs suppress
Tconvs in a cell-contact or cytokine-dependent manner. A defective selection of nTregs and
Tconvs in thymus, in terms of cell numbers and quality, or disturbed interplay between these
cells in periphery could result in unbalanced immune responses. In this study, induction and
maintenance of the immune balance in different stages are analyzed by mathematical models.
An agent-based modeling approach, which is suitable to consider heterogeneity among
cells, is employed to identify the critical factors that affect the outcome of thymic selection.
A novel signal integration model of thymic selection is proposed and used to study TCR
properties of cells that are selected as nTreg and Tconvs. This model takes into account the
history of TCR stimulations perceived by precursor cells during their interactions with APCs.
The model is advantageous in predicting how the balance between selected repertoires are
changed by manipulations in thymic environment. This would help in a better understanding
of unwanted tolerance induction and autoimmunity in peripheral T cell repertoires, and may
suggest strategies for inducing or breaking immune tolerance for therapeutic purposes.
After thymic selection, quality and interplay of selected nTregs and Tconvs determines
whether a major immune response can be initiated in periphery. A major proliferation of
Tconvs, which is down-regulated by nTregs, is required for antigen clearance. Proliferation of T
cells in addition to suppression of Tconvs by nTregs result in a nonlinear interplay between these
two repertoires that demands a mathematical analysis. By constructing a set of hierarchical
models based on ordinary differential equations (ODE), interplay of activated Tconvs and
nTregs is studied. By using parametric stability and bifurcation analysis of proposed models,
it is shown that the relative number of nTregs and Tconvs and their absolute numbers are
the major determinants for an immune activation against an antigen. The model helps in
understanding the nonlinear dynamics of the immune response and the emergence of chronic
infections and inflammageing.
In addition to a direct pathway, nTregs indirectly suppress Tconvs via down-regulation
of stimulatory capacity of APCs. By using a series of ODE-based mathematical models that
represent the experimental protocols, Treg-associated regulation of immune stimulation is
quantified.
By targeting different interdependent immunological stages, this theoretical study presents
a multi-stage view on the induction and maintenance of immune balance, which cannot be
gained solely by experimental studies.

vZusammenfassung
Eine erfolgreiche Immunantwort muss die Balance zwischen Abwehr interner und externer Beedrohun-
gen und ihrer Unterdru¨ckung zur Vermeidung von Scha¨den an gesundem Gewebe halten. Eine Abwe-
ichung von dieser Balance fu¨hrt einerseits zu Autoimmunreaktionen und TransplantatabstoÃ§ung oder
andererseits zu Krebs und chronischen Infektionen. Unter den zahlreichen Faktoren, welche die Balance
des Immunsystems kontrollieren, nehmen konventionelle T-Zellen (Tconv), natu¨rliche regulatorische T-
Zellen (nTreg) und deren Wechselwirkungen eine Schlu¨sselposition ein. Tconvs und nTregs werden aus
Vorla¨uferzellen selektiert, die zufa¨llig generierte T-Zell Rezeptoren (TCR) exprimieren. Bei Aktivierung
durch antigenpra¨sentierende Zellen (APC) versta¨rken Tconvs die Immunreaktion durch die Produktion
proinflammatorischer Signale (Zytokine), wa¨hrend Tconvs von nTregs mittels Zellkontakt oder Zytoki-
nen gehemmt werde. Eine fehlerhafte Selektion von nTregs und Tconvs im Thymus in Bezug auf die
jeweilige Anzahl und Qualita¨t oder ein gesto¨rtes Zusammenspiel dieser Zellen ko¨nnen zu unausgeglich-
enen Immunreaktionen fu¨hren. In dieser Studie werden Herstellung des Immungleichgewichts und dessen
Aufrechterhaltung in unterschiedlichen Stadien durch mathematische Modelle untersucht.
Es wird ein agentbasierter Modellierungsansatz verwendet, der eine Beru¨cksichtigung der Heterogenita¨t
der Zellen ermo¨glicht, um Faktoren zu identifizieren, die kritisch fu¨r das Ergebnis der Selektion im Thymus
sind. Ferner wird ein neuartiges Modell der Signalintegration bei der Selektion im Thymus eingefu¨hrt
und die Eigenschaften des TCR von Zellen, die als nTreg oder Tconv selektiert werden, werden anhand
dieses Modells untersucht. Dieses Modell beruht auf den TCR Stimulationen, welche die Vorla¨uferzellen
wa¨hrend ihrer Interaktionen mit APCs in der Vergangenheit erfahren haben. Das Verfahren hat den Vorteil,
Vorhersagen u¨ber den Einfluss von Manipulationen im Umfeld des Thymus auf das Gleichgewicht zwischen
den selektierten Zellrepertoires zu ermo¨glichen. Es kann zu einem besseren Versta¨ndnis von unerwu¨nschter
Toleranz und Autoimmunita¨t in peripheren T-Zellen beitragen und eine Empfehlung von Strategien zur
Induktion oder Vermeidung von Immuntoleranz zu therapeutischen Zwecken ermo¨glichen.
Nach der Selektion im Thymus entscheiden Qualita¨t und Zusammenspiel der selektierten nTregs und
Tconvs daru¨ber, ob eine Immunantwort in der Peripherie ausgelo¨st wird. Fu¨r die Beseitigung von Antigen
ist eine massive Proliferation von Tconvs no¨tig, welche von nTregs heruntergeregelt werden. Prolifera-
tion von T-Zellen in Verbindung mit der Unterdru¨ckung von Tconvs durch nTregs fu¨hrt zu nichtlinearen
Wechselwirkungen zwischen den beiden Repertoires, die eine mathematische Analyse no¨tig machen. Dieses
Wechselspiel zwischen Tconvs und nTregs wird anhand eines Satzes hierarchischer Modelle auf der Basis von
gewo¨hnlichen Differentialgleichungen (ODE) untersucht. Durch die Ausnutzung parametrischer Stabilita¨ts-
und Bifurkationsanalyse der hier eingefu¨hrten Modelle kann gezeigt werden, dass die relative Anzahl von
nTregs und Tconvs sowie ihre absolute Zahl die entscheidenden Faktoren fu¨r eine Immunreaktion gegen
ein Antigen sind. Das Modell hilft bei dem Versta¨ndnis der nichtlinearen Dynamik der Immunantwort und
des Entstehens chronischer Infektionen und Inflammageing.
Neben dem direkten Weg unterdru¨cken nTregs Tconvs durch das Herunterregulieren der stimula-
torischen Kapazita¨t von APCs. Mit Hilfe einer Reihe von ODE basierten mathematischen Modellen, welche
die jeweiligen experimentellen Verfahren repra¨sentieren, wird die durch Tregs vermittelte Regulation von
Immunstimuli quantifiziert.
Diese Studie ermo¨glicht durch die Untersuchung verschiedener voneinander abha¨ngiger immunologis-
cher Stadien einen Blick auf verschiedene Stadien der Herstellung und Aufrechterhaltung der Balance des
Immunsystems, der nicht allein durch experimentelle Studien mo¨glich ist.
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Chapter 1
Introduction
Our immune system normally fights against a wide spectrum of pathogens reliably, thanks to a complex
collaboration between diverse immune cells and proteins. The immune system usually initiates responses
against external intruders (referred to as nonself or foreign) in a tightly regulated way to avoid any harm
to self-tissues. However, diseases may arise when the pathogens find a way to deceive the immune system,
or the immune system is not shaped or working properly. Understanding how the immune system works is
essential for designing therapies to reduce debilitating effects that diseases bring.
Our understanding of the immune system has progressed significantly over recent decades. Several
infectious diseases such as measles, tuberculosis and diphtheria are no longer uncontrolled threads to our
community. However, still fundamental questions are remained to be answered. For example, a major
challenge in immunology is to explain how self and nonself are discriminated by the immune system.
Among diverse immune cells, helper T cells has a critical role in coordinating the immune response.
These cells belong to a branch of the immune system known as adaptive immune system, and can promote
or suppress immune responses. Helper T cells release chemical messages, called cytokines, that are used
to regulate immune responses. It is not irrelevant to call helper T cells as the “generals” of the immune
system since they can order troops of other cells, such as B cells and cytotoxic T cells, to when and how
tolerate or fight against an antigen (defined here as any protein that potentially could stimulate immune
system).
Immune tolerance is the state of unresponsiveness of the adaptive immune system to antigens. Clearly,
the immune system should tolerate self-antigens derived from healthy tissues, or harmless foreign-antigens
such as those derived from food. In contrast, the immune system should lunch effective immune responses
against foreign-antigens derived from pathogens, or self-antigens derived from altered-self tissues such
as tumors. Excessive or misguided reactions that would harm the host should be avoided. For example,
aberrant activation of self-reactive immune cells may harm self-tissues in autoimmune diseases. An excessive
immune response against harmless foreign agents may damage healthy tissues like in allergy. Autoimmune
diseases may also arise if stimulation of immune cells is indefinite and is not terminated properly. Therefore,
immune response should have a suppressor arm to maintain homeostasis of the individual. However, a strong
suppressor arm may induce immune tolerance to foreign or altered self antigens (such as tumor), or may
result in an ineffective immune response that fails to clear an antigen. Hence, a balance between effector
and suppressor mechanisms in the immune system is critical.
Conventional T cells (Tconv) and natural regulatory T cells (nTreg) are two types of helper T cells with
opposing functions. Upon activation by antigen presenting cells (APC), Tconvs boost the immune response
via the production of pro-inflammatory cytokines and other effector functions that lead to antigen clearance.
In contrast, nTregs suppress Tconvs in a cell-contact or cytokine-dependent manner to down-regulate the
immune response. These two different cell types are the key players in maintaining the homeostasis of the
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individual, by balancing immune activation and suppression.
Immune tolerance is induced and maintained in multiple stages, with respect to time and place.
At the construction phase in thymus, where helper T cells are generated, T precursor cells (known as
thymocytes) with randomly generated antigen recognition receptors (T cell receptor or TCR) undergo a
series of selections. During negative selection, those thymocytes that recognize self-antigens in thymus
are eliminated. Self-tolerance induced by negative selection in thymus is called central tolerance. Negative
selection is an error prone process, and some self-reactive thymocytes can escape thymus and enter periphery
as autoreactive Tconv. A part of detected self-reactive thymocytes are differentiated into nTregs instead
of being eliminated. nTregs are key players of inducing peripheral tolerance, by avoiding unwanted self-
reaction or by regulating the magnitude of the immune response to foreign-antigens. nTregs tightly regulate
effector functions of Tconvs, and the stimulatory capacity of APCs. Therefore, selection of nTregs and
Tconvs in thymus and their interplay in periphery, as well as regulation of peripheral immune stimulation
by nTregs are the critical stages where the balance between immune activation and suppression is affected.
In this thesis, induction and maintenance of the immune balance is studied by a series of mathematical
models and computer simulations. A very simplistic view of the immune system is taken to construct a
series of quantitative and qualitative models. At the stage of thymic selection, where adaptive immune
system is shaped by selection of nTregs and Tconvs, an agent-based modeling approach is taken to study
the properties of TCRs in nTregs and Tconvs. Biological evidences suggest that nTregs are self-reactive;
however, little is known about their TCR specificities. Despite being self-reactive, nTregs react to foreign
antigens, which seems contradictory to autoreactivity of nTregs. Agent-based modeling approach allows us
to consider heterogeneity in TCR specificity of cells, to track their interactions with thymic environment,
and to study differences between selected nTregs and Tconvs. The results of the thymic selection model
are given in chapter 4, which are based on the published article [1].
After thymic selection, interplay of selected nTregs and Tconvs are studied qualitatively by a series of
hierarchical models for immune activation. Basic components of the adaptive immune system is considered,
and additional complexities are incrementally added to a degree that the balance between immune activation
and suppression can be studied. Nonlinear dynamics emerging from immune stimulation, cell proliferation
and immune suppression is characterized without relying on quantitative experimental data. These are
mainly done by parametric linear stability and bifurcation analysis. The analysis of proposed immune
activation models are given in chapter 5, which are based on the published article [2].
Immune response in periphery starts with stimulation of T cells by APCs. APCs express antigens
and co-stimulatory molecules on their plasma membrane to stimulate interacting nTregs and Tconvs. In
addition to Tconvs, APCs are tightly regulate by nTregs. By physically removing co-stimulatory molecules
expressed by APCs, nTregs are able to control the level of immune stimulation and by that, indirectly
regulate activation of Tconvs. This critical role of nTregs possibly determines the initiation, magnitude
and termination of immune responses. In order to quantify this antigen-nonspecific pathway of immune
regulation, a series of ODE-based mathematical models are constructed based on experimental protocols.
By employing parameter estimation procedures, the sub-processes involved in nTreg-associated removal
process of co-stimulatory molecules are quantified. The results are given in chapter 6.
This thesis is structured in the following chapters. Basic components of the immune system are
introduced in chapter 2. But detailed knowledge and questions of interest in each part of the study are
given separately in each chapter. In chapter 3, modeling strategies and mathematical methods that are
used in this study are introduced. A review of previous theoretical attempts of studying the immune
system is given in the same chapter. Chapter 4 is devoted to the analysis of thymic selection. Chapter 5
contains the analysis of interplay between nTregs and Tconvs during an immune response. In chapter 6,
the regulation of immune stimulation by nTregs is studied. Finally, a summary, conclusion and outlook for
the presented study are given in chapter 7.
Chapter 2
Biological background
The main goal of this thesis is to dissect how the immune system is shaped and designed to fight pathogens
without being harmful to healthy tissues. Before entering in the depths of this thesis, some background
knowledge on the immune system is given in this chapter, specially regarding the repertoire of one of the
most important cellular components in the immune system, T cells.
2.1 Immune system
The immune system is a complex biological system comprises of collaborative components, interactions
and processes within an organism with the aim of protection against internal or external disturbances. The
immune system is divided in two main branches, the innate immune system and the adaptive immune
system, which communicate with each other via different molecules and cellular components.
2.1.1 Innate immune system
The innate immune system is the first line of defense against invading pathogens in vertebrates, invertebrates
and plants. It exhibits a great variety of humoral and cellular components that act upon antigens in
a generic and non-specific manner. The innate immune system comprises different cell types, such as
macrophages, neutrophils, natural killers etc., which express germline encoded pattern recognition receptors
(PRRs). These receptors are only able to recognize features that are conserved among pathogens, known
as pathogen associated molecular patterns (PAMPs), such as lipopolysaccharides and peptideoglycans that
are commonly expressed in bacteria.
Recognition of conserved features among pathogens is not sufficient to face all different kinds of
disturbances that might occur throughout lifetime of an individual, by considering the case where slow
evolving vertebrates are exposed to a fast changing pathogens. For example, some pathogens might take
advantage of a high mutation rate to change drastically their phenotype, and escape the detection by innate
immune receptors. Therefore, despite providing immediate defense against pathogens, the innate immune
system cannot provide long-lasting immunity to the host. However, the innate immune response has a
crucial contribution to the activation of adaptive immune system which is aimed to provide a comprehensive
and antigen-specific protection. Namely, innate cells such as dendritic cells, macrophages and natural killer
cells link the innate and adaptive immune responses by activating lymphocytes.
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2.1.2 Adaptive immune system
Unlike innate immune system which contains receptors that are encoded in the germline, the adaptive
immune system is made of receptors that are acquired throughout the life. Acquisition of new receptors
allows the adaptive immune system to prepare for future and unknown challenges. The adaptive immune
system comprises of two class of lymphocytes, namely B and T cells, which carry out the antibody or cell-
mediated immune responses, respectively. B and T cells exhibit their pathogen-specific receptor (called B
cell receptor or BCR, and T cell receptor or TCR, respectively) on the cell membrane. These receptors are
generated during B- and T-cell ontogeny by somatic recombination, the so-called V(D)J recombination
process. This process allows a limited number of genes to generate a repertoire of antigen receptors with
enormous diversity which could potentially recognize all pathogens present in nature.
Each antigen recognition receptor is expressed on each individual lymphocyte (with tens to hundreds
of thousands copies). T and B lymphocytes can become activated when the innate immune cells, namely
antigen-presenting cells (APCs) - such as dendritic cells (DCs), macrophages, or even B cells - present
pathogen-derived antigens complexed with a carrier molecule like class I or class II major histocompatibility
complex (MHC) molecules. Antigen-specific lymphocytes then recognize the presented antigen and initiate
a very specific immune response.
This thesis focuses on T cell repertoire and, thus, more emphasis will be given to T cells in this general
introduction.
2.2 T cell repertoire
2.2.1 CD4+ and CD8+ T cells
A majority (≈ 95%) of the T cell pool is αβ T cell repertoire that will be the focus of the thesis. These T
cells are divided into two lineages: CD4+ and CD8+ T cells. These lineages express exclusively CD4 and
CD8 molecules on the cell surface, respectively. These two molecules serve as co-receptors in the interaction
of TCR with peptide-MHC complexes. The co-receptors are essential for efficient signal transduction, which
ultimately lead to T-cell activation.
CD4+ T cells (also known as helper T cells), have a central role in the immune system. They regulate
innate immune cells, B cells and their CD8+ counterparts to either mount or suppress major immune
responses against self or foreign antigens. CD4+ T cells recognize antigen-derived peptides complexed
with MHC class II molecules on the surface of APCs. The importance of CD4+ T cells is more evident
in individuals infected with human immunodeficiency virus (HIV), where these cells are the target of HIV.
When the number of CD4+ T cells drops below a certain limit, the individual is not longer immune against
other opportunistic infections that ultimately lead to death of the individual [3, 4].
CD8+ T cells (also known as cytotoxic T cells) are capable of fighting against a wide range of infectious
agents, such as, viruses, bacteria, or eliminating cancer or damaged cells. Unlike CD4+ T cells, TCRs of
CD8+ T cells recognize antigens presented by class I MHC molecules on the surface of infected cells. CD8+
T cells directly engage and eliminate target cells via release of several toxic molecules, such as perforin
that lead to cytolysis and cell death.
2.2.2 Regulatory T cells
CD4+ T cells are divided into two distinct lineages: regulatory T cells (Tregs) and conventional helper T
cells (Tconvs). Unlike Tconvs that activate other immune cells such as CD8+ cytotoxic T cells, B cells and
macrophages, Tregs suppress potentially deleterious activities of Tconvs. Tregs are essential maintaining
immune tolerance to healthy self-tissues, suppressing immune responses after elimination of pathogens, and
limiting chronic inflammations. However, they are involved in limiting anti-tumor immunity. Considering
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the positive and negative effects of Tregs, there is considerable interest in the generation and action of
these cells.
Upon antigen-specific activation, Tregs suppress immune response in various ways. Tregs secrete
cytokines like IL-10, IL-35 and transforming growth factor-β (TGFβ) that inhibits effector Tconvs. Human
and mouse Tregs express granzyme A and B, respectively, that lead to the cytolysis (cell death) of activated
Tconvs. Similar to Tconvs, Tregs consume IL-2 as a growth factor. Tregs highly express IL-2 receptor
(indicating high IL-2 consumption) while they are unable to secrete IL-2. This suggests that Tregs may
disrupt metabolic activity of proliferating effector T cells by depleting the IL-2. The direct suppression
effect of Tregs on Tconvs is discussed in Chapter 5. However, Tregs may directly suppress APCs. Direct
interactions between Tregs and APCs have been observed in vivo. These interactions were proposed
to function in attenuating T cell stimulation capacity of APCs in a process that involves cytotoxic T-
lymphocyte antigen-4 (CTLA4), which is an inhibitory molecule constitutively expressed by Tregs. CTLA4-
based regulation is further discussed in Chapter 6.
Two types of Tregs are existing in peripheral lymph nodes, Tregs that are selected by thymus (called
as natural regulatory T cells or nTregs), and Tregs that are differentiated from Tconvs (referred as induced
Tregs or iTregs) in peripheral lymphoid organs. Molecular markers are essential tools for defining and for
analyzing a sub-population of immune cells. Unfortunately, a Treg-specific molecular marker is not available
[5]. CD25, CTLA4 and Foxp3 are the markers that widely used for identifying regulatory T cells, although
these cannot exclusively discriminate Tconvs and Tregs, or nTregs and iTregs. This thesis investigate nTreg
selection and functions. Our work regarding iTreg generation is given elsewhere [6]. Similar to other T
cells, nTregs are selected in the thymus from progenitor cells during a selection process known as thymic
selection. Like other T cells, Tregs bear TCRs generated by V(D)J recombination process, which can
recognize specific antigens via interacting with cognate ligands (ligands that activate mature T cells).
2.3 Thymic selection
T cell antigen recognition is achieved via TCR. When the adaptive immune system is under construction,
there is not any information about pathogens that the individual will encounter through life. Therefore,
an enormous diversity of TCRs in immune system seems required for recognition of the entire antigenic
universe. Indeed, this diversity is generated early in life in an specialized organ called thymus. V(D)J
recombination is a unique process of genetic recombination that randomly rearrange variable (V), joining
(J) and diversity (D) gene segments and therefore, generates novel TCRs. The TCR repertoire resulted
from random rearrangement process are able to react to any antigen, including self-antigens. Therefore,
the repertoire has to be shaped to efficiently react to harmful pathogens (bacteria, viruses, parasites,
worms and altered-self such as cancer cells) and at the same time, tolerate healthy tissues. Thymus is
active during the first two decades of life and maintains the diversity of T cell repertoire. Afterwards, the
thymically generated diversity is partially maintained through life via homeostatic proliferation of T cells.
Shaping of randomly generated (pre-selection) TCRs is occurred via a series of distinct selection steps.
These steps that are defined by the expression of co-receptors are the double-negative (DN) stage, in which
T precursors (thymocytes) do not express any co-receptor, followed by the double-positive (DP) stage when
thymocytes express both co-receptors in addition to αβ TCR, ending up in the single-positive (SP) stage
when thymocytes uniquely express one type of co-receptor molecules (CD4 or CD8).
αβ TCRs are expressed in double-positive stage. After expression of TCRs, thymocytes sequentially
encounter various APCs (mainly thymic epithelial cells) each expressing diverse self-peptides on the cell
surface. On each APC, self-peptides are presented by individual’s MHC molecules and are corresponding
to proteins that build individual’s healthy tissues. It is believed that thymocyte-APC encounters and the
quality of self-antigen recognition is the primary determinant of cell fates, namely cell maturation and
differentiation, or cell death. Thymocytes that complete the maturation steps leave the thymus as CD8+
Tconvs, or CD4+ Tconvs or CD4+CD25+Foxp3+ Tregs (or nTregs).
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2.3.1 Affinity model of thymic selection
The strength of the binding between two interacting proteins is called affinity. The affinity is commonly
represented by a dissociation constant (Kd), which indicates how easy it is to separate protein complex
into its constituents. A smaller Kd indicates a stronger or higher affinity interaction. In the context
of protein interactions bound to interacting cells, avidity indicates the combined strength of interacting
proteins. Abundance of a peptide indicates to the fraction of APCs that express the peptide (Figure 2.1).
If a peptide is highly abundant, thymocytes interact with the peptide with high frequency.
The classical affinity/avidity model of thymocyte selection relies on the affinity/avidity between TCR
and self-peptide-MHC complex (spMHC) as determinant of cell fate (Figure 2.2). According to this model,
during positive selection, weak affinity/avidity interactions are required for maturation of double-positive
thymocytes to single positive thymocytes and to protect them from cell death by neglect. In contrast,
during negative selection (also known as clonal deletion), double-positive or single-positive thymocytes
that encounter high affinity/avidity interactions undergo apoptosis (cell death) [7]. This model does not
state how nTregs are selected.
2.3.2 Selection of regulatory T cells
TCR-transgenic mice models were extensively used for studying thymic selection. In these genetically
engineered models, all thymocytes express identical αβ TCR with known specificity. By manipulating the
antigen presentation in thymus and expression of a ligand with known TCR affinity via a second transgene,
the role of affinity/avidity in thymic selection can be investigated.
According to TCR-transgenic studies, high-affinity interactions were shown to deviate clonal deletion
to nTreg differentiation. This suggests that nTregs may be selected from thymocytes with autoreactive
(self-reactive) TCRs. A modified version of the affinity model is currently favored in which nTreg selection
occurs within an affinity-window between positive selection and negative selection (Figure 2.3).
However, the alternative models exist in which nTreg differentiation are, at least partially, independent
of TCR specificity to self-antigens. These models are summarized in Figure 2.4. In this thesis, we
propose a signal integration model of thymic selection in which thymocyte fate determination relies on the
Figure 2.1: Affinity, avidity and abundance of ligands. Affinity is the strength of interaction between TCR
and a single peptide-MHC complex. Avidity is the combined strength of interaction between TCRs on a
single T cell and multiple peptide-MHC complex on the APC. Abundance of a ligand indicates the fraction
of thymic APCs that express the ligand.
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Figure 2.2: Affinity/avidity model of thymic selection. Most thymocytes (≈90% of pre-selection cells)
express TCRs that do not bind spMHCs, do not receive a survival signal and die by neglect (grey cells).
Low affinity interactions of TCRs with spMHCs rescue cells from death (blue cells), whereas high-affinity
interactions induces cell death (red cells). Positively selected thymocytes undergo cell maturation and
migrate out of the thymus and enter the peripheral T cell pool.
C
el
l n
um
be
r
Death by neglect
Positive selection Negative selection
TCR Affinity
nTreg differentiation
Stochastic overlap
Figure 2.3: Modified affinity model of thymic selection. nTreg selection occurs within an affinity-window
between positive selection and negative selection. This window is subjected to some stochastic influences.
For example, in TCR-transgenic systems, expression of a high affinity ligand may induce either nTreg or
Tconv selection, or nTreg selection and clonal deletion. A broad range of affinities seems to be permissive
for nTreg differentiation.
integrated TCR signal over a sequence of thymocyte-APC interactions. In the proposed model, not only
affinity/avidity contributes to the fate decision, but abundance of presented self-peptides play a major role
(peptide abundance is defined in Figure 2.1). Signal integration model is presented in chapter 4.
2.4 Immune activation and response
After maturation in thymus, T cells migrate to peripheral lymphoid organs and continuously scan the
environmental antigen presentation. T cells cannot recognize “free” antigens, but only when they are
processed by other cells (like APCs) and presented via carrier molecules such as MHC molecules. CD8+
T cells respond to their specific antigens when presented by MHC I molecules. MHC I molecules are
expressed by most cells in the body. CD4+ cells recognize their specific antigens that are carried by MHC
II molecules. MHC II molecules are only expressed by professional APCs such as macrophages and dendritic
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Figure 2.4: Models of nTreg selection. The current models are divided into (A) TCR instructive and (B)
stochastic. According to TCR instructive (affinity) model, intermediate levels of TCR stimulation Foxp3
expression, whereas higher levels and lower levels induce clonal deletion and Tconv selection respectively. In
stochastic model, the Foxp3 expression is induced in some thymocytes by an early TCR-independent signal
during double-negative stage (before expression of TCR). As the result, these cells become more resistant
to clonal deletion than Foxp3− thymocytes whenever interact with their specific spMHCs. Therefore, these
autoreactive TCRs can survive and build nTreg repertoire. Figure is modified from [8].
cells.
The activation of immune response starts with phagocytosis of invaded pathogen by APCs. The
engulfed material are digested and presented on the cell surface in the form of antigen fragments (pep-
tides) complexed to MHC molecules. Among all the antigen fragments, only a few may stably bind MHC
molecules (see Figure 2.5). If APCs encounter a dangerous pathogen, they express costimulatory ligands
CD80 and CD86, on their plasma membrane (cell surface). CD80 expression is poor on professional APCs,
but increases several days after interaction with T cells. In contrast, CD86 is constitutively expressed on
professional APCs, which increases rapidly after antigen presentation to T cells [9]. The expression of cos-
timulatory ligands on APCs is critical for T cell activation. Ligation of TCR with cognate pMHC can leads
to T cell activation, proliferation and differentiation into effector cells only when costimulatory receptors
on T cells, called CD28, is sufficiently ligated with costimulatory ligands [10, 11]. If the costimulation is
not provided to T cells within hours of TCR engagement, they convert to an unresponsive state known as
anergy, or undergo apoptosis.
Another receptor of T cells that bind to costimulatory ligands, is CTLA4. Unlike CD28 that is expressed
by nearly all T cells in steady state and during infection, CTLA4 is maximally expressed by Tconvs 1-2 days
after T cell activation [12]. In steady state, CTLA4 expression is confined to Tregs. CTLA4 and CD28
differs in their binding affinity to co-stimulatory ligands. CTLA4 binds to both costimulatory ligands with
higher affinity and avidity than does CD28 (Figure 2.6). Therefore, it is believed that CTLA4 can act as
an antagonist of CD28-ligand interactions, meaning that by winning the competition, CTLA4 interferes the
induction of costimulation. In CTLA4-deficient mice (mice that are unable to express CTLA4), conventional
T cells undergo unregulated proliferation in lymph nodes which results in death in 3-4 weeks after birth.
Further, blocking CTLA4 receptor in mice models resulted in amplification of T cell response. These
experimental evidences clearly indicate to inhibitory function of CTLA4. However, how CTLA4 works is
widely debated. Namely, it is not clear that CTLA4 inhibition is cell-intrinsic, or rather CTLA4 acts on
other cells via cell-extrinsic mechanisms. Chapter 6 is devoted to the study of unusual cellular trafficking
of CTLA4 molecules and its possible role on cell-extrinsic inhibition of immune activation.
Once activated, CD4+ T cells orchestrate different phases of adaptive immune response (Figure 2.7).
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Figure 2.5: Antigen presentation. (1) APCs continuously scan their local environments and engulf dead
cells, invaded substances, microbes and cancer cells. (2) In cytoplasm (inside the cell), the phagosomes
that carry the engulfed material are fused with lysosomes. (3) Then, the engulfed material are digested by
special enzymes and broken into small fragments (peptides). (4) Those fragments that successfully bind
to MHC molecules are then expressed to the cell surface. (5) Left over fragments are either released by
exocytosis or assimilate. (6) If APCs encounter a dangerous pathogen, in addition to the expression of
peptide-MHC complex, they express CD80 and CD86 molecules which are known as co-stimulatory ligands.
CD28 and CTLA4 are the receptors on T cells that can bind co-stimulatory ligands. (7) Upon ligation
of specific TCRs with pMHC molecules and CD28 with CD80/CD86 ligands, T cells can be activated.
Otherwise, activation does not occur.
20 µM
µ
CD86 CD80
CD28
4 µM 2.6 µM 0.2 µM
CD86 CD80
CTLA4
Affinity
Figure 2.6: Costimulatory receptor-ligand interactions [13]. The numbers shown represent the values of
the monovalent solution dissociation constant (Kd), measured in [14]. This figure is taken from [13].
CD4+ helper T cells proliferate and differentiate into effector cells by acquiring effector functions such as
cytokine secretion. For example, effector Tconvs secrete the cytokine interleukin-2 (IL-2), which is a growth
factor that stimulates clonal expansion (proliferation) of the antigen-specific T cells. Some Tconvs secrete
cytokines that stimulate leukocyte recruitment and production of microbicidal substances in phagocytes
(like macrophages). Other CD4+ helper Tconvs secrete cytokines that help B cells produce antibodies
which are substances that identify and neutralize invaders such as bacteria and viruses.
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When CD4+ T cells orchestrate an effective immune response that successfully eliminates the threat,
a contraction phase occur druing which effector T cells are reduced and homeostasis is restored. However,
long-lived memory cells will remain for years after the infection to re-initiate another effective immune
response upon re-stimulation by the same pathogen. In each phase of immune response, Tregs function as
regulators. Before T cell activation, Tregs control the homeostatic proliferation of Tconvs that may limit
their clonal size (thymocytes with identical TCR make a clone). Further, they continuously interact with
APCs and control the expression of costimulatory ligands. Once activated, Tregs undergo cell proliferation
and expand their clonal size. By acquiring cytokine-driven or cell-contact dependent inhibitory functions,
Tregs regulate the population size of activated Tconvs and stimulatory capacity of APCs.
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Figure 2.7: Time-course of T cell response. T cell response consist of distinct phases. Interaction with
activated APCs lead to recognition of antigen by specific T cells. Upon activation T cells expand their
clonal size and effector response until the antigen is eliminated (the effector phase). The response declines
by apoptosis of effector cells and Treg-associated suppression. This restores T cell homeostasis. Some
antigen-specific T cells remain as memory T cells for immunity against later invasion of pathogen. The
duration of each phase may vary depending on pathogen and associated immune responses.
2.5 Scope of the study
A state in which the immune system does not elicit a response to an antigen or a set of antigens is called
immune tolerance. This does not imply that TCRs recognizing the tolerated antigen do not exist in the
repertoire, rather the overall status of immune system (such as antigen density, number of antigen specific
Tconvs versus Tregs etc.) for the antigen does not allow an antigen-specific immune response. In other
words, immune tolerance is not inability to recognize an specific antigen, but it is an antigen-specific
suppressive response. Immune tolerance can be also achieved under conditions that effector immune
response is suppressed after initiation. Immune tolerance is clearly required for proteins that build healthy
tissues, and should be broken for foreign-antigens and altered self-antigens. How immune tolerance is
induced, is kept and is broken in the immune system is the driving force behind this study. In this thesis,
tolerance induction in helper T cells is studied in different stages, namely T cell selection, T cell activation
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and response. We start with thymic selection during which central tolerance (the result of negative
selection or clonal deletion) is induced in T cells repertoire by eliminating thymocytes with self-reactive
TCRs. Although negative selection eliminates a vast majority of self-reactive TCRs, this process still leaking
some autoreactive TCRs. Therefore, generation of nTregs that keeps immune tolerance in periphery (called
peripheral tolerance or dominant tolerance) is critical. It is important to know which TCRs are deviated
to nTreg differentiation instead of clonal deletion. Next, nTregs and Tconvs are considered after thymic
selection when they migrate to peripheral lymphoid organs. Interplay between nTregs and Tconvs after they
are stimulated by antigen (both self and nonself) is studied by a series of simple mathematical models. It
is shown how different functions and properties of nTreg and Tconvs lead to emergence of antigen-specific
immune response and tolerance. In addition to antigen-specific immune tolerance, immune system benefits
from antigen-nonspecific mechanisms to keep the tolerance. A major antigen-nonspecific suppression
mechanism which is imposed by T cells-associated inhibitory receptor CTLA4 is studied.

Chapter 3
Mathematical background
Mathematical models can quantitatively describe, in a systematic and dynamic way, immunological pro-
cesses which contain complex networks with nonlinear interactions. These models help in interpretation of
experimental data, extraction of information from a large amount of complex data, behavioral prediction
of the immune system in different scenarios, and finding new drug or vaccine target. Two major theoreti-
cal approaches have been utilized to study the immune system: unbiased data-driven modeling approach
that aims to identify, from massive amounts of quantitative data, cellular and molecular components of
the immune system and their possible interactions; and hypothesis-based modeling approach aiming to
understand the functioning principles of the immune system by extracting a minimal and fundamental set
of variables and their underlying rules [15]. This thesis takes hypothesis-based modeling approach and,
therefore, different strategies and methods that have been used in this modeling approach to study the
immune system is briefly reviewed.
3.1 Hypothesis-based modeling approach
In hypothesis-based modeling approach, one asks a question based on a specific hypothesis, and then
by employing models tries to answer the question of interest. These models are simplified version of
immune mechanisms, and are developed by translating presumed knowledge about the system of interest
into mathematical formulations. Different hypothesis require different equations that lead to different
predictions, which can then be compared to experimental data. Comparison between model predictions
and validating experimental data reveals the most relevant hypothesis that best matches the observations.
Depending on complexity, quantity and quality of experimental data, different strategies may be taken to
study the immune system.
3.1.1 Conceptual modeling
In theory, it is possible to develop mathematical models of immunological networks, and study them by
means of classical analysis and simulation tools. But, this is not easy to achieve in practice, as experimental
data with sufficient quantity and quality are usually not available for kinetic parameters of most immuno-
logical systems. Moreover, complex models with many variables are highly nonlinear and consist of different
time-scales, making the model analysis difficult to handle with analytic and computational approaches. To
cope with system complexity and lack of sufficient experimental data, one can take conceptual modeling
approach in which the immunological system is translated into the mathematical formulation just in an
abstract and mechanistic way. The biological details of components and their interactions are usually
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neglected. Although this approach may not provide accurate quantitative conclusions about the system of
interest, it may provide qualitative insights about the regime in which the system is functioning.
A typical example of such modeling strategy, is modeling of the interaction between antigens and anti-
bodies. Perelson and Oster [16] developed a simple model to estimate the probability that an antigen can
be recognized by, at least, an antibody (or antigen receptor) from a set of distinct and randomly generated
antibodies. A “shape space” concept to represent the binding of antigen and antibody was introduced. In
shape space, each point corresponds to an antigen or antibody. When two points representing an antigen
and antibody are located in sufficiently close proximity, there exists a probability of antigen-antibody bind-
ing (Figure 3.1). This does not imply an actual proximity in physical space. By using their simplifying
assumptions, authors approximated the size of an immune repertoire that would be required in order to
provide immunity against an infinite number of antigenic variants. Note that in the model, it is assumed
that the antibodies in the repertoire are randomly distributed in shape space. This assumption is certainly
not strictly satisfied. Antibodies are not made by a fully random process, but generated from random
rearrangement of a finite set of genes. Further, the model cannot map the shape space to physical space
and make statements in the protein level.
X
X
X
X
X
V
ε
S
Figure 3.1: Shape space for antigen-antibody binding [16]. Within shape space S there is a volume V
in which the shapes of antibody combining site (•) and antigenic determinant (X) are located. All the
antigens that are within a distance  of an antibody are assumed to be recognized by the antibody.
3.1.2 Data-driven mechanistic modeling
Once appropriate biological data is available, one can analyze biological theories by data-driven modeling
approach. This approach starts with developing models based on underlying immunological mechanisms
and theories. For building models, one should carefully understand experimental protocols, observations
and possible interpretations regarding the immunological process. In general, models are constructed by
parameters of interest with unknown biologically relevant value; by using experimental measurements the
biological value of parameters may be estimated. In case that measurements are not enough for estimation
of all parameters, new experiments can be designed to specifically estimate parameters that were not
identified. Models should be validated by comparing mathematical and experimental results which were
not used in the parameter estimation step. The model has to be modified until such a validation achieved.
Then, the established model can be used to predict system behavior in new scenarios and suggest new
hypothesis and experiments to test the predictions. An example of steps that is followed in data-driven
modeling approach is shown in Figure 3.2.
We took this modeling strategy to study homeostasis of regulatory T cells [6]. The aim of our study
was to quantify the contribution of different mechanisms that sustain the homeostatic cell number of
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Figure 3.2: Data-driven mechanistic modeling approach. This figure shows an example of a workflow that
is followed in data-driven modeling approach. Not all the steps in this workflow can be done in every case;
for example, model validation and verification of predictions in some cases might not be feasible due to
limitations in technology.
regulatory T cells, an important phenotype of T cells that is critical for self-tolerance. These mechanisms
are thymic output, migration of cells between different lymphoid organs, cell proliferation/death, and in
particular, induction of regulatory T cells from conventional na¨ıve T cells (conversion mechanism) (Figure
3.3). Although the Tconv-Treg conversion is a well documented mechanism [17], its contribution to the
homeistatic number of Tregs is not experimentally quantified, mainly due to paucity of unique markers to
distinguish thymically-selected (natural) and Tregs [18]. By using a combined in vivo and in silico approach,
the first estimation of the peripheral regulatory T cell conversion rate is provided, which cannot be verified
experimentally for the moment. This is an exciting example of employing hypothesis-based modeling
strategy in estimation of a critical biological parameter which cannot be quantified experimentally with the
current technology.
3.1.3 Hierarchical modeling
Clearly, simple (minimal) models cannot fully describe details of a complex system. Using highly simplistic
models is often necessary due to practical limitation and uncertainties. Despite their limitations, simple
models can give valuable insights about the system and drive predictions that raise motivation for further
investigations. Despite being simplistic, simple models are attractive as they can be treated with variety
of analytic tools and, thereby, provide a better understanding. The importance of using minimal models is
represented by some quotes. According to principle of parsimony (also known as Ockham’s razor), among
competing hypotheses that has similar prediction quality, the one with the fewest assumptions should be
chosen. Using simplest model is also demanded by Albert Einstein, “Make everything as simple as possible,
but not simpler”.
It is not always easy to find the minimal model that can sufficiently describe the functioning principles
of the system. Further, minimal model may not be unique, and multiple minimal models may equally able
to describe the system under study. Essentially, as George Box said, all models are wrong, but some are
useful [19]. For finding a useful model, the degree of model complexity and details has to be chosen, which
depends on the purpose of the model. One way to construct a model with minimal but necessary degree
of complexity, is to start with very basic model, and then by adding complexity in a hierarchical manner,
obtain the simplest model that could match to the experimental findings. Along with the procedure, useful
information can be gained about the deficits of simpler models and the contribution of each additional
complexity.
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Figure 3.3: A multiorgan mathematical model of T cell homeostasis including LNs and spleen [6]. The
thymus generates na¨ıve T cells (fraction α) and Treg cells (fraction 1− α) at rate ρ; both fractions
distribute to LNs (fraction η, left) and spleen (fraction 1− η, right). Na¨ıve T cells and Treg cells die with
rate δn and δr, are activated to homeostatic division with rate qn and qr , divide with rate pn and pr , and
return to the resting state with rate rn and rr in both organs, respectively. Activated Treg cells modulate
na¨ıve T cell activation, while activated na¨ıve T cells modulate Treg cell activation. Activated na¨ıve T cells
convert into Treg cells with rate gn. Resting T cells migrate between both organs with rate mST from
spleen to LNs and back with rate mTS. Treg-cell transorgan migration is reduced by the factor 0 ≤ χR ≤ 1.
A mice strain was used to transiently eliminate Tregs and observe their rebound. The best parameter set
was obtained to fit rebound kinetics. Experimentally, it is not possible to quantify Tconv-Treg conversion.
This model was used to estimate the conversion rate.
A classical example of such modeling strategy is the study of de Boer and Hogeweg [20], where the
authors studied emergence of self/nonself discrimination by cytotoxic and helper T cells with incorporating
varying degree of immunological complexity. Self/nonself discrimination emerged in their models from
nonlinearities that were assumed in the T cell activation and proliferation processes. In their simplest
model (Figure 3.4), helper and cytotoxic T cells are not discriminated. The authors assumed that memory
cells accumulate when the antigen stimulation is low. Such conditions occur when the antigen density or
the affinity between TCR and antigen is low. According to this critical assumption, the authors suggested
that the continuous self stimulation in immune system does not allow memory accumulation for self-reactive
T cell clones that have high affinity to self. Therefore, self-tolerance can emerge. In contrast, T cells with
low self-reactivity are accumulated as memory T cells, which upon high affinity foreign-antigen stimulation
are converted to effector T cells and, therefore, immunity arises.
In the next model, helper and cytotoxic T cells were treated as separate populations: cytotoxic T
cells eliminate the antigen, and helper T cells produce IL-2. Both populations use IL-2 for proliferation.
Later, the difference of antigen recognition by helper versus cytotoxic T cells was included. Finally, the
expression of IL-2 receptors on cytotoxic T cells was assumed to be regulated by a factor derived from
helper T cells. By comparing the hierarchical models, authors concluded that only the most complex and
the simplest models can represent self-nonself discrimination sufficiently well which is resulted from memory
cells accumulation with low self-affinity.
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Figure 3.4: Helper independent cytotoxic T cell model. Na¨ıve cell (Tconv) population is maintained by
thymic export at a constant rate; these cells can be activated by antigen-stimulation, or they undergo cell
death. Activated cells acquire effector functions in the presence of antigenic stimulation, which are IL-2
secretion (a growth factor) and IL-2-dependent proliferation, convert to memory cells in the absence of
antigenic stimulation, undergo cell death, and can eliminate antigen. Memory cells are generated from
effector cells; By re-stimulation they convert into effector cells, or they undergo cell death. Effector cells,
which needs continuous antigen stimulation, compete with other sub-populations to occupy antigenic
petides.
3.1.4 Model selection
Often, there is a set of competing hypotheses for explaining a set of observations. These different hypothe-
ses have different mathematical representation among which the best model can be selected. The “best”
model has controversial meanings. Although the models with more complexity may fit better to the obser-
vations, the additional complexities may not represent useful information/mechanism. Therefore, the best
model should balance the goodness of fit and simplicity. When more than one model have similar quality of
fitness and degree of complexity, one has to rely on the differences in model predictions. Due to differences
in governing rules of models, one can find a (simple) scenario in which the predictions of competing models
diverge. It is challenging to find the simple scenario which can be tested by current technologies. Then,
the best model can be chosen by validation of simple prediction. Curve fitting problems, where a curve
that best fits to data points given by a function, is a standard example of model selection.
3.2 Methods
3.2.1 Ordinary differential equations-based model
Models based on ordinary differential equations (ODEs) are the most popular models in studying the immune
system. They have been extensively employed in cancer immunology [21, 22], T cell responses [23, 24],
regulatory T cell dynamics [6, 25–27] and B cell responses [28, 29] to name a few example. Most of this
popularity owes to the mature theories that exist for analysis of these models and huge informative literature
of their applications in population dynamics, reaction kinetics and other physical systems. Additionally,
analysis of these systems is simpler than other modeling approaches due to high efficiency of numerical
methods for solving these models. The literature about the methods for ODE-based dynamical system
modeling and analysis is enormous. In the following, a brief introduction is given solely for the methods
that have been employed in this thesis.
Trajectories that follow evolution rules as functions of time on a set of states (phase space) are called
dynamical systems. The behavior of dynamical systems can be analyzed according to the properties of
their phase space (denoted by M). In this thesis, we consider systems of order n with continuous phase
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space that is Rn with a continuous time variable, t ∈ R. Relation between a function and its derivatives
is a differential equation. A differential equation is called ordinary if the function depends only on a single
variable; otherwise, it is called partial. The general system of first order ODEs can be written in the form
of
x˙ = f(t, x), x = x(t) ∈M ⊆ Rn (3.1)
where x represents the states of the system. f(t, x) determines the velocity at point x and at time t;
consequently, f : R ×M → Rn. A dynamical system is called autonomous when it does not depend
explicitly on time, which can be written in the form of
x˙ = f(x), x = x(t) ∈M ⊆ Rn. (3.2)
In (3.2), the function f : M → Rn which assigns a velocity (the direction and speed of motion in a point)
at each point in the phase space M is called vector field. The problem of finding a solution x(t) of a
physical system represented in the form of (3.2) that satisfies initial value x(t0) = x0 at a given time t0 is
called the initial value problem.
In this thesis, we are dealing with obtaining analytic and numerical solutions of initial value problems,
bifurcation analysis and parameter estimation in autonomous systems. Therefore, methods that have been
used in this study are briefly introduced.
3.2.1.1 Analytic solutions
Consider initial value problem for a system of the form (3.2). A solution x(t; c) that depends on a set of
parameters c called the general solution of the system if for any initial value x0, there exists a choice of c
such that x(t0; c) = x0.
The goal in theory of ODEs is to find the general solution of ODE systems in a closed form. However,
usually this goal cannot be achieved since the solutions can become highly complex. The only case where
always the general solution can be found is autonomous linear ODE systems. In chapter 6, we are dealing
with models described by linear ODEs, which are solved analytically. Next, we briefly introduce the methods
used in this study to obtain the analytic solutions.
3.2.1.1.1 Homogeneous linear ODEs
Linear differential equations describe systems in which the response is proportional to the input. Such
linear systems are described by
dx
dt
= Ax, x ∈ Rn (3.3)
where A is an n × n matrix. For solving this linear system, we can use the eigenvalues and eigenvectors
of the matrix A. An eigenvector v is a nonzero solution to the equation Av = λv for an eigenvalue λ. For
this equation, a solution exists only when the characteristic polynomial Q(λ) = det(λIn − A) is equal to
zero; In is the identity (unit) matrix of size n. If n linearly independent eigenvector can be found, then a
general solution to equation (3.3) exists which is of the form
x(t) = Φ(t)c =
n∑
j=1
cje
λjtvj (3.4)
for any values of the constants cj . The non-singular matrix-valued function Φ(t) is called fundamental
matrix.
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3.2.1.1.2 Nonhomogenous linear ODEs
An autonomous linear system that is exposed by an external force can be represented by the following set
of ODEs
x˙ = Ax+ g(t), x(t0) = x0. (3.5)
where g(t) is a continuous vector-valued function, and A is an n× n matrix. The solution of the system
is of the form
x(t) = xc(t) + xp(t) (3.6)
where xc(t) is the solution of the homogeneous equation and has the form (3.4), and xp(t) is called a
particular solution of the nonhomogeneous equation. Let Φ(t) be the fundamental matrix for the homoge-
neous version of the system. Let’s replace c in the general solution of homogeneous system given in (3.4)
with variable vector-function u(t). Additionally, let’s assume that the particular solution of the system has
the following form
xp(t) = Φ(t)u(t). (3.7)
Then, by taking a time derivative, we have
x˙p(t) = Φ˙(t)u(t) + Φ(t)u˙(t). (3.8)
Next, by substituting this into differential equation (3.5), we obtain
Φ˙(t)u(t) + Φ(t)u˙(t) = A(t)Φ(t)u(t) + g(t). (3.9)
By knowing that equation (3.4) is the solution of the homogeneous system, or equivalently Φ˙(t) = AΦ(t),
then, Φ˙(t)u(t) = AΦ(t)u(t). Therefore, equation (3.9) can be simplified to
Φ(t)u˙(t) = g(t)⇒ u(t) =
∫
Φ−1(t)g(t)dt. (3.10)
Since Φ(t) is reversible, u(t) can be obtained. Therefore, the analytic solution of the nonhomogeneous
system (3.5) is
x(t) = Φ(t)c+ Φ(t)
∫
Φ−1(t)g(t)dt. (3.11)
The method presented here is variation of parameters, which is used in chapter 6. An alternative to this
method is the method of undetermined coefficients. In contrast to the method of variation of parameters,
which works for any form of functions g(t) in (3.5), the method of undetermined coefficients can only be
applied to a restricted class of functions g(t).
3.2.1.2 Numerical solutions
Most ODE models cannot be solved analytically. However, an approximate solution can be obtained by
numerical methods. Among diverse methods, we explain in the followings two methods used in this thesis
for obtaining numerical approximation of initial value problem, which is of the form
x˙ = f (t, x) , x(t0) = x0 (3.12)
where f is a function that maps [t0,∞)× Rn → Rn, and the initial condition x0 ∈ Rn is a given vector.
Theorem 3.1 Consider the initial value problem of the form (3.12). If f (t, x(t)) and ∂f∂x are continuous
functions in α < t < β and γ < x(t) < δ containing the point (t0, x0), then a unique solution to the initial
value problem exists in an interval t0 − h < t < t0 + h that is contained in α < t < β.
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3.2.1.2.1 Euler method
The most basic explicit method for numerical integration of ODEs is the (forward) Euler method. Consider
an initial value problem of the form (3.12), which satisfies the conditions of theorem 3.1 in an interval that
contains t = t0. From the problem itself, we know the derivative at t = t0
x˙(t0) = f (t0, x(t0)) . (3.13)
The tangent line to the solution at t = t0 is
x̂(t) = x(t0) + f (t0, x(t0)) (t− t0). (3.14)
By choosing a t = t1 sufficiently close to t0, the corresponding point on the tangent line
x1 = x̂(t1) = x(t0) + f(t0, x(t0))(t1 − t0) (3.15)
should be close to x(t1), the actual value of the solution at t = t1. By using the approximated value
x1 instead of the exact solution x(t1), the approximate solution x2 in the next time point t = t2 that
is sufficiently close to t1 can be obtained. In the same fashion, approximate solution in next time steps
(tn+1) can be obtained from previous ones (tn)
xn+1 = xn + f(tn, xn)h (3.16)
where h = tn+1 − tn for every n is called step-size.
The Euler method is a first-order method, i.e. local error (error per step) is proportional to the square
of the step-size, and the global error (error at a given time) is proportional to the step size. The explicit
Euler method is equivalent to the first-order explicit Runge-Kutta method.
3.2.1.2.2 Classical Runge-Kutta method
Explicit Euler method is not very accurate and suffers from instabilities when the ODE is highly nonlinear.
Explicit Runge-Kutta methods are alternative methods which are based on making multiple Euler steps. In
the following, we present a motivation for the formulation of explicit 4th order Runge-Kutta method.
Consider that x(t) is the solution to initial value problem. A typical solution curve is shown in Figure
3.5A in the first time interval [t0, t1] with step-size h = t1 − t0. The value f1 is the slope of the solution
curve at time t0, f2 and f3 are two different estimates in the middle of time interval, and f4 is the estimate
at the end of time interval. These slopes are
f1 = f (t0, x(t0)) , f2 = f
(
t0 +
h
2 , x(t0) +
h
2 f1
)
,
f3 = f
(
t0 +
h
2 , x(t0) +
h
2 f2
)
, f4 = f (t0 + h, x(t0) + hf3) . (3.17)
The actual next point (t1, x(t1)) can be obtained by integrating the slope function (Figure 3.5B)
x(t1)− x(t0) =
∫ t1
t0
f (t, x (t)) dt. (3.18)
By applying Simpson’s rule step-size h/2, the integral in (3.18) can be approximated to∫ t1
t0
f (t, x (t)) dt ≈ h6
[
f (t0, x(t0)) + 4f
(
t1/2, x(t1/2)
)
+ f (t1, x(t1))
]
. (3.19)
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Figure 3.5: 4th order Runge-Kutta. (A) Estimated slopes mj of the solution curve x(t). (B) Integral
approximation x(t1)− x(t0) ≈ h6 (f1 + 2f2 + 2f3 + f4).
where t1/2 is the middle time point of the interval. We use the following approximations for the values of
function f(t, x(t)) in the time interval:
f (t0, x(t0)) = f1,
f
(
t1/2, x(t1/2)
) ≈ f2 + f32 ,
f (t1, x(t1)) ≈ f4. (3.20)
These values are substitute into (3.19), which is used in equation (3.18) to get an approximate to x(t1),
which is x1
x(t1) ≈ x1 = x0 + h6 (f1 + 2f2 + 2f3 + f4) . (3.21)
In the same fashion, the approximate solution of x(t1) will be used to approximate next data point. The
Runge-Kutta method presented here (4th order) has a local error (error per step) proportional to h5, and
the global error (error at a given time) proportional to h4.
In addition to the explicit methods presented here and other explicit methods exist in the literature,
one can choose implicit methods, such as implicit Euler or Runge-Kutta methods, especially when the ODE
is stiff, i.e. exact solution of ODE x(t) contains a term that decays exponentially to zero as t increases,
but whose derivatives are much greater in magnitude than the term itself. For example, consider the
initial value problem x˙(t) = −100x(t) with x(0) = 1. The exact solution of this ODE is x(t) = e−100t,
which rapidly decays to zero as t increases. If we employ Euler method with step size h = 0.1, we have
xn+1 = xn−100hxn = −9xn which yields to a exponentially growing approximate solution xn = (−9)n. If
we choose h = 10−3, we obtain approximate solution xn = (0.9)n, which correctly capture the qualitative
behavior of the exact solution. Explicit methods need to take small step size to accurately estimate the
solution, which increases the computational cost. Implicit methods allow for a more reasonable step size for
stiff ODEs. In this thesis, we are not dealing with stiff ODEs, and the rate of changes in the immunological
processes that we study is smooth. Therefore, Euler and Runge-Kutta methods are sufficient to obtain
numerical solutions of our proposed models.
3.2.1.3 Steady state and linear stability analysis
A constant solution x(t) ≡ x∗ is called a steady state (equilibrium, critical or fixed point) for a differential
equation. It is a solution where the value of x(t) does not change over time. In other words, the steady
state values (x∗) are the solutions which satisfy x˙ = f(x) = 0.
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A steady state x∗ in Rn is called stable if for every neighborhood O of x∗, a neighborhood O1 exists
such that every solution with initial condition x(0) = x0 inside O1 is defined and stays in O for all t > 0.
Additionally, if O1 exists such that x∗ is stable and limt→∞ x(t) = x∗, then x∗ is asymptotically stable. The
equilibrium x∗ is called unstable if there exists a neighborhood O of x∗ such that for every neighborhood
O1 of x∗ in O, at least one solution x(t) starting at x(0) ∈ O can be found which does not entirely remain
in O for all t > 0. In simpler words, steady state x∗ that is not stable, is unstable.
To see how we can check the asymptotic stability of an autonomous system of the form (3.2), let’s
take multivariate Taylor expansion of the right-hand side of equation (3.2)
x˙ = f(x) = f(x∗) + (x− x∗) ∂f
∂x
∣∣∣∣
x=x∗
+ higher order terms. (3.22)
Since x∗ is the equilibrium point, f(x∗) = 0 in (3.22). For function f(x), the partial derivative at point x
is defined as the Jacobian matrix
J(x) = ∂f
∂x
=

∂f1
∂x1
∂f1
∂x2
· · · ∂f1∂xn
∂f2
∂x1
∂f2
∂x2
· · · ∂f2∂xn
...
...
...
...
∂fn
∂x1
∂fn
∂x2
· · · ∂fn∂xn
 (3.23)
For x sufficiently close to x∗, the higher order terms in (3.22) will be close to zero when function f(x) is
sufficiently smooth, and therefore, we can drop them to obtain the following approximation
x˙ = f(x) ≈ J(x∗)(x− x∗) (3.24)
Let’s define the perturbation state as δx = x−x∗. By taking time derivative, we have ˙δx = x˙. Therefore,
by using the approximation in (3.24), we have the following linear system
˙δx = J(x∗)δx. (3.25)
The matrix J(x∗) is a constant, and hence, equation (3.25) is a linear differential equation. Therefore, we
know that the solution of (3.25) is of the form (3.4), where λj is the set of eigenvalues of the Jacobian
matrix at x = x∗. Let λj = µj + ivj , where µj and vj are the real and imaginary parts of the eigenvalue
respectively. Then, each of the exponential terms in the expansion (3.4) can be written as
eλjt = eµjt (cos(vjt) + i sin(vjt)) (3.26)
Therefore, the contribution of imaginary part of the eigenvalue is limited to the oscillatory component of
the solution. If real part of eigenvalue (µj) is positive for any j, there exists an exponential component of
the solution which grows with time and hence, equilibrium point x∗ is unstable.
Theorem 3.2 Let f : M → Rn be C1 and have an equilibrium point x∗ such that all the eigenvalues of
J(x∗) have negative real parts. Then x∗ is asymptotically stable. If among the eigenvalues, at least one
has a positive real part, the equilibrium point is unstable.
Note that we made a local linear approximation of the vector field in (3.22); thus, an analysis based on
this theorem is a linear stability analysis. Theorem 3.2 is silent about the stability of the system, when there
exists eigenvalue with zero real parts; the higher order terms that we neglected in (3.22) determine the
stability in this case. In theory, a system might have eigenvalues with repeated real parts; in this case, the
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stability of the equilibrium points depends on linearly independence or orthogonality of eigenvectors that
are associated with repeated eigenvalues, and determination stability in equilibrium points requires further
analysis. In practice, however, identical eigenvalues for real life systems are rare, and one can assume that
eigenvalues are different and very close but not identical, and employ theorem 3.2.
The HartmanâĂŞGrobman theorem gives insight about how the solution of linearized system and full
system are related. This theorem states that the nonlinear system has the same qualitative structure as
the linear system in the neighborhood of a hyperbolic equilibrium point, which is a point where all the
eigenvalues of the Jacobian matrix have nonzero real part.
Theorem 3.3 (Hartman-Grobman). Let xâĹŮ be a hyperbolic equilibrium point of a C1 vector field f(x)
with flow φt(x). Then, there is a neighborhood N of xâĹŮ such that φ is topologically conjugate to its
linearization on N .
Note that the flow φt(•) is defined such that φt(x(0)) = x(t) according to x˙ = f(x). Also, a function
is C1(M) - i.e. continuously differentiable - if the elements of Jacobian matrix J(x) are continuous on the
open set M .
3.2.1.4 Bifurcation analysis
A bifurcation is a drastic qualitative change in trajectories in the phase space, or equivalently, in the
structure of solutions of a dynamical system upon a small change in a parameter. Let’s consider a family
of continuous-time systems depending on a parameter,
x˙ = f(x, α), x ∈ Rn, α ∈ R1 (3.27)
where α is the parameter of interest and fα is differentiable for all degrees (C∞) with respect to α. The
simplest types of bifurcations occur when the number and stability of equilibrium solutions changes as α
varies. Saddle-node (fold) and Hopf bifurcations are common examples of such simple bifurcations. In the
following, fold and Hopf bifurcations are introduced.
Consider one-dimensional dynamical system below
x˙ = α+ x2. (3.28)
At α = 0, the system above has a nonhyperbolic equilibrium point x0 = 0, with eigenvalue λ = 0. For
α < 0, two equilibrium points x1,2(α) =
√
α exists, with positive equilibrium point x1 being unstable,
and negative equilibrium point x2 being stable node. For α > 0, no real equilibrium point exists. By
increasing the value of α from negative to positive, two equilibrium points x1 and x2 (unstable and stable,
respectively) collide at α = 0, and disappear (see Figure 3.6).
The equation f(x, α) = 0 is shown in Figure 3.7 in (x, α)-plane, which is called a bifurcation diagram
which shows at the same time equilibrium manifold and the stability of equilibrium points.
Theorem 3.4 (Saddle-Node bifurcation). Consider first order differential equation (3.27) for which
fα0(x0) = 0, f˙α0(x0) = 0, f¨α0(x0) 6= 0, ∂fα0∂α 6= 0. Then, a saddle-node bifurcation occurs at α = α0.
Consider the following two-dimensional dynamical system that depends on parameter α
x˙1 = αx1 − x2 − x1(x21 + x22)
x˙2 = αx1 + αx2 − x2(x21 + x22) (3.29)
This system has the equilibrium point (x1, x2) = (0, 0) irrespective of the value α. The Jacobian matrix
of system (3.29)
J =
(
α −1
1 α
)
. (3.30)
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has eigenvalues λ1,2 = α± i. Let’s define complex variable z = x1 + ix2 with the following properties
z¯ = x1 − ix2, |z|2 = zz¯ = x21 + x22. (3.31)
By taking time derivative of variable z, we have the following differential equation
z˙ = x˙1 + ix˙2 = α(x1 + ix2) + i(x1 + ix2)− (x1 + ix2)(x21 + x22), (3.32)
By using equation (3.32), we can rewrite system (3.29) in the following complex form
z˙ = (α+ i)z − z |z|2 . (3.33)
By replacing representation z = ρeiφ in equation (3.33), we obtain
z˙ = ρ˙eiφ + ρiφ˙eiφ, (3.34)
Figure 3.6: Fold bifurcation. Fixing some α, the number of equilibrium points in the system (3.28) can be
easily determined. At (x, α) = (0, 0), a fold bifurcation occurs in which unstable and stable equilibrium
points collide.
0
Figure 3.7: Fold bifurcation in the phase-parameter space. Black solid line shows the stable equilibrium
points and red dashed line shows unstable equilibrium points. The equilibrium points in a particular case
α = α0 is shown by circles.
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Figure 3.8: Supercritical Hopf bifurcation. System (3.36) has an equilibrium point at the origin which
is a stable focus for α < 0 and an unstable focus for α > 0. At α = 0, the equilibrium point is a
weakly attracting focus, which is nonlinearly stable and topologically equivalent to the focus. For α > 0,
this equilibrium point is surrounded by an isolated closed orbit (so-called limit cycle) that is unique and
stable. The stable cycle is a circle with radius ρ0(α) =
√
α. Every Orbit that starts from a non-zero
initial point inside or outside of the cycle approaches to the cycle as t→∞. This bifurcation is also called
Andronov-Hopf bifurcation.
or equivalently,
ρ˙eiφ + iρ ˙phieiφ = ρeiφ(α+ i− ρ2), (3.35)
which gives the polar form of system (3.29)
ρ˙ = ρ(α− ρ2)
φ˙ = 1. (3.36)
System (3.36) consists of uncoupled equations for ρ and φ, and therefore, suitable for analyzing bifurcations
of phase portrait when α passes through zero. The first equation of system (3.36) has equilibrium point
ρ = 0 for all values of α. This equilibrium point is linearly stable if α < 0, remains stable at α = 0
nonlinearly (i.e. rate of convergence of the solution to zero is not exponential), and become unstable
when α > 0. Another equilibrium point of first equation is ρ = α for α > 0 which is linearly stable. The
second equation of system (3.36) describes a rotation with constant speed. Therefore, two dimensional
system (3.36) has a bifurcation diagram shown in Figure 3.8. This bifurcation can also be presented in
(x1, x2, α)-space (Figure 3.9).
3.2.1.5 Parameter estimation
Consider a system represented by the following ODEs
x˙(t) = f (x(t), u(t), p)
y(t) = g (x(t), s) +  (3.37)
where u(t) is an external force, p is the parameter set of the system, g is an m-dimensional mapping of
the system states to observations y(t) which involves scaling and offset parameters s, and (t) is noise in
observations.Typically, complex systems are partially observed, which is equivalent with dimension m of
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x1
x2
Figure 3.9: Supercritical Hopf bifurcation in the phase-parameter space of system (3.29).
observations being smaller than the dimensions n of system states. Together with the initial value of states
x(0) for system (3.37) we define
θ = {p, x(0), s} . (3.38)
as set of parameters necessary to fully specify the system. The quality of fitting of the model prediction
to the experimental measurements is typically measured by an objective function, such as
χ2(θ) = 1m∑
k=1
dk
m∑
k=1
dk∑
l=1
 ŷkl − yk(θ, tl)
max
(
{ŷkl}dkl=1
)
2 (3.39)
where ŷkl denotes dk data-points for observable k, measured at time-points tl and yk(θ, tl) denotes the
k-th observable as predicted by parameters θ for time-point tl. The best parameters set can be estimated
numerically by minimizing the objective function
θ̂ = argmin
[
χ2(θ)
]
. (3.40)
We use differential evolution algorithm for finding the parameter set that minimizes this objective function.
3.2.1.6 Differential evolution
Differential evolution (DE) is an evolutionary computation method suitable for real-valued problems. DE
tries to optimize an objective function by improving a population of candidate solutions in a stochastic
manner. The core idea behind this method is to use differences between candidate solutions for perturbing
the population. This method starts with a random generation of a solution set according to user-defined
ranges for parameter set. These solutions are modified to moved around in the search parameter space
and improve the value of objective function, until a satisfactory criterion is met.
In pseudo-code 1, description of DE algorithm we use in this thesis is given. In this pseudo-code,
each generation consists of Np candidate solutions each with n parameters. Trial solutions are created by
mutation and crossover. If the trial solutions yield better value for objective function, they replace the old
solutions; otherwise, the old solution remains for next generation. Once a termination criterion is satisfied
or the maximal number of generations is reached, the algorithm terminates.
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Generate Np initial solutions (G0 = {x1, x2, . . . , xNp}) each with n parameters randomly
distributed in appropriate intervals;
for k ← 0 to Gmax do
check the best candidate solution;
if termination criterion then
break;
end
for i← 1 to Np do
select different parent solutions p1, p2, p3 from Gk excluding xi;
generate mutated solution: vi = p1 + F.(p2 − p3);
pick random integer r ∈ [1, n];
for j ← 1 to n do
generate a random number s;
if j = r or s < CR then
take parameter from mutated solution: uj = vij ;
else
take parameter from old solution: uj = xij ;
end
end
evaluate objective function for new solutions;
if χ2(uj) < χ2(xj) then
replace xi by ui for next generation Gk+1;
else
retain xi for next generation Gk+1;
end
end
end
return best candidate;
Pseudo-code 1: Differential evolution algorithm.
3.2.2 Agent-based model
In contrast to PDE models which are dealing with collective populations, agent-based models (ABM) relies
on the concept of discrete and distinguishable agents, such as individual cells or isolated molecules. It is
easier to study probabilistic uncertainty or stochasticity in biological interactions by ABMs. For example,
an individual agent may changes its state or location at a certain probability but not by a deterministic
process.
Partial differential equations are widely used for studying dynamics of biological systems. However, the
usage of PDEs are restricted to applications where the system of interest has a large density of interacting
components, the local fluctuations are smoothed by high diffusion rates, and no delay is existing between
cause and effect [30]. These conditions are not fully satisfied in most cellular systems. Further, biological
systems are composed of discrete entities that make microscopic inhomogeneity in the system. Neglecting
such inhomogeneity by PDE models sometimes lead to false interpretation. For example, Shnerb et al. [31]
presented diverging outcomes from an agent-based and a PDE-based representation of a simple system.
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In this system, the interaction of two agents, immortal A and mortal B, is considered. It is assumed that
A is uniformly distributed on an area with density nA and move with diffusion coefficient DA. Agents B
spread in the area with initial uniform distribution nB(0) and move with diffusion coefficient DB . Further
it is assumed that agents B die with a constant rate (µ) and proliferate in the presence of agents A (with
rate λ). The dynamic of B population is as follows
∂nB
∂t
= DB∇2nB + (λnA − µ)nB . (3.41)
When the proliferation rate is lower than the death rate, the PDE-based model predicts an extinction for
B, and uniformization for A. In contrast, an agent-based implementation of the same system shows that
agents B are resilient and trace agents A as they randomly walks, allowing agents B to place their center
of mass in A’s location and grow (see Figure 3.10). The authors concluded that inhomogeneity and
fluctuations among interacting populations are the nature of the discrete structure of such systems that
cannot be represented by PDE models or their stochastic version [30].
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Figure 3.10: Discrete versus continuous model [31]. This figure shows different predictions of PDE-based
and agent-based representation of a system with two interacting populations, A and B. See equation
(3.41) for the PDE-based model.
ABMs are attractive tools for immunological application and their usage is growing. To name a few
examples, Catron et al. [32] employed a complex model for interaction between T cells and dendritic cells
to extract the frequency of interactions and duration of T cell stimulation required for activation from
imaging data. In [33], authors developed a simulation model to study T cell competition for specific and
nonspecific stimuli presented by APCs. For a scenario with low antigen expression by APCs, the antigen-
driven competition between T cells is evident which results in coexistence of different T cell clones specific
for different target antigens. However, this competition vanishes when the antigen expression is high, which
allow the highly reactive T cell clones to exclude other T cell population.
The main advantage of ABMs that is used in this thesis is the ability to account for probabilistic
uncertainty and individual diversity within a large population. This advantage make agent-based modeling
approach suitable for studying thymic selection where diverse premature T cells interact with a finite
number of APCs for fate determination. However, assuming such individual diversity in ABMs has the cost
of huge computational complexity that accompanies such sophisticated models.
Chapter 4
A signal integration model of thymic
selection
The sections of this chapter are partially reprinted from published article [1], which can be accessed by the
link: http://www.jimmunol.org/content/193/12/5983.full.
4.1 Background
A functional and self-tolerant T cell repertoire is required for a robust immune defense. Functionality of
a T cell repertoire refers to the ability to effectively recognize foreign pathogen, and self-tolerance refers
to avoiding destruction of healthy self-tissues. Initially produced with rearranged surface T cell receptors
(TCRs) that could theoretically bind any antigen fragments, T cells complete their development in the
thymus through multiple processes of selection, necessary to restrict a randomly generated (pre-selection)
TCR pool to a functional and self-tolerant repertoire. In thymus, CD4+ CD8+ thymocytes (T progenitor
cells) migrate through a directive path from thymic cortex to thymic medulla. During this migration,
thymocytes repeatedly interact with their environmental cells. The thymic environmental cells are cortical
(cTEC) and medullary (mTEC) thymic epithelial cells, thymic resident dendritic cells and those migrated
from peripheral lymphoid organs. These environmental cells express a collection of self-peptides by MHC I
and MHC II molecules, and therefore, they are acting as antigen presenting cells (APCs). During migration
in thymus, thymocytes perceive the self-reactivity level of their TCR - i.e. the ability to bind to self-peptides
MHC complexes (spMHC) - by sequentially interacting with APCs and scanning diverse self-peptides [34].
It is believed that the decision of thymocytes to exit the thymus as mature T cells or not is made by these
thymocyte-APC interactions.
The classical theory of thymic selection (affinity/avidity model) is based on the premise that thymocytes
with no self-reactivity die by neglect, with weak self-reactivity are positively selected, and highly self-reactive
cells are clonally deleted by negative selection [35]. In Figure 2.2, a graphical presentation of affinity/avidity
model of thymic selection is given.
It is believed that thymocytes with inability to bind to MHC molecules would not be rescued by positive
selection process, and thymocytes that are specific for self-peptides would be clonally deleted by negative
selection process; this would ensure that potentially dangerous self-peptide specific T cells are absent in
the peripheral lymphoid organs [36]. However, in an interaction of TCR with self-peptide-MHC complex,
both self-peptide and MHC molecules contribute to the affinity of interaction as a single complex, but
not as separate molecules (Figure 4.1). Therefore, the level of (self-) reactivity for a TCR is resulted
from both, the loaded peptide and the MHC affinities. The relative importance of these two components,
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MHC and self-peptide, in thymic selection processes is not yet known. A T cell repertoire recognizes
foreign-peptides when presented by self-MHC molecules [37–39]. Intuitively, for increasing the chance of
recognizing foreign-peptides, T cells should at least be able to bind presenting MHC molecules.
According to early experimental evidences, the specificity of T cell-mediated immune responses is biased
towards antigens presented by MHC molecules by which T cells were selected in the thymus (referred
to as self- or selecting-MHC); However, the immune response is not fully restricted to selecting-MHC
molecules [40–44]. The notion of MHC-restriction in T cell responses which indicates to the restriction of
T cell recognition of antigens presented by one MHC but not other MHCs, was discovered from chimeric
experiments (described in Figure 4.2) [40, 41, 45]. These experiments indicates the major contribution of
thymus in MHC-restriction. However, there is no clear mechanistic explanation of how and to what degree
such a self-MHC specificity might be imposed on the T cell repertoire during thymic selection.
In addition to MHC molecules, the set of MHC-bound self-peptides influences the T cell selection. In
mice models, by reducing the diversity of thymically expressed self-peptides, the thymic output reduces
[46–48]. This suggests that some TCRs are specific for the thymically-expressed self-peptides, and only
can be selected in their presence. Another possibility would be that selection of some TCRs may not solely
depend on a particular self-peptide, but rather depends on a ”gemisch” (a mixture) of self-peptides [49,50].
Theoretically, a thymocyte with low self-MHC affinity can be selected by a self-peptide when it provides
sufficient signal for positive selection. Also, a TCR that is highly specific for a self-peptide might be able
to escape negative selection by having a low MHC specificity.
While self-peptide specific T cells are observed in the periphery even in healthy individuals [51], their
activation is regulated by natural Tregs (nTregs), a subpopulation of T cells arising from the thymus
[52]. nTregs are characterized by CD4, Foxp3 and high CD25 expressions. In thymus, nTreg precursor
cells display high levels of TCR signaling [53], but the mechanisms underlying the fate diversion (nTreg
differentiation versus clonal deletion) are not fully understood.
For explaining the overall observations in nTreg generation studies, a few general models have been
proposed (reviewed in [8]): a TCR instructive model, where selection of nTregs depends exclusively on
higher level of TCR self-reactivity, which is at or near the negative selection threshold; a two-step model
where TCR instruction facilitates IL-2 dependent expression of Foxp3; a stochastic model according to
which the fate of nTreg differentiation is decided randomly earlier than negative selection phase, which
makes nTregs resistant to clonal deletion (see Figure 2.4).
TCR transgenic mice models are the models that generate thymocytes with a identical and known
TCR sequence. In TCR transgenic mice that express high affinity peptides for a particular TCR in the
thymus, nTregs were observed [54–56]. These observations suggest that TCRs which shows higher reactivity
T cell contact residue of peptide
Polymorphic residue of MHC
Anchor residue of peptide
Pocket of MHC
MHC
TCR
Peptide
Figure 4.1: Interaction surface of T cell receptor and peptide-MHC complex. Peptides bind to MHC
molecules via a non-covalent interaction mediated by residues in the clefts of the MHC molecules (pocket)
and in the peptides (anchor residue). The amino acid side chains of peptides that is accessible from the
open top of the cleft of the MHC molecule by a specific TCR. At the same time, TCR bind to polymorphic
residues of the α helices of the MHC molecule.
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(affinity/avidity) to thymically expressed self-peptides than conventional T cells (Tconv), would appear in
the peripheral nTreg TCR repertoire. This idea would predict that nTreg and Tconv repertoires carry T
cells with distinct TCR specificities, with nTreg TCRs being more specific to self-peptides. The different
requirements of self-reactivity level for selection of nTreg versus Tconv repertoires have been validated by
using TCR signaling reporter mouse model [53] (see Figure 4.3).
If one assumes an extreme case of affinity-based nTreg selection hypothesis, i.e. each self-peptide
selects a specific TCR as nTregs, then the resulting diversity of TCR specificities in nTreg repertoire would
be equal and limited to the diversity of self-peptide pool. In the context of experimental observations,
however, overlap between the specificities of nTregs and Tconvs has been observed [58–62]. Further, there
is evidence that nTregs are diverse [58, 61, 63–67] and are activated by foreign antigens in the periphery
[68–71]. It is not know how diverse TCR specificities in nTreg repertoire could be resulted from a selection
with high self-reactivity criterion, and how this repertoire contains TCRs that can recognize foreign antigens.
By additionally considering that nTregs represent only 5% to 10% of the overall CD4+ T cell pool in mice
and human [67], how can such a small fraction can cover antigenic space, i.e. both foreign- and self-peptide
pool?
A single TCR-spMHC interaction cannot determine the fate of a cell, but interacting with many
spMHCs repeatedly is required for completing the selection [72,73]. Blocking thymocyte-APC interactions
or TCR signaling at different selection stages prevents successful positive selection[72–74]; this implies
to the requirement of sustained TCR signals for a successful positive selection. In contrast to positive
selection, negative selection which requires strong TCR signaling event is a fast process [75]. It was shown
that negative selection was preceded by a strong and transient increase in the level of TCR-mediated signals
Bone marrow donor
Irradiated bone marrow recipients
MHC A MHC AxB MHC B
MHC AxB
Magnitude of
recipient T cell response 
to antigen presented by 
MHC of type X
A B
X
A B
X
A B
X
Magnitude of
recipient T cell
response 
Magnitude of
recipient T cell
response 
Figure 4.2: MHC-restriction. MHC-restriction indicates to the restricted ability of T cells to recognize
antigens presented by MHC molecules that were available in thymus, but not by other MHC molecules.
Bone marrow chimeras were used to show the MHC-restriction concept. In these experiments, bone marrow
from a AxB donor is transplanted in recipient individuals expressing MHC A, B or both in their thymuses.
The thymocytes derived from AxB donor can express TCRs that can potentially be selected by MHC A
and MHC B. The recipient mice are irradiated so that the they cannot produce thymocytes from their own
bone marrow, but the epithelial cells and APCs are not affected and they present antigens in the context
of their own MHC. The resulted T cell repertoire is then stimulated by antigens presented by MHC A or
B. The magnitude of T cell responses shows that MHC-restriction, although is not complete, is imposed
by MHC molecules which drive the thymic selection.
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[76]. Additionally, by using reporter mouse model in which GFP levels were correlated with TCR signal
strength [53], it was observed that nTreg precursor cells perceive higher levels of sustained TCR signaling
than Tconv precursor cells during thymic selection (see Figure 4.3).
An experimental paper [75] was published when our manuscript [1] was under revision, which nicely
showed different TCR signaling requirements for positive and negative selection of CD8+ T cells. A mouse
model was engineered in which TCR signaling can be inhibited in a ZAP70-dependent manner by special
inhibitors. By using inhibitors in various regimes, it was shown that even a small duration of TCR signaling
inhibition can disrupt positive selection significantly. In contrast, a transient TCR signaling is sufficient for
efficient negative selection (see Figure 4.4).
Different temporal TCR signaling patterns (sustained and transient signals) that are shown to be
associated thymocyte fate decisions (positive and negative selections) [74–81], indicate to the relevance
of the TCR signaling dynamics for fate decisions. Hence, for a model of thymic selection, the history
of TCR signaling has to be taken into account. Furthermore, the TCR signaling strength perceived by
cells at any given time might depend on previous interactions (in a short time-window) in addition to
the current thymocyte-APC integration. Due to the limitations of experimental methods, mathematical
modeling would be a well-suited tool to investigate the information that might be encoded in the dynamics
of TCR signaling.
Numerous theoretical models were employed to study thymic selection and its impact on the TCR
specificity and cross-reactivity of the T cell repertoire [82–86]. In [83], an affinity based model was
investigated by using random numeric sequences as a representation for TCR and spMHC sequences. By
checking for all possible interactions between TCR and spMHCs, the maximum affinity was was translated
to cell removal only if it is insufficient (positive selection) or excessive (negative selection). By using the
model, it was predicted that negative selection would remove TCRs with high cross-reactivity from the
repertoire. In [84], a thymic selection model was proposed in which the activation threshold of cells was
adaptable. According to this model, by assuming that TCR stimulations can decrease signaling sensitivity
for the next interactions, it was shown that different levels of T cell cross-reactivity could be resulted. In
the aforementioned theoretical studies, the stochastic nature of interactions, the abundance of spMHCs
and different dynamical criteria in TCR signaling for positive versus negative selections were not considered.
Further, nTreg differentiation as additional outcome of thymic selection was not considered. Recently, a
theoretical study investigated thymic selection by incorporating nTreg differentiation [87]. It was assumed
∞ ∞GFP Cre1 2 3 4 5 6BsiWI ATG Stop Nr4a1 (Nur77) gene BsiWI(A)
(B)
Figure 4.3: TCR signal strength in nTreg versus Tconv [53]. A reporter mouse is developed in which the
level of a fluorescent protein reflects the strength of antigen receptor signal. In this transgenic mouse
model, GFP is inserted into the Nr4a1 (Nur77) locus of a bacterial artificial chromosome (BAC). Nur77 is
an immediate early gene, which is a gene that can be transiently and rapidly activated by TCR stimulation
in thymocytes and T cells [57]. (B) According to reporter mouse model, nTregs express higher GFP levels
compared with Tconvs, both in thymus and lymph nodes (LN). nTreg progenitors were defined as CD4SP
CD25+CD122hiFoxp3+. NTg: nontransgenic.
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that binding strengths for the TCR-spMHC interactions have a log-normal distribution; by underlying to
this distribution, variations in TCR sensitivity and the numbers of simultaneous TCR-spMHC interaction
per APC were studied. This model recapitulated experimental observations where the numbers of Tconv
and nTregs were affected by changing the amount of thymically expressed self-peptides [88]. In all these
theoretical studies, maximum encountered TCR-spMHC affinities were the only determinant of cell fates,
and except [87], nTreg differentiation was not incorporated in the proposed models.
In this chapter, we investigate a signal integration model for thymic selection by considering a random
polyclonal (multiple clones of TCRs) repertoire of thymocytes. In particular, we consider the contribution
of the two binding regions of the TCR (MHC and self-peptide) in the interaction affinity. By employing
an agent-based simulation, we consider sequential interactions of thymocytes with diverse spMHCs during
which affinity-dependent TCR ligation signals are integrated. The characteristics of the integrated signal,
namely sustained and transient signaling levels (SSL and TSL, respectively), are of the focus in this model.
These signaling components are quantified for each thymocyte during thymic selection. We assume a SSL
threshold for positive selection after which 10% of the total thymocyte pre-selection pool are kept. For
negative selection, we assume a TSL-based negative selection threshold after which 50% of the positively
selected cells are eliminated. Further, 5% of the remaining cells with highest SSL are considered to be
selected as nTregs. By using the proposed model, we show that the strength and dynamics of the integrated
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Figure 4.4: TCR signaling requirements for positive and negative selection [75]. (A) Thymocytes expressing
the OT-I TCR transgene (a TCR that is specific for ovalbumin-OVA peptide) are added to thymic tissue
slices containing positive selecting ligands. TCR signaling inhibitor is added for 12 hours after different TCR
signaling duration. These inhibitions, especially between 12 h and 48 h, all resulted in markedly impaired
positive selection. (B) For identifying the TCR signaling requirement for negative selection, high affinity
ligands (OVA peptide) is added to thymic slices containing thymocytes with OT-I TCR. Additionally, to
quantify negative selection, thymocytes expressing F5 TCR transgene (specific for influenza nucleoprotein
peptide) that can be positively selected in this system were also used. In the presence of high affinity ligands,
negative selection is significant. Negative selection is significantly impaired only when TCR signaling is
fully inhibited.
34 CHAPTER 4. A SIGNAL INTEGRATION MODEL OF THYMIC SELECTION
signal would be a successful basis for extracting specificity/affinity of thymocytes to MHC and detecting the
existence of cognate spMHC in the presentation pool. These information would be essential for selecting
a self-MHC-biased self-tolerant T cell repertoire. A nTregs selection based on the high SSL results in an
nTreg repertoire that contains TCRs with higher affinity to MHC than in Tconv repertoire. Such nTreg
repertoire is more ready for activation than Tconvs due to higher signaling status, and consequently, nTreg
repertoire is more cross-reactive with the ability to recognize both self- and foreign-peptides. According
to the signal integration model, for selecting a self-MHC-biased T cell repertoire, thymically expressed
self-peptide pool has to be diverse and low-abundant.
4.2 Model
In order to be able to study the thymic selection, the model should be able to represent diversity in TCR
sequences. Further, biologically relevant assumptions for TCR-pMHC interactions and their properties has
to be made. Next, in the cellular level the interaction of thymocytes and APCs in thymus has to be
represented. In this section, we try to make biologically relevant assumptions to investigate the thymic
selection in silico.
4.2.1 Representation of proteins and their binding affinity
In order to make a sufficient diversity in TCR sequences, we use take binary sequences as a simplified
structural representations of proteins. This simplification has been used in several studies [83–86]. This
allows us to create a large set of TCRs and peptides and to generate different possible affinities of binding
interaction. We use the following approach to calculate the affinity of a TCR-pMHC interaction:
Assume that X and Y are binary sequences with length l, which represent the “facing” binding regions
of two proteins
X = {xi}Li=1 , Y = {yi}Li=1 with xi, yi ∈ {0, 1}. (4.1)
We consider that a site in the sequence X is “matching” (contributing to the interaction) if the
respective site in the other sequence Y is complementary (opposite value). We call a binary sequence of
matching sites as “Complementarity sequence” C, defined as
C(X,Y ) = X ⊕ Y = {ci}Li=1 with ci =
{
1 xi 6= yi
0 xi = yi
. (4.2)
Since adjacent matching sites (AMS) may contribute more to the global affinity than other sparse
single matching sites, AMS sizes are listed in the “Adjacency Match” M in the following way:
M(C) = mj with mj = pj − qj + 1
s.t. {pj , qj ∈ [1, L] | (∀i ∈ [pj , qj ] : ci = 1) ∧ (cpj−1 ⊆ 0) ∧ (cqj+1 ⊆ 0)}, (4.3)
Therefore, adjacency match M is the list of lengths of consecutive 1s that exist in the complementarity
sequence C. Here, pj and qj are the locations of the first and last 1s in j-th AMS. Next, we define global
affinity (A) of the interaction as the sum of the sizes of the AMS raised to power r, called specificity
parameter, normalized to the maximum possible value.
A(X,Y ) =
∑
j(mj)r
Lr
, (4.4)
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With the specificity parameter (r), we can tune the relative contribution of the largest AMS in the
global affinity; this dependency is illustrated in Figure 4.5. By increasing the value of r, the dependency
of the affinity to the largest AMS increases, which results in a high sensitivity of affinity to a single bit
alteration in this region and dramatic decrease in the interaction affinity. Such a dependency to single
point mutations has been observed experimentally [89].
Through the TCR complementarity regions (CDR1/2/3), a T cell can interact with a peptide when it
is loaded on a MHC. CDR3 is positioned at the center of the binding interface which can establish contact
with both, the peptide and the MHC; CDR1/2 loops are mostly in contact with the top of MHC helices and
surround the central CDR3-peptide region [90–92]. While CDR1 and CDR2 are mostly conserved, CDR3
loop is a hypervariable element of the TCR which is mediates a major part of the interaction between MHC
and TCR. Due to hypervariability of CDR3, various affinities to MHC would be resulted from randomly
generated TCRs. In the model, we assume that the variable part of TCR binds to both the peptide and the
borders of MHC surrounding the peptide. Since the conserved part of TCR interacting with MHC would
contribute equally to each TCR-pMHC interaction, it is not considered in the model. It is assumed that
binary sequences of TCR and pMHC proteins are aligned in such a way that the middle part of the TCR
sequence with length Lp contacts the peptide sequence, whereas the sides of the TCR sequence, each with
length LMHC/2, contact the MHC sequence; this is illustrated in Figure 4.5. The affinity of TCR-pMHC
interaction is computed using equation (4.4)
ApMHC = A(TCR,pMHC). (4.5)
In order to distinguish between the specificity of a TCR to a MHC and a peptide, we calculate TCR
affinity to MHC by just considering the MHC binary sequence without peptide and the corresponding part
of the TCR binary sequence
AMHC = A(TCR,MHC). (4.6)
TCR
peptide
1  1  0  0  0  0  1  1  1  0  0  0  1  1  
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Figure 4.5: A binary representation of the TCR-pMHC binding interface. In this particular example, with
r = 1 in equation (4.4), the contribution of the largest adjacency match to the affinity is 50%, whereas
this contribution increases to 75% with r = 2. A single bit mutation in TCR or pMHC in the center of
the largest adjacency match region decreases the affinity approximately by 17% and 58% with r = 1 and
r = 2, respectively. See Table 4.1 for the simulation values.
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In a similar fashin, the affinity of TCR to a single self-peptide (sp) is computed by using the binary
sequence of the self-peptide and the corresponding part of the TCR sequence
Asp = A(TCR, sp). (4.7)
The separation of TCR-pMHC interaction affinity to MHC and peptide affinities is artificial and not bio-
logically relevant; it only provides us with an index to characterize TCRs according to their specificities
to a particular MHC and peptide (higher affinities indicate to higher specificities). We further define the
average self-peptide affinity of a TCR to all Nsp self-peptides as
A¯sp =
∑Nsp
i=1Asp,i
Nsp
(4.8)
where i enumerates the self-peptides and Asp,i is calculated with equation (4.7). Note that we consider
only a small subset of all possible peptide-MHCs (pMHCs) as thymically expressed ligands. In general,
since TCRs are specific only to a few pMHCs, A¯sp is low for a sufficiently large subset of possible pMHCs;
however, by considering a small subset of high-affinity pMHCs, this value increases.
4.2.2 Signal integration
4.2.2.1 Importance of time in TCR signaling
Each T cell express unique TCR with thousands of copies [93]. Upon cell movement, T cells continuously
sample their environment. In a the course of few hours, T cells interact with a considerable number of APCs
[94]. In the context of a single TCR-pMHC interaction, the affinity is low and the resulting intracellular
signals, such as ERK or calcium flux [95], are transient, short-lived and insufficient for activating T cell.
In order to overcome an activation threshold, signaling events have to be prolonged for several hours and
maintain translocation of transcription factors to the nucleus [96]. Frequent TCR-spMHC interactions,
even though not activating the T cell [97–99], are required for maintaining the TCR-mediated intracellular
signals at a level sufficient for cell survival, homeostasis [100–102] and responsiveness to foreign pMHCs
[103,104]. In order to represent the aforementioned time-dependent properties of signaling, we assume that
thymocytes (or T cells in periphery) collect TCR signals and quantify them by activation and accumulation
of downstream intracellular signals. This assumption is irrespective of the nature of presented antigen (self
and foreign pMHCs).
4.2.2.2 Integrated TCR signal
In our simulation, each cell from the pool of thymocytes interaction with a series of APCs. During this in
silico APC scanning, an APC is assigned to a thymocyte at each time point or, when there exists a low
number of APCs, a thymocyte may stay without interaction until the next time point. For each thymocyte,
we simulate a TCR signaling level. This allows us to describe, for each thymocyte, the characteristics of
TCR signaling resulting from scanning different peptides over time. At any time point, the signaling level
can increases as a function of the affinity of all simultaneous TCR-pMHC interactions. This signaling level
also decays with a constant rate. Each thymocyte expresses nTCR identical TCRs. We assume that an
affinity-dependent TCR ligation signal pi(t) is induced via ligation of its i-th TCR (TCRi) with a pMHC
molecule:
pi(t) =
{
Ai during thymocyte-APC interaction
0 no thymocyte-APC interaction
(4.9)
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where Ai is the TCRi-pMHC interaction affinity computed by equation (4.4). Each of the TCR ligation
events give rise to TCR-mediated intracellular signals S(t)
dS(t)
d t = α
nTCR∑
i=1
pi(t)− δS(t) (4.10)
where nTCR is the number of expressed TCRs by thymocyte/T cell, α is the accumulation rate and δ is
the degradation rate of TCR-mediated intracellular signals. In the rest of this manuscript, we call S(t) as
integrated TCR signal (ITS). Since foreign peptides are not normally presented by thymic resident APCs,
ITS of thymocytes encodes the level of TCR self-reactivity.
4.2.3 Simulation settings: thymocyte-APC interactions and signal integration
4.2.3.1 Settings of cells and peptides
We consider a set of Nsp random sequences (non-identical) as self-peptide pool, which is only a subset of
all possible presentable peptides (binary sequences with length Lp); the remaining ones are considered as
foreign-peptides. We assume only a single type MHC in the thymus (the selecting-MHC) which is presented
by all APCs. Peptide sequences are combined with MHC sequences in similar way shown in Figure 4.5.
Let’s assume a thymic selection with nAPC number of APCs which express nspMHC spMHCs randomly
from the pool of spMHCs. If the size of the self-peptide pool is greater than the number of spMHCs
expressed by each APC (Nsp > nspMHC), we make sure that a self-peptide is presented by an APC with
only a single copy. In this way, presented spMHCs have identical density among all APCs. Then, each
self-peptide is presented, on average, by a fraction of APCs equal to
F = nspMHC
Nsp
(4.11)
When we decrease the diversity of self-peptides and keep the total number of ligands (spMHCs)
presented in the thymus (nAPC and nspMHC and consequently nAPC × nspMHC), the abundance of self-
peptides increases (see Figure 2.1 for definition of abundance of a ligand). By decreasing the abundance of
a particular self-peptide, the probability of finding it in subsequent APC interactions increases. To represent
the experimental observation that self-peptides in thymic cortical region are diverse and low-abundant
[105,106], F in equation (4.11) is assumed sufficiently small, i.e. self-peptide diversity is sufficiently larger
than the carrying capacity of an APC. In biological context, an APC expresses approximately 105 molecules
for MHC I and MHC II, and presents approximately 104 different bound peptides, each with 1 to 103 copies
per APC [107]. It has been estimated that thr total possible self-peptide with presentable length (8 to
10 amino acids) in the mouse proteome is around 3 × 107 [108], and a typical MHC may present 3% of
all possible nonameric peptides [109], yielding to 0.03 × 3 × 107 = 9 × 105 self-peptides presentable by
each MHC. Thus, each APC may present 104/(9 × 105) ≈1% of all self-peptides. Since our model is a
simplified and reduced form of the reality, we keep a close value of peptide abundance (F =2%) instead
of generating a high dimensional model.
4.2.3.2 T cells and in silico scanning of APCs
A subset of total possible (distinct) TCR binary sequences (2L) are assigned to thymocytes with population
size nT . At any given time-point, we assign a random interaction event between thymocytes and APCs.
Then, for each thymocyte, we calculate the affinity of TCRs to the presented spMHCs and we update
the integrated signal S(t). We assume that the duration of thymocyte-APC interaction ∆t is identical
for all cell interactions. For having a uniformly distributed self-peptides, we have to assume a sufficiently
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large number of APCs (nAPC  nspMHC). After a critical value, more larger numbers of APCs does
not affect the results of the simulation. When the number of thymocytes is equal to or smaller than the
number of APCs (nT ≤ nAPC), no competition for APCs exists in the simulation and therefore, tymocytes
have independent fates. In this case, the number of thymocytes (nT ) does not represent any physiological
number and only has statistical significance. In contrast, when the number of APCs is smaller than the
number of thymocytes (nT > nAPC), thymocytes compete for interacting with APCs at any given time
and with a uniform probability. As the result, at any time step, a subset of thymocytes remain without
interaction. The parameters used in the presented results are given in Table 4.1.
4.2.4 Dynamics of integrated TCR signal and fate determination
Herein, after a simulation with parameter values given in Table 4.1, we checked the temporal properties
of TCR signaling in the scale of single cell. In Figure 4.6, some typical ITS curves are shown. As it can
be seen in this figure, ITS generally shows fluctuations; however, due to repeated interactions with APCs
and affinity contribution from the MHC which presents a mixture of self-peptides, the signal never goes to
zero.
In addition to steady fluctuations, some strong signaling peaks in ITS can be observed (Figure 4.6). By
recalling the fact that all the APCs in the simulation carry identical MHCs, one possible reason for strong
peaks could be encountering of cell to high affinity peptide; another possibility would be encountering
of cell to multiple peptides with moderate affinities presented by one APC, which creates a high avidity
thymocyte-APC interaction; or, consecutive moderate affinity interactions with APCs could lead to an
increase of the TCR signaling.
In order to investigate the information lies within ITS dynamics, we decompose the signal of each cell
into two distinct components: the basal value of ITS after a stabilization time-window, called ”Sustained
Signaling Level” (SSL) which is determined by the minimum value of the ITS (Figure 4.6); the peak value,
hereby called ”Transient Signaling Level” (TSL), obtained as the maximum value of the ITS during the
APC scanning period. These signaling components obtained for each thymocyte during simulation, will be
used for thymocyte fate determination.
Table 4.1: Thymic selection model: parameter descriptions and values
Parameter Value Description
Nsp 500 Diversity of self-peptides
nT 106 Number of different thymocytes/TCR sequences
nAPC 106 Number of APCs
α 1 Activation/accumulation rate of TCR signaling
δ 0.1 Degradation rate of TCR signaling
r 7 Specificity parameter
L 24 Sequence length of TCR and self/foreign-peptide-MHC
LMHC 8 Sequence length of MHC
Lp 16 Sequence length of self/foreign-peptides
nspMHC 10 Number of distinct spMHCs presented by each APC
nTCR 10 Number of TCRs on surface of each thymocyte/T cell
S(0) 0 Initial condition of integrated TCR signals
∆t 0.5 hours Thymocyte-APC interaction duration
Ts 500∆t Thymic selection time-window
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Figure 4.6: Integrated TCR signal (ITS). Dynamic changes of integrated TCR signal (ITS) of two different
thymocytes are shown. The fluctuations are resulted from sequential interactions with APCs which are
presenting diverse spMHCs. The sustained signaling level (SSL) is defined as the minimum value of the
ITS in a window of sequential interactions. The transient signaling level (TSL) is determined by the
maximum ITS value in the same window of interactions. Note that SSL and TSL are individual properties
of thymocytes, which depends on the specificity of TCR to encountered spMHCs. In the shown example,
thymocyte 1 (black curve) has a low SSL and a high TSL, whereas thymocyte 2 (blue curve) displays a
higher SSL and a lower TSL than thymocyte 1.
4.2.4.1 SSL-based positive selection
It is geneally believed that thymocytes with TCRs unable to recognize any of encountered spMHCs in
thymic cortex cannot receive a TCR-mediated survival signal and therefore, die by programmed-cell death, a
process known as death by neglect [110]. Further, thymocytes have short life-spans and a few engagements
with spMHCs are not sufficient for their survival and maturation. Hence, repeated engagements of TCRs
with spMHCs are require in order to sustain TCR-mediated signaling in a sufficient level to prevent cell
death [72]. Evidences showing that sustained levels of TCR-mediated signals, such as ERK or calcium flux,
are associated with positive selection [74, 76–81] further supports the idea that positive selection relies on
sustained TCR-mediated signals in the thymic selection process.
In the context of our model, we incorporate this notion of positive selection as the elimination of
thymocytes that have low SSL. We remove thymocytes that are unable to sustain their ITS at a higher
level than positive selection SSL threshold (Figure 4.7).
Out of all pre-selection thymocytes, approximately 5% are able to mature and enter the periphery
[111]. By relying on the estimation that 50% of positively selected thymocytes are clonally deleted by
negative selection [112], we can assume that 90% of the cells die by neglect during positive selection.
4.2.4.2 TSL-based negative selection
In contrast to positive selection, it has been shown that negative selection is associated with a strong
transient increase in TCR-mediated signals [74, 76, 77, 81], and therefore, negetive selection relies on a
transient event. In the context of our model, we assume that all cells with a TSL above a threshold are
negatively selected (Figure 4.7), and therefore, clonally deleted. We estimate this TSL threshold in such
a way that it eliminates 50% of the positively selected cells.
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Figure 4.7: Signal integration model of thymic selection. SSL- and TSL-based rules for thymic selections
and nTreg commitment.
4.2.4.3 SSL-based nTreg selection
In the presented study, we focus on the selection of CD4+, and out aim is to incorporate a signal-based
nTreg fate commitment; however, the previous definitions apply for both contexts of CD4+ and CD8+
T cell development. Various experimental evidences have shown that selection of nTregs in the thymus
depends on interactions of MHC class II-restricted TCRs with high affinity/avidity ligands [54,55,113–115];
therefore, the dominant hypothesis for nTreg selection is that these cells express self-reactive TCRs [116]
and they perceive stronger TCR signals than their Tconv progenitor counterpart [53]. Further, it has been
suggested that nTregs originate from thymocytes expressing TCRs with affinities/avidities to self-peptides
that lie between the affinities/avidities that drive positive and negative selection [8, 117, 118].
The ability of nTregs to sustain high strength TCR signals is not only required for nTreg differentiation,
but also for their homeostasis and functionality in the periphery [119]. In the context of out model, we
assume that the selection of nTregs requires a sufficiently high SSL. We consider an SSL-threshold for nTreg
selection after which only 5% of the selected repertoire can be selected as nTreg phenotype (physiological
value: 5%-10% of total peripheral CD4+ T cells [67] or 4%-6% of total CD4+ thymocytes in mice [63])
(Figure 4.7).
A typical simulation of thymic selection follows the flow chart in Figure 4.8. According to different
experiments, different modifications are made to the configurations of antigen presentation.
4.3 Results
4.3.1 Sustained and transient components of integrated TCR signal (ITS):
MHC and cognate peptide affinities are segregated by the sustained and
transient components of ITS
It has been suggested that specificity of T cell responses is biased toward foreign-antigens presented by
the MHC molecules that they have been selected on (referred to as selecting- or self-MHC) [40–43] (see
Figure 4.2 for MHC-restriction concept). Yet, T cells are tolerant to self-antigens presented by the same
MHC in the periphery. Therefore, thymocytes should be sensitive to MHC affinity and be able to detect
cognate self-peptide during the selection process. Here, we checked how signal integration would allow
thymocytes to interpret the TCR signals they perceived by APC scanning in a way that allows distinction
of MHC and peptide affinities.
A repertoire of thymocytes with random TCR sequences was generated and allowed to sequentially
interact with APCs (described in section 4.2). Thereafter, the components of the TCR signaling history
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Figure 4.8: Simulation flow chart.
for each thymocyte (SSL and TSL, defined in Figure 4.6) were obtained and the potential relation between
the signaling components and affinity of cells to MHC as well as spMHCs was investigated on the population
level. A correlation analysis showed that MHC affinity of thymocytes correlated with their SSL (Figure
4.9A). No significant correlation between MHC affinity and TSL was observed (data not shown). Instead,
TSL correlated with the affinity of the best spMHC existing in the thymus (Figure 4.9B). No significant
correlation could be observed between maximum spMHC affinity and SSL (data not shown), showing that
MHC affinity and maximum spMHC affinity are encoded by two independent components of ITS, namely
SSL and TSL, respectively. This offers a biological mechanism of how cells could discriminate between
their affinity to MHC and cognate self-peptide by relying on the temporal properties of their signaling.
4.3.2 Positive selection based on SSL: positive selection ensures a high MHC
affinity of thymocytes
As positive selection requires sustained TCR signaling [74–81], we asked how the MHC specificities would
be shaped if the TCR repertoire is selected based on SSL. For this, the average MHC affinity of the
positively selected population was calculated. Note that we do not aim to give absolute affinity values
since TCRs are represented by a simplified and artificial binary space. Therefore, no realistic affinity values
can be extracted, but rather a distribution of possible affinities. Selection of 10% of the cells (Figure 4.10)
caused an 8-fold increase in the average MHC affinity (from ≈ 0.013 to ≈ 0.1, see Figure 4.11). Despite
neglecting the majority of thymocytes, the resulting average MHC affinity was still low in comparison to
the higher average of MHC affinity that could be acquired with a more stringent positive selection, i.e.
higher positive selection threshold (Figure 4.11). This suggests a trade-off between selecting the cells with
higher MHC affinity and selecting a large number of cells. The TSL-distribution of the repertoires of the
different fates (Figure 4.12) showed that positively selected cells displayed higher TSL levels. However,
having a high TSL did not guarantee positive selection for a substantial number of cells (cells in dotted
area of Figure 4.12).
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Figure 4.9: SSL and TSL versus TCR-MHC affinity. (A) Boxplot of SSL distribution (showing the max-
imum, minimum, median and quartiles of SSL) of thymocytes with respect to their MHC affinity. A
positive correlation between MHC affinity and SSL is found. (B) Boxplot of TSL distribution of thymo-
cytes with respect to their maximum spMHC affinity among the total pool of self-peptides. A positive
correlation between TSL and the maximum existing spMHC affinity is found. Note that because of the
binary representation of proteins, only finite sets of MHC and spMHC affinities are possible. For the sake
of clear presentation, the thymocytes with close proximity of affinity values are grouped. This applies to
all subsequent figures.
Figure 4.10: Distribution of thymocyte SSLs. The positive selection SSL threshold is determined by
selecting the 10% thymocytes with highest SSL. The different peaks of the SSL-distribution are reflecting
discrete possible values of MHC affinities (and consequently, SSL values) and the decreasing number of
cells with higher MHC affinity.
4.3.3 Negative selection based on TSL: negative selection limits the number
of MHC-specific thymocytes
We asked whether the MHC affinity of the repertoire is only controlled by positive selection, or whether
negative selection also plays a role. Negative selection was based on the TSL. 50% of the positively selected
cells with highest TSL were deleted. The distribution of thymocytes was investigated with respect to their
MHC affinity for the whole population (pre-selection repertoire), positively selected and selected (after
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Figure 4.11: Positive selection threshold versus MHC affinity of repertoire. Fraction of thymocytes that
are selected by different positive selection SSL thresholds (solid line), and the corresponding average MHC
affinity of the selected fraction (dashed line) are shown. A higher positive selection SSL threshold results
in a stronger MHC-bias (MHC-affinity or MHC-specificity) and strong reduction of surviving cell numbers.
A healthy immune system requires a sufficient daily production of T cells by thymus. Therefore, SSL
threshold for positive selection cannot be extremely high. Consequently, positive selection can only impose
a maximum MHC-bias in the repertoire (here represented by average MHC-affinity of cell population) that
is lower than theoretically possible value.
Figure 4.12: Distribution of repertoires with respect to TSL. The graph distinguishes thymocytes that were
not positively selected (white area), positively selected cells (gray area), cells which were not positively
selected but would have been removed by negative selection anyway (dotted area) as well as the final
selected repertoire (hatched area).
both selections) repertoires (Figure 4.13A). Additionally, these distributions are shown as the fraction of
the total population (Figure 4.13B). First, while positive selection imposed a lower bound on the MHC
affinity of the selected repertoire (Figure 4.13A-B), which is consistent with an increased MHC affinity
after positive selection (Figure 4.11), a wide range of MHC affinities survived positive selection. Note
that all the MHC-specific cells (MHC Affinity = 1) were kept by positive selection (Figure 4.13B, solid
line). Secondly, looking at the fraction of the selected repertoire distinguished by MHC affinities (Figure
4.13B, dash-dotted line), the whole spectrum of MHC affinities was affected by negative selection. In
particular, a higher fraction of MHC-specific thymocytes was deleted (average MHC affinity of positively
selected repertoire ≈ 0.1 and selected repertoire ≈ 0.08). Therefore, negative selection based on TSL
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Figure 4.13: Distributions of MHC affinity in different repertoires. (A) Distribution of cell numbers and
(B) fraction of all cells that are positively selected (solid line) and selected (dash-dotted line) with respect
to their MHC affinities. Positive selection imposed a minimum MHC affinity on the repertoire and highly
impacted the lower-end of MHC affinity spectrum, whereas negative selection impacted the whole spectrum
with a higher impact on higher-end spectrum.
limited the MHC affinity of the repertoire by preventing MHC-specific cells to survive.
4.3.4 Shaping self-peptide and MHC specificity in thymus: selected
thymocytes are either affine to MHC or to self-peptide but not both
As shown before, positive selection increased the affinity for MHC on a population level. However, cells with
an above threshold MHC affinity (Figure 4.13B, solid and dash-dotted lines) might be able to complete
positive selection by having proper self-peptide affinity. For this reason, we monitored the average self-
peptide affinity of thymocytes according to equation (4.8), including the whole pool of self-peptides. This
quantity was calculated for groups of thymocytes with similar MHC affinity (Figure 4.14). The self-peptide
affinity displayed a large spectrum of possible values (not shown), as expected from uniform random TCR
generation. Therefore, the average self-peptide affinity of the whole population before any selection was
independent of MHC affinity by construction (Figure 4.14, see dashed line).
After positive selection, the cells with lower MHC affinity exhibited higher self-peptide affinity and
this tendency was conserved after negative selection. Therefore, low MHC affinity thymocytes required
a stronger specificity for self-peptides to survive positive selection. In contrast, the cells with higher
MHC affinity were not influenced by positive selection in terms of self-peptide affinity. Negative selection
constrained the self-peptide affinity on the whole spectrum of MHC affinities, with a higher impact on
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Figure 4.14: Average self-peptide affinity of the thymocyte repertoires at different stages of thymic selection.
Equation (4.8) is calculated for groups of thymocytes with defined MHC affinity. Positive selection affects
the lower-end spectrum of MHC affinity, whereas negative selection affects the whole spectrum.
thymocytes with strong affinity for MHC (Figure 4.14, compare solid and dash-dotted lines). The com-
bination of positive and negative selection imposed constraints on both MHC and self-peptide affinity and
consequently, the selected repertoire showed a compromise between these two constraints.
4.3.5 MHC-specificity of nTreg repertoire: nTreg repertoire is enriched with
MHC-specific TCRs
Negative selection is not perfect and autoreactive T cells may escape it [51]. This also happens in the model
because of its stochastic nature and the probabilistic scan of APCs in a limited time frame. Selection of
nTregs, which respond to the autoreactive stimuli together with Tconvs, would limit autoreactive responses
in the periphery mediated by these accidental self-reactive T cells. nTregs were shown to have a higher
sustained TCR signal than Tconvs in thymus and periphery [53] (see Figure 4.3). This property motivated
the definition of nTregs in the model (see Model section 4.2). The 5% of selected thymocytes with highest
SSL were committed to the nTreg phenotype while all others acquired the Tconv phenotype.
To investigate the TCR characteristics of nTregs versus Tconvs, their respective distributions were
monitored in dependence on their MHC affinity (Figure 4.15A-B). As expected from the definition of
the nTreg commitment, nTregs were biased towards higher MHC affinity whereas Tconvs are composed of
cells with lower MHC affinity. However, the overlap of both subsets in terms of MHC affinities was large
(Figure 4.15A-B).
The compromise between MHC affinity and average self-peptide affinity that was observed in the
selected repertoire (Figure 4.14), was also conserved in nTreg and Tconv repertoires (Figure 4.16).
4.3.6 Autoreactivity of pre- and post-selection repertoires
Starting from an initial random sequence of thymocyte-APC interactions, we checked how many cells from
the pre-selection repertoire would be autoreactive. The cells which crossed their signaling level over negative
selection TSL-threshold being defined as autoreactive cells. Next, the fate of these particular autoreactive
cells was examined with a different random sequence of thymocyte-APC interactions. Out of 10% of
the pre-selection thymocytes that showed autoreactivity in the initial random sequence of thymocyte-APC
interactions, nearly 50% failed to pass positive selection in the second random sequence of thymoycte-APC
interactions due to low MHC affinity (average MHC affinity ≈ 0.006). Note that in contrast to the whole
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Figure 4.15: Distributions of MHC affinity of nTreg versus Tconv repertoires. (A) Distribution of cell
numbers and (B) fraction of all cells that are selected (dash-dotted line), selected as Tconvs (solid line)
and selected as nTregs (dashed line) with respect to their MHC affinity. Tconvs and nTregs have a large
overlap in their MHC affinity spectrum. nTreg repertoire is more enriched in MHC-specific TCRs than
Tconv repertoire.
population where only 10% survived positive selection, autoreactive thymocytes reached 50% of survival
due to high MHC affinity (with average MHC affinity ≈ 0.13).
From the positively selected autoreactive thymocytes, approximately 88% were negatively selected by
the second random sequence of thymoycte-APC interactions. Therefore, autoreactive TCRs were more
targeted by negative selection. From the escaped autoreactive cells, a high number (89%) matured as
Tconv. Note that the escaped autoreactive Tconvs had a lower MHC affinity (in average ≈ 0.06) than
negatively selected autoreactive thymocytes (average ≈ 0.13) or autoreactive cells that selected as nTregs
(average ≈ 0.33). We also observed that the fraction of autoreactive TCRs in nTreg repertoire was
approximately 2.5-fold higher than autoreactive TCRs in Tconv repertoire, proving higher autoreactivity of
nTreg than Tconv repertoire in our model.
These results show that some autoreactive TCRs ended up in the Tconv repertoire due to stochastic
variations of thymocyte interactions with APCs within a limited time-frame. Negative selection was more
efficient than nTreg differentiation in restricting the autoreactive TCRs in the Tconv repertoire. But the
nTreg repertoire was more enriched with autoreactive TCRs (and with higher affinity for MHC) than the
Tconv repertoire.
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Figure 4.16: Average self-peptide affinity of the nTreg and Tconv repertoires. Equation (4.8) is calculated
for groups of thymocytes with defined MHC affinity. In contrast to nTreg repertoire, Tconv repertoire
contains low MHC affinity TCRs which are skewed to recognize self-peptides in an average fashion. In
overlapping spectrum of MHC affinity, nTreg repertoire has TCRs with higher self-peptide affinities than
Tconv repertoire, which is consistent with nTregs being more self-reactive than Tconvs.
4.3.7 Cross-reactivity and degeneracy of thymic and peripheral repertoires:
nTregs are more cross-reactive than Tconvs
Recognition and activation of individual T cell is not limited to a unique specific peptide sequence, but
multiple peptide sequences with sufficient specificity can be recognized by an individual T cell [120]. This
allows the immune system to provide a comprehensive immunity against the antigen universe and cope
with antigenic variations during infection [121]. This feature can be observed in two different forms: an
individual T cell is able to recognize multiple non-homologous peptides, defined as cross-reactivity here,
or T cells are able to respond to variants of their agonist antigen (i.e. point-mutations in amino acid
sequences), defined as degeneracy here.
In order to assess the degree of cross-reactivity in the selected T cell repertoire and the impact of
positive and negative selection on shaping cross-reactivity, the ability of cells to recognize multiple foreign-
peptides was examined. First, a set of non-identical and random foreign-peptide sequences was generated
and combined with the self-MHC sequence (as shown in Figure 4.5) to set up a pool of 100 distinct
foreign-peptide-self-MHC (fpMHC) sequences. Then, all the cells were stimulated for 2 days by APCs each
carrying extra fpMHC. The pool of APCs was configured with the same settings as for thymic selection,
and the negative selection TSL-threshold was considered as activation threshold. The autoreactive cells
that responded to the APCs without loading any foreign-peptide were excluded from the analysis.
We observed that while most cells from the pre-selection repertoire were not activated, a high percent-
age of positively selected or selected cells got activated (not shown). This is due to the fact that in our
system, which is a reduced-scale of the physiological system, the number of foreign-peptides tested (100
distinct foreign-peptides) is large (20% of the pool of self-peptides). However, this is required to allow for
a statistical analysis of responsiveness to foreign-peptides. Activated thymocytes from the pre-selection
repertoire were separated in groups depending on how many of the foreign peptides they could recognize.
For each group, the percentage of pre-selection cells remaining after positive and negative selections were
obtained (Figure 4.17). The results showed that positive selection avoided the selection of cells with low
cross-reactivity. In contrast, negative selection mainly affected the cells with higher cross-reactivity.
The cross-reactivity was examined for Tconv and nTregs. We observed that foreign peptides led to
the activation of both nTregs and Tconvs (4.8±1.6% of nTregs and 2.3±0.4% of Tconvs responded to
each of the foreign peptides; not shown). Additionally, the distribution of the number of foreign-peptides
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recognized by the same cells (Figure 4.18) showed that more nTregs than Tconvs were able to recognize
multiple foreign peptides. This shows that the in silico nTreg repertoire exhibits higher cross-reactivity
than Tconvs.
The degree of degenerate recognition in cells was assessed by measuring the ability of cells to recognize
variations in their cognate foreign-peptide. First, all the cells were stimulated by one foreign peptide. Then,
the reactive cells were stimulated by altered foreign-peptides generated by single-bit mutations in the binary
sequence of initially considered foreign-peptide.
We observed that positive selection allowed the selection of cells that were more degenerate in rec-
ognizing altered cognate peptides. In contrast, negative selection largely restricted the cells with high
degeneracy (Figure 4.19). The same analysis on nTreg and Tconv repertoires showed that as compared to
Tconvs, the distribution of nTregs was shifted towards a more degenerate recognition of altered peptides
Figure 4.17: Cross-reactivity assay: A set of 100 randomly generated foreign-peptides was presented by all
the APCs by adding one MHC loaded with a single type of foreign-peptide on each APC. The stimulation
was done by two days of APC scanning and the TSL-based activation threshold is assumed to be equal
to the negative selection threshold. The cells in the pre-selection repertoire were grouped according to
the number of peptides that could activate them. For each group, the percentage of cells that remain
after positive selection (black bars) and subsequently, after negative selection (gray bars) are given. For
instance, among the cells activated by 5 of the foreign peptides, nearly 70% were kept by positive selection
while only 40% completed thymic selection.
Figure 4.18: Distribution of the number of foreign-peptides recognized by Tconvs and nTregs in cross-
reactivity assay.
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(Figure 4.20).
4.3.8 Role of self-peptide diversity: diversity of self-peptides in the thymus is
required for selection of a self-MHC-biased repertoire
Next, the role of self-peptide diversity in the selection of self-MHC-biased repertoire was analyzed. As shown
in Figure 4.9A, in a thymus with diverse low-abundant self-peptides the SSL of thymocytes was correlated
with their MHC affinity. We calculated the correlation coefficient between the SSL of thymocytes and their
MHC affinity for different diversities of self-peptides (Figure 4.21). The positive correlation between SSL
and MHC affinity increases and saturates with higher diversity of self-peptides presented in the thymus. This
implies that SSL-based positive selection requires a large self-peptide diversity to select a self-MHC-biased
T cell repertoire.
To examine the impact of restricting APC availability onto the MHC-specificity of the repertoire, the
correlation coefficients between SSL and MHC affinities were obtained for various APC numbers. As
Figure 4.19: Degeneracy assay: starting from a random foreign peptide, all reactive cells were consid-
ered. These were stimulated by every possible single-point mutations of the initial foreign peptide. The
stimulation was done for 2 days by APCs fully expressing the same mutated peptide. The cells in the
pre-selection repertoire were grouped according to the number of single-point mutated peptides that could
activate them. For each group, the percentage of cells that remain after positive selection (black bars) and
subsequently, after negative selection (gray bars) are given.
Figure 4.20: Distribution of the number of single-point mutated peptides recognized by Tconvs and nTregs.
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Figure 4.21: Impact of self-peptide diversity on self-MHC-bias. The correlation coefficient between SSL of
thymocytes and their MHC affinity in thymuses with varying self-peptide diversity.
depicted in the Figure 4.22, the SSL-MHC affinity correlation was lost when the number of APCs was
critically low. Therefore, the number of APCs could be a limiting factor in the thymus for selecting a
MHC-biased T cell repertoire.
4.3.9 Thymic selection with single peptide: single spMHC selects a repertoire
with wider range of MHC affinity
Although a diverse set of self-peptides is essential for selection of diverse TCR specificities, expression
of a single self-peptide-MHC molecule was shown to allow for the selection of a large number of T cells
[48, 49, 122] and that these cross-react with allogeneic MHC [48]. Here, an MHC that is not expressed in
the thymus is called allogeneic MHC or allo-MHC. In order to analyze the extent of self-MHC-bias of the
repertoire selected by single spMHC presented in the thymus, the diversity of self-peptides in the model
was decreased to a single spMHC but with the same density of total peptide presentation as in the diverse
system.
Despite the abundant expression of a single peptide, it was possible to positively select 7.5% (compare
to 10% in the model based on diverse spMHCs), and to select 4% (compare to 5% in the model based on
diverse spMHCs) of the pre-selection repertoire, showing a decreased yet considerable amount of selected
thymocytes. In experimental systems expressing a single spMHC, about 20%-50% of the normal number of
T cells are selected (in silico, this corresponds to 80% of the normal T cell number) [49]. Presentation of
the single spMHC in these experimental systems is not efficient and constitutes approximately one-tenth of
the wild type antigen presentation level, and the expression level of spMHCs is shown to be important for
the outcome of the thymic selection [49]. Therefore, the absolute number of thymic output in our model
with abundant presentation of a single spMHC was an upper limit; by decreasing the density of the single
spMHC per APC, the number of selected cells decreased further (not shown).
As shown in Figure 4.23A-B, a single spMHC selected a repertoire with a wider range of MHC affinity
in comparison to the repertoire selected by diverse spMHCs, indicating that the thymic output by a single
spMHC was less self-MHC-biased. Therefore, the fact that T cells specific to different allogeneic MHCs
exist in the single spMHC-based model is a natural result in the framework of the presented model of
thymic selection. Nearly 20% of the cells positively selected in the model based on diverse spMHCs were
also positively selected in the model based on single spMHC. This overlap was decreased to 10% by negative
selection, which shows that the thymic outcome is different in both models. This is consistent with the
observations that TCRs with known specificities were not selected by single spMHC, despite being selected
in normal mice which express diverse spMHCs [122–124].
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Figure 4.22: Impact of APC availability on self-MHC-bias. The correlation coefficient between SSL of
thymocytes and their MHC affinity in thymuses with varying cell number ratio of APCs to thymocytes.
Figure 4.23: Thymic selection with single peptide. (A) Fraction and of pre-selection thymocytes and (B)
number of thymocytes that are selected by single spMHC (solid line) versus diverse spMHCs (dashed line)
in dependence on their MHC affinity. Compared to a selection based on diverse spMHC presentation, a
restriction of APC presentation to a single spMHC leads to selection of thymocytes with a wider range of
MHC affinities.
The relative number of selected cells in both models was dependent on the specificity parameter r that
controls the relevance of specific adjacency matching sites (see Model section 4.2). By considering low
values of r, and keeping the same SSL- and TSL-selection thresholds, the number of positively selected
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cells in the single spMHC-based model was higher than in the diverse spMHCs model (not shown) which
is not consistent with experimental observation. Consistency between model and experiment was found
with r ≥ 7, which emphasizes the relevance of specific adjacency matching sites [see equation (4.4)]. The
biological implication of requiring such a large specificity parameter (r) is that for a signal-integration-
based positive selection, a group rather than sparse complementing features between binary sequences is
required in TCR-spMHC interactions during thymic selection; otherwise, positive selection would become
highly and unrealistically peptide-promiscuous (peptide-independent).
4.3.10 MHC-restriction versus MHC-bias: after thymic selection, T cell
recognition is self-MHC-biased but not self-MHC-restricted
It has been suggested that thymic selection biases the T cell repertoire towards recognizing foreign peptides
in the context of the selecting-MHCs, referred here as self-MHC-bias (see [125] for a review and Figure
4.2 for the concept of MHC-restriction). However, T cell responses are not self-MHC-restricted as T cells
selected with one MHC may respond to other (allogeneic) MHCs as well [126, 127]. Here, we assessed
the degree of MHC-bias and MHC-restriction in our model by an in silico alloreactivity experiment. First,
33 distinct MHCs with different levels of similarity to self-MHC were taken as allo-MHCs. Among the
foreign-peptide sequences, 100 sequences were combined with these allo-MHC sequences. Then, all the
pre-selection cells were stimulated with APCs fully loaded with one of these combinations and categorized
based on the fates they would have during thymic selection. The negative selection TSL-threshold was
used as activation threshold. The level of alloreactivity to each allo-MHC was measured by examining the
extent of T cell cross-reactivity to allo-MHCs, i.e. the number of foreign-peptides (presented by alloMHC)
recognized by each T cell. The distributions of T cell cross-reactivity to each allo-MHC were compared
with respect to the degree of similarity between allo- and self-MHCs (Figure 4.24).
The T cell repertoire selected with diverse spMHCs was more reactive to the self-MHC than to allo-
MHCs. Further, the level of alloreactivity depended on how similar the examined allo-MHCs were to
the self-MHC. This result shows that thymic selection does not guarantee self-MHC-restriction, despite
imposing self-MHC-bias for recognition of foreign peptides. The cells selected with diverse spMHCs were
more biased to the self-MHC than the cells selected by single spMHC (Figure 4.24A, compare gray and
black boxplots). This is an additional support for the result given in Figure 4.21, showing that diversity
of self-peptides was required for self-MHC-biased T cell recognition.
Next, the contribution of positive and negative selection in MHC-restriction was assessed by performing
the same analysis on the cells that were either not positively selected or eliminated by negative selection
(in a thymus with diverse spMHCs). In that way, the cells that were both neglected and negatively selected
(the cells existing in dotted area of Figure 4.12) were included in both pools, making sure that the impact
of positive and negative selection were examined independently.
The distributions of cell cross-reactivity to each allo-MHC were compared with respect to the degree of
similarity between allo- and self-MHCs (shown in Figure 4.24B). The result shows that positive selection
was more efficient than negative selection in avoiding the cells recognizing allo-MHCs that were not similar
to self-MHCs. However, with increasing the similarity to self-MHC negative selection became more efficient
and the efficiency of positive selection decreased.
Another way to quantify the efficiency of positive and negative selection in restricting alloreactivity is
to look at the number of cells that can be activated by each foreign-peptide presented by an allo-MHC.
This number was averaged over 100 foreign-peptides per allo-MHC. The average was then normalized to
the population size of each repertoire (Figure 4.24C). The same trend of efficiencies as Figure 4.24B
was found.
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Figure 4.24: Self-MHC-bias versus self-MHC-restriction of T cell repertoire. (A) A set of 100 foreign-
peptide sequences were combined with a set of allo-MHC sequences. For each of allo-MHCs, all the cells
were stimulated for 2 days by allogeneic APCs fully loaded with a single-type foreign-peptide-allo-MHC.
(A,B) The cross-reactivity to each stimulating-MHC, i.e. number of foreign-peptides recognized by each
cell, was obtained. These distributions were compared for all allo-MHCs with respect to the degree of
similarity between allo- and self-MHC. Similarity is measured by equation (4.4) using the sequence of one
MHC and the complementary sequence of another MHC. The analysis was done for (A) cells selected by
single or diverse spMHCs, and (B) for cells removed from the repertoire in different stages of selection
with diverse spMHCs. Box-plots show median and quartiles. (C) Reactivity to foreign peptide, i.e. the
average number of cells activated by one foreign peptide was obtained for the repertoire of cells neglected
by positive selection or eliminated by negative selection. The plot represents the percentage of cells among
their corresponding repertoire.
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4.4 Discussion
4.4.1 Selection of a self-MHC-biased T cell repertoire
Affinity of a TCR-peptide-MHC interaction is resulting from the combination of a peptide and a MHC
molecule rather than a peptide alone (see Figure 4.1). The signaling strength of a single TCR-peptide-
MHC interaction is not enough for a thymocyte to discriminate between the contribution of peptide
and MHC molecules. The requirement that T cells should recognize foreign peptides in the context of
their own individual MHC molecules for a proper immune response, implies that thymic selection should
impose a bias towards recognition of self-MHC in a pre-selection repertoire that potentially bears TCRs
with different MHC specificities. In this paper, we studied a potential mechanism allowing thymocytes
to extract information regarding their MHC- and self-peptide-specificities in the course of the selection
process.
We proposed a TCR signal integration model capturing the requirement of repeated interactions for
successful T cell selection/activation. From the TCR stimulation history generated by sequential interac-
tions with different spMHCs, two distinct components emerged, namely sustained and transient signaling
levels (SSL and TSL). The model showed that SSL is correlated with the TCR affinity to MHC, which can
serve as an indirect measure of MHC affinity to the cell. Indeed, we illustrated that a SSL-based positive
selection imposes a lower limit on the MHC affinity range of the repertoire, which gives a signal-based
explanation for the selection of a self-MHC-biased T cell repertoire (see Figure 4.13).
According to the model, the SSL relies on the frequency of successful (signal providing) interactions
during APCs scanning. To provide a positively selecting stimulus from the peptide component, positively
selecting self-peptides would have to be highly abundant in order to provide sustained signaling above the
SSL-threshold of positive selection. The observation that self-peptides are diverse and rare in the thymic
cortical region [105, 106] implies that finding enough positively selecting self-peptides for multiple subse-
quent interactions is unlikely. Since the common component in low-abundant spMHCs during sequential
interactions is the MHC sequence, the SSL largely correlates with the MHC affinity and less with the affinity
to self-peptides. Consequently, an increased abundance of self-peptides would result in an increased likeli-
hood of finding repeated and identical signal-providing sequences (for some TCRs) that may even exceed
the likelihood of finding signal-providing sequences in the MHC (if Lp > LMHC). Indeed, we showed that a
repertoire selected with an adundant single-type spMHC is less self-MHC-biased. This is further supported
by the observations that the repertoire selected with a single (and abundant) ligand is cross-reacting with
allogeneic APCs [48]. Therefore, presentation of diverse and low-abundant self-peptides by MHC molecules
is required in the thymus for efficient quantification of self-MHC affinity and selection of a MHC-biased T
cell repertoire.
According to Gemisch model, postulated by Bevan [50], a TCR could be positively selected by multiple
peptides with sufficient aggregate contribution, but with low affinity for each. This can naturally occur
in the signal integration model in two ways: multiple low affinity peptides can raise the avidity of one
thymocyte-APC interaction, but also different peptides in consecutive APCs can sustain an integrated
TCR signal sufficient for positive selection. According to our model, selection with a single spMHC could
not select cells that were selected based on diverse spMHCs, implying that in silico positive selection of
these cells depended on one or multiple other self-peptides. This prediction of the signal integration model
is in agreement with the gemisch selection model.
4.4.2 Negative selection and peptide specificity
In contrast to the sustained component of the TCR signaling, the strong transient increase (TSL) is a
property that occurs at specific interactions and harbors a more stochastic nature than the sustained
component (Figure 4.6). The emergence of a strong TSL could result from the ligation of TCRs with
cognate spMHCs, suggesting TSL as an indicator of self-peptide reactivity. Indeed, we showed that the
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TSL is correlated with the affinity of TCRs to the most specific spMHC in the ligand repertoire (Figure
4.9B). It can be concluded that the discrimination between sustained and transient components in TCR
signaling offers a mechanism for separate detection of self-MHC and cognate self-peptide.
We observed that a TSL-based negative selection reduced the self-reactive TCR repertoire. Negative
selection targeted TCRs with a wide-spectrum of MHC affinities with a dominant effect on the higher
end (Figure 4.13A-B). However, due to the stochastic nature of finding cognate spMHC in a limited
number of interactions, a TSL-based negative selection was prone to error, as experimentally detected [51].
Consistently, the model predicts that self-peptide reactive T cells exist in both nTreg and Tconv repertoires
which would cross the negative selection TSL threshold if a sufficient number of cell interactions were
allowed. In silico, increasing the frequency of interactions in thymus decreased the number of escaped
self-reactive cells.
4.4.3 Impact of selections on the cross-reactivity of repertoires
As extensively discussed by Mason [128], TCR cross-reactivity enables recognition of a larger spectrum
of peptides without requiring an enormous number of T cells that respond specifically to single foreign-
peptides. In our model, this cross-reactivity was already present in pre-selection repertoire and was pro-
nounced by positive selection during which cross-reactive cells were enriched (Figure 4.17). This guaran-
tees a comprehensive peptide coverage by the positively selected repertoire. However, a repertoire with cells
cross-reacting with self-peptides bears the potential of autoimmunity. Negative selection has to cope with
cells reacting with different affinities for a large range of peptides, and a 100% efficient negative selection
would delete all T cells because of cross-reactivity. Therefore, there is a tradeoff between self-tolerance
and cross-reactivity of the selected repertoire [128, 129].
4.4.4 The efficiency of positive and negative selection for MHC-restriction
depends on the extent of similarity between allo- and self-MHCs
It has been suggested that all MHC proteins in the genome of one species might share some features and
that germline-encoded TCR variable elements might have an inherent predisposition to react with these
shared features in all MHCs [127,130]. Although we did not assume any bias in random generation of TCR
sequences, we showed that in the case of existing similarities between selecting- and allo-MHCs, negative
selection is more efficient in MHC-restriction than positive selection. This in silico result is consistent
with the work of Huseby et al. [126,127] using single-point amino-acid mutations of the selecting-MHC to
assess alloreactivity in vitro. However, our model predicts the opposite trend in the case of dissimilar MHCs,
meaning that negative selection is not efficient to restrict alloreactive T cells. A noteworthy point is that
the conclusion drawn by Huseby et al. [126,127] that negative selection is responsible for MHC-restriction
relied on the assumption that a thymus with single-peptide presentation disrupts negative selection but not
positive selection. According to our model, cells that were not normally selected by diverse self-peptides
were selected based on single-peptide. Moreover, these cells were less self-MHC-biased. Therefore, the
results in [126,127] might be influenced by the cells that were not normally selected in a wild-type model.
Our result regarding the importance of negative selection in controlling the specificity of T cells to foreign
peptides by removing cross-reactive T cells is also in agreement with the work of Huseby et al. [126, 127].
4.4.5 Selection of regulatory T cells
It is believed that the activation of escaped autoreactive T cells is suppressed by regulatory T cells in the
periphery [131]. nTregs can be derived from antigens over-expressed in the thymus of TCR transgenic
mice, and the selected nTregs exhibit a high affinity to these antigens [54]. This suggests a self-peptide
specific repertoire of nTregs and led to the TCR instructive model. According to this view, self-specific
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TCRs generate nTregs whereas less self-specific TCRs (but more foreign specific) generate Tconvs (see
Figure 2.4A).
The TCR-instructive model predicts that the respective specificities of the Tconv and nTreg repertoires
are distinct and that the diversity of nTregs is limited by the diversity of selecting ligands in the thymus.
While several studies argued for distinct repertoires of Tconvs and nTregs [132,133], there is also evidence
for an overlap between them and for similar diversity [58–62]. Although the nTreg repertoire is a minority
of the whole CD4+ T cell population, nTregs can recognize both self- and foreign-peptides. One possible
explanation would be that nTreg activation is non-specific. There is evidence that the suppressive activity of
Tregs is triggered in an antigen-specific manner and relies on recognition of cognate antigen [55,67,134,135].
However, once Tregs are activated, they can suppress Tconvs with different antigen specificities in vitro
[67, 134] and in vivo [136–138], implying that they may suppress in a non-specific manner [139]. Another
possible explanation would be that the nTreg repertoire consists of cross-reactive TCRs. Cross-reactivity
was indeed observed in TCRs [120,121], but the extent of cross-reactivity in nTregs versus Tconvs has not
been experimentally evaluated. Here, we defined the nTreg population based on the observation that nTregs
show higher sustained signaling [53], and we managed to reproduce the aforementioned observations. We
found that, under the hypothesis of higher SSL, nTregs show higher MHC specificity (linked to sustained
signaling) as well as higher cross-reactivity (lower peptide sensitivity) compared to Tconvs.
In the model, cross-reactivity emerged from two different mechanisms. First, nTregs could recognize
foreign peptides since their higher MHC affinity removed strong bias toward self-peptides. Second, having
higher MHC affinity resulted in a higher level of signaling close to the level required for their activation.
Hence, they required less peptide affinity contribution for activation. This resulted in the recognition of a
wider range of activating ligands and represented a signal-based cross-reactivity (not affinity-based). This
nTreg cross-reactivity would be a way to allow 5% of the CD4+ population to recognize a broad spectrum
of possible peptides and be the safekeeper of immune activation, while Tconv are designed to be more
peptide-specific. In the model, we observed that peptides could activate both nTreg and Tconvs suggesting
that an immune reaction for these peptides would activate simultaneously a pro-inflammatory response and
a suppressive response. It would be of interest to know the amount of peptides recognized only by Tconv
as they could be more pathogenic, or the relative populations of nTregs versus Tconvs recognizing the
same antigen depending on its similarity to self-peptides. In the next chapter, I show that the ratio of
antigen-specific Tregs to Tconvs and their absolute numbers are the major determinants for the onset of
an immune response against the antigen [2].
Given an abundant source of signaling, any cell can become an nTreg according to the SSL-based
selection model. If diverse and low-abundant self-peptides are presented, the MHC affinity is the major
determinant of SSL. However, under the condition of high abundance of selecting self-peptides, our in-
tegration model would predict that self-peptide specific cells (existing in pre-selection repertoire due to
random TCR rearrangement) would be selected as nTregs. In the case of transgenic TCRs, an additional
requirement to become a nTreg would be to provide a peptide with sufficient affinity (in a level that does
not exceed negative selection threshold). In agreement with this, thymocytes differentiate to nTregs in
transgenic mouse models in which an additional selecting peptide is abundantly expressed [54]. In silico,
no nTregs would be selected if the quality of the abundant peptide is not high enough for the transgenic
TCR, consistently with experimental observations [54].
If the density of a particular self-peptide per APC was increased on a small fraction of APCs, it would not
be sufficient to sustain the TCR signal for nTreg differentiation. However, this would affect the efficiency
of negative selection. In a recent theoretical work by Bains et al. [87], the authors were able to recapitulate
in vivo experiments where a controllable expression of one agonist-peptide in the thymus leads to selection
of a varying number of nTregs and Tconvs from thymocytes with transgenic TCR [88]. Selection of T
cells in the work of Bains et al. was assumed to rely on the maximum and minimum thymocyte-APC TCR
signal strength. Tconv and nTreg repertoires were distinguished by an intermediate threshold between the
positive and negative selection thresholds. The over-expressed peptide had an affinity to the TCR that
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induce nTreg selection or deletion by negative selection. In an alternative scenario, the authors assumed
that the sensitivity of the TCR increased step-wise such that the interaction with the over-expressed peptide
led to different fates with time. This article gave insights on the impact of thymic selection manipulation
in vivo by over-expression of an agonist peptide for a transgenic TCR, and provided a simple mechanistic
explanation for the non-intuitive variation in the amounts of selected nTregs and Tconv. Note that cell
fates in the model of Bains et al. are determined by single interactions and independent of TCR stimulation
history, which is the focus in the present model.
4.4.6 Roles of TCRs on the borders of MHC-affinity spectrum
As shown, thymic selection imposes higher and lower limits on the MHC spectrum of the selected repertoire.
The low end of the MHC affinity spectrum encompasses Tconvs with higher average affinity to self-peptides
as a consequence of the pressure of positive selection. One could speculate that these cells would cause
autoimmunity and be potentially pathogenic. However, this has to be mitigated by the following ideas.
First, due to the low MHC affinity, they have the lowest SSL in the repertoire, which means that activation
under homeostatic conditions is hard. Furthermore, self-peptides could only activate them under over-
presentation condition by increasing the integrated signal level. This would not naturally happen unless
self-peptide disturbances occurred as a result of non-homeostatic conditions such as cancerous cells or self-
similar pathogens. Therefore, these cells would be good candidates to recognize such self-disturbances. I
explain this idea in the next chapter [2]. Secondly, they are less self-MHC-biased. Hence, upon interacting
with allogeneic APCs, they might recognize foreign MHCs. These are the cells that would reject grafts via
recognizing foreign MHCs on the donor’s APCs.
The high end of the MHC affinity spectrum contains Tconvs and nTregs with lower average affinity to
self-peptides as a consequence of the pressure of negative selection. We showed that these cells are more
cross-reactive for the peptides. However, they might be easily detected in the thymus due to their higher
SSL. Efficient negative selection or differentiation of these cells to nTregs are two processes that minimize
the risk of having a pathogenic autoreactive response.
According to the model, the borders of the MHC affinity spectrum change by variations in the diversity
of self-peptides that bind to a MHC molecule. In the extreme case, we showed that a selection with single
spMHC comprises cells with no MHC-bias.
4.4.7 Heterogeneity of antigen presentation in the thymus
Thymic APCs are heterogeneous in the type of self-peptides they present and in signaling resources they
provide to thymocytes (particularly by differential co-stimulation levels). Thymic APCs can be categorized
into cTEC and migratory DCs in the cortex and mTEC, migratory and resident DCs in the medulla.
Some peptides, denoted as private self-peptides [7], may only be presented by cTECs but by no other
thymic and peripheral APCs. Some other peptides are presented by all the cells, known as ubiquitous
peptides. AIRE-dependent Tissue-Restricted-Antigens (TRA) are presented by mTECs allowing to mimic
the peripheral self-peptides. Additionally, a spectrum of peripheral antigens is presented by migratory
DCs. As potential extensions to the model, such heterogeneity could be translated by considering sets
of peptides with different abundance [different values of F , see equation (4.11)] and density per APC: a
set of self-peptides with low-abundance but higher density to represent TRAs, and a highly abundant set
representing the ubiquitous peptides (presented by a higher fraction of APCs) [7].
Regarding the role of co-stimulation, as generally accepted in T cell activation, higher co-stimulation
provides higher signaling strength and increases the sensitivity of T cells to antigen stimulation [140]. By
assuming this property, the model can potentially be adapted in two ways by either associating different co-
stimulation levels to particular peptides i.e. allowing muliple copies of particular self-peptides on APCs; or
by associating co-stimulation to particular APCs i.e. provide a stronger TCR signal integration rate (higher
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α, see Table 4.1). Incorporating heterogeneity of APCs and self-peptides in a realistic biological way would
increase the number of unknown parameters (e.g. the number of APCs of each kind, the difference in
peptide presentation capacity and co-stimulation expression heterogeneity, the degree of abundance of each
different type of self-peptides) and would therefore reduce the predictive power of the model. Therefore,
we restricted ourselves to simpler representations of APCs and reserve the distinction of different APC
subsets to future work.
4.5 Summary
The extent of TCR self-reactivity is the basis for selection of a functional and self-tolerant T-cell repertoire,
and is quantified by repeated engagement of TCRs with a diverse pool of self-peptides complexed with
self-MHC molecules. The strength of a TCR signal depends on the binding properties of a TCR to the
peptide and the MHC, but it is not clear how the specificity to both components drive fate decisions. In this
chapter, we proposed a TCR signal-integration model of thymic selection that describes how thymocytes
decide among distinct fates, not only based on a single TCR-ligand interaction, but taking into account
the TCR stimulation history. These fates are separated based on sustained accumulated signals for positive
selection and transient peak signals for negative selection. This spans up the cells into a 2-dimensional space
where they are either neglected, positively selected, negatively selected, or selected as natural regulatory T
cells (nTregs).
We showed that the dynamics of the integrated signal can serve as a successful basis for extracting
specificity of thymocytes to MHC and detecting the existence of cognate self-peptide-MHC. It allows to
select a self-MHC-biased and self-peptide-tolerant T cell repertoire. Further, nTregs in the model are
enriched with MHC-specific TCRs. This allows nTregs to be more sensitive to activation and more cross-
reactive than conventional T cells. The presented model provided a mechanistic model showing that the
time integration of the TCR-mediated signals, as opposed to single-cell interaction events, is needed to
gain a full view on the properties emerging from thymic selection. See Figure 4.25 for a summary and
highlights of signal integration model of thymic selection.
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Figure 4.25: A summary for signal integration model. Thymocytes are generated, selected and mature in
the thymus to create a diverse, functional and self-tolerant T cell repertoire. Self-reactivity of thymocytes
is quantified by repeated engagement of their TCRs with a diverse repertoire of self-peptides complexed
with self-MHC molecule (spMHC) and may originate from either part of the complex. The fact that the
selected T cell repertoire is MHC-biased, requires a good mechanistic explanation of how thymocytes are
able to quantify their affinity to MHC. In order to analyze how thymocytes quantify their self-reactivity,
extract their MHC affinity, and how they use this information for cell fate determination, we developed
a signal integration model for thymic selection, mimicking the requirement of repeated TCR signaling for
successful selection and cell maturation. (A) A polyclonal repertoire of thymocytes sequentially interact
with diverse spMHCs and integrate the affinity-dependent TCR ligation signals. Proteins are represented
by binary sequences. Binding affinity between TCR and self-peptide-MHC (spMHC) depends on the
complementarity of sequences. (B) Schematic for a dynamic change of integrated TCR signal (ITS) upon
sequential interactions with APCs presenting diverse and low-abundant spMHCs is shown. The sustained
signaling level (SSL) is determined by the minimum value of the ITS in a window of sequential interactions.
The transient signaling level (TSL) is defined as the maximum ITS value in the same window of interactions.
SSL and TSL are individual properties of thymocytes and correlate with MHC affinity and cognate spMHC
affinity, respectively. In thymic selection model, both the strength and dynamics of the integrated signal is
taken as a reference for cell fate determination. (C) MHC and cognate self-peptide affinities are segregated
by the sustained and transient components of ITS. Therefore, quantification of the integrated signal and
discrimination between its sustained and transient dynamics turns out as a successful basis for extracting
affinity of thymocytes to MHC, detecting the existence of cognate self-peptide, and selecting a MHC-biased
self-tolerant T cell repertoire. We provided a mechanistic model that questions the view that affinity to self-
peptides is the major determinant of cell fates in thymic selection and highlights two central points instead:
MHC specificity and peptide specificity are different properties of TCRs, and the time integration of the
TCR-mediated signals during APCs scanning is necessary to gain a full view of the properties emerging
from thymic selection.

Chapter 5
Immune activation model
The sections of this chapter are partially reprinted from published article [2], which can be accessed by the
link: http://journal.frontiersin.org/article/10.3389/fimmu.2013.00474/full.
5.1 Background
The immune system is continuously exposed to a wide variety of disturbances. Such disturbances are
recognized by T cells via antigen presentation. Antigen presentation is a process in which antigen presenting
cells (APCs) capture the antigens, break them into small peptides, combine them with MHC molecules and
present them on the cell surface, thus enabling their recognition by T cells [141–143]. Antigen presentation
process is described in Figure 2.5). The majority of disturbances that the immune system encounters are
pathogenic nonself (foreign). Since the APCs break down the nonself antigens into smaller peptides and
present them on their surface, the presented peptide of nonself antigen might share some similarities with
self peptides [144, 145]. In addition, rapidly evolving nonself pathogens, such as Hepatitis C virus, might
acquire similarities to self antigens by high rate of mutation [146]. Apart from nonself, altered self such
as cancer cell is also a disturbance that has to be recognized by the immune system. Therefore, an
ideal immune system has to find a solution for dealing with nonself, self-similar nonself, and altered self
disturbances (Figure 5.1).
As a general solution, the immune system generates T cell clones in thymus with random specificities
that could potentially recognize any peptide, including self-peptides. The classical idea that the T cell
repertoire has to be self-tolerant and T cells should not react to self-peptides, assumes that self-reactive
T cells should be eliminated in the thymus. This assumption is partially true, as T cell clones which fully
recognize self-peptides in the thymus undergo clonal deletion, in the so-called negative selection process
[147, 148], which is studied in chapter 4.
The self-tolerance resulting from negative selection is called central tolerance. A stringent central
tolerance induction and deletion of all autoreactive T cells is believed to create holes in the specificity
space of the T cell repertoire [149, 150] by removing T cells that are able to initiate immune responses
against self-similar nonself and altered self. Such holes may facilitate persistence and growth of cancer
cells. Further, they allow highly mutating pathogens to acquire self-similar structures and take advantage
of self-tolerance. Hence, a too stringent central tolerance does not seem beneficial. In line with this
idea, there is evidence that negative selection only partially deletes autoreactive T cells mainly because
availability of self-peptides required for negative selection in the thymus is limited. Additionally, T cells
spend only a limited time in the thymus and may not interact with high-affinity self-peptides [151–153].
In silico, we also observed that some self-reactive thymocytes escape the negative selection chapter 4.
Autoreactive T cells normally exist in healthy individuals and are quiescent in the presence of their cognate
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self-antigen [154]. However, involvement of escaped autoreactive T cells in autoimmunity has been shown
[155].
Escaped autoreactive T cells are under the control of peripheral tolerance mechanisms in healthy
individuals. A prominent mechanism of peripheral tolerance among others (reviewed in [156]) is induced by
CD4+ Foxp3+ regulatory T cells (Tregs) [8]. The majority of these cells, known as natural Tregs (nTreg),
are hypothesized to be selected from self-reactive T cells in the thymus [54,157] (see Figure 2.4A for TCR
instructive model of nTreg selection). Tregs suppress effector functions of conventional T cells (Tconvs)
and by that, regulate the immune response.
Despite the necessity of suppression by Tregs for avoiding autoimmunity [158, 159], production of a
too large amount of Tregs by the thymus might prevent beneficial effector responses. Therefore, a too
stringent induction of peripheral tolerance by selection of a large number of Tregs in the thymus does not
seem favorable.
In the view of this background, how does the immune system balance the tolerance mechanisms in
order to ensure immune responses to any type of disturbances including self-disturbances, yet being tolerant
to self in a healthy homeostasis? Here, we address this question by using a mathematical model of immune
activation that relies on identical components for self and nonself, i.e. using the same set of ordinary
differential equations. The proposed model considers the thymic production of Tregs and Tconvs as well as
the dynamic interplay between Tregs, Tconvs and IL-2 molecules in the presence of antigen(Ag)-stimulation
in the periphery. The model is exploited to reveal the parametric regime of the immune system in which
an immune response against self is restricted, but not impossible.
The interplay between Tregs and Tconvs during immune responses is a topic of extensive mathematical
modeling [25–27, 160–163]. Leo´n and co-workers [160] proposed a series of models for studying immune
tolerance by considering APCs, Tconvs and Tregs. Their models rely on the assumption that regulatory
interaction between Tregs and Tconvs takes place only in simultaneous conjugation with an APC. As a
result of this assumption, efficient suppression of Tconvs requires a minimum population of Tregs per APC
[164]. As an extension, a crossregulation model is proposed by Carneiro and co-workers [26] in an attempt
to incorporate Tregs in a coherent theory of the immune system. Their model shows a bistable behavior.
Bistability is a property of dynamical systems with two stable steady states. In such systems, depending
on the initial condition, the states of the system evolve towards one or the other steady state (see Figure
5.2). According to crossregulation model, immunity to a given Ag arises as competitive exclusion of Tregs
by the expansion of Tconvs, and tolerance results from limited APC availability or above threshold Treg
Figure 5.1: Conceptual figure of different disturbances in the immune system. Pathogenic nonself are
recognized and attenuated by nonself-specific T cells. However, recognition and attenuation of altered
self and self-similar nonself disturbances are challenging for the immune system due to the existence of
self-tolerance mechanisms; without self-specific immune cells, the immune system is not able to initiate an
immune response against these disturbances.
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Figure 5.2: Stable, unstable and bistable dynamical systems. In a 1-dimensional dynamical system x˙ =
f(x), equilibrium points can be determined by the slope in intersections of dynamic function f(x) with
the x-axis. (A) Equilibrium point is attractor when the slope of the dynamical function is negative and
corresponds to a stable state for perturbations. (B) Equilibrium point is repellor when the slope of the
dynamical function is positive and corresponds to an unstable state for perturbations. (C) A bistable
dynamical system has two attractors, separated by an repellor. Unlike systems with only one attractor,
a bistable dynamical system exhibit a threshold associated with the presence of repellor between two
attractors. While each attractor corresponds to a stable state for small perturbations, when the magnitude
of the perturbation exceeds a critical threshold, the system can cross the potential barrier imposed by the
repellor, and move from one attractor to the other.
numbers. Since the interactions between Tregs and Tconvs is assumed to depend on the density of the
APCs, increasing the APC availability decreases the simultaneous conjugate formation of Tregs and Tconvs
with the same APCs and hence, it is sufficient to break the immune tolerance.
An alternative concept was brought forward in a model proposed by Carneiro and co-workers [161] that
assumes APC-independent interactions between Tconvs and Tregs for immune suppression which will be
also used in our model. A direct suppressive interactions of Tconvs and Tregs was identified by experiments
[139]. The authors concluded that efficient immune suppression still requires a minimum population of
Tregs regardless of the number of APCs.
In contrast to the aforementioned studies, we do not consider the conjugate formation of Tregs and
Tconvs with APCs and therefore, there is not a competition between these cells for Ag presented by APCs.
Instead, the role of APCs is indirectly captured by an Ag-stimulation factor which is the activation rate of
na¨ıve T cells and resting Tregs with identical Ag-specificity by APCs that present cognate Ag. In addition,
we explicitly consider the dependency of Tregs on Tconvs through the growth factor IL-2.
Burroughs and co-workers [25] investigated Treg-induced inhibition of cytokine secretion by effector T
cells. By assuming that Tregs are activated by self Ag and locally maintained by nonlinear competition
for tissue-derived cytokines that are solely utilized by Tregs, the authors analyzed the role of local active
Treg population size in the balance between suppressor and effector responses. Stimulation of Tregs and
Tconvs is described by independent parameters. In contrast to their model, thymic output maintains the
homeostatic population of Tregs in our model. Another essential difference is that Ag-stimulation of Tregs
and Tconvs is described with a unified self-nonself concept and Tregs are assumed to also respond to
nonself Ag-stimulation, which has been shown experimentally [69].
Parametric steady state and stability analysis of the model provides insights about the physiological
range of model parameters, and determines the overall conditions under which immune responses against
self are possible. Furthermore, the impact of model parameters on the requirements for the initiation of
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immune reactions against self is analyzed. The model proposes that disturbed homeostatic balance between
autoreactive T cells and Tregs increases the susceptibility to autoimmunity or cancer.
5.2 Model
For constructing a simple immune activation model, the conceptual and hierarchical modeling approaches
are taken (described in 3.1.1 and 3.1.3 respectively). In the conceptual modeling approach, it is aimed
to model the qualitative behavior of the immune response. However, a data-driven modeling approach
can be taken once the experimental data exist. As the simplest model, only essential components of an
effector immune response is considered. These components include the dynamics of Tconv activation,
Tconv proliferation and secretion of growth factor IL-2. Then, the compatibility of the model to the
immune system is discussed. If the model cannot be validated in a qualitative fashion, by taking the
hierarchical modeling approach, additional complexities are incrementally added to the model to a degree
allowing for validation and analysis of tolerance versus immunity. This approach allows us to investigate
the contribution of added complexities and biologically relevant range of their associated parameters. The
scheme of the most complex model in this study is depicted in Figure 5.3, which is constructed and
analyzed in sequential steps. Note that the model is conceptually independent of the self/nonself nature of
the immune response. Instead, differences in the immune responses against self versus nonself are derived
from different parameter values of the same model.
5.2.1 Conventional T cell response: an immune response requires sufficient
division and IL-2 secretion of activated T cells
In peripheral lymphoid organs, only a few T cell clones in the na¨ıve Tconv pool are able to recognize an
antigen. Effector functions of a few activated Tconv are not sufficient to effectively remove a pathogen,
especially pathogens with high growth rate. Therefore, a growth mechanism in activated T cell population
would allow the expansion of a few initially activated T cells. This growth mechanism is mainly via
growth factor IL-2 which is secreted by activated Tconvs. IL-2 secretion and consumption by activated
T cells lead to T cell division and production of daughter cells. This processes is called cell proliferation.
An effective immune response arises from massive proliferation of activated T cells and their subsequent
effector functions. Our simplest model attempts to capture the dynamic characteristics of such expansion
in T cells population (represented by T ) by secretion and consumption of IL-2 molecules (represented by
I)
T˙ (t) = aI(t)T (t)− bT (t),
I˙(t) = dT (t)− eI(t)T (t)− fI(t). (5.1)
In model (5.1), activated T cells have a mean lifespan 1/b, and secrete IL-2 (I) with rate d. Available
IL-2 decays with rate f and is consumed by activated T cells with rate e. Activated T cells are able to
proliferate in the presence of IL-2. This IL-2 dependent proliferation rate is a linear function of IL-2, in the
form of aI(t). The impact of considering a nonlinear proliferation rate (a Hill-function of IL-2) instead of
the linear term aI(t) will be given in section (5.2.5).
Remark: Model (5.1) with d = 0 and f < 0 is in the form of classical predator (Tconv) - prey (IL-2)
model. But this particular case of parameter range does not represent the regime of IL-2 dependent Tconv
proliferation. In contrast to predator-pray model, the production of IL-2 in model (5.1) depends on the
consumers of IL-2 when d 6= 0. Further, IL-2 molecules cannot reproduce themselves, meaning that f > 0.
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Figure 5.3: Model of dynamic interplay between conventional T cells and regulatory T cells: Nonself-specific
as well as some self-specific thymocytes that escaped negative selection in thymus and were not selected
as Tregs enter the periphery as na¨ıve T cells. A part of detected autoreactive thymocytes differentiate into
Tregs in the thymus and reside in the periphery in resting state. Upon Ag-stimulation by APCs, na¨ıve T
cells and resting Tregs become activated. In contrast to activated T cells, activated Tregs do not secrete
IL-2, but both activated populations proliferate in dependence on IL-2 [165]. Activated Tregs suppress
activated T cells in a cell-contact dependent and cytokine-driven manner. Activated T cells undergo Fas-
induced apoptosis by interacting with each other (fratricide). In contrast, Tregs are resistant to Fas-induced
apoptosis [166].
Proposition 5.1 Assume that all parameters are positive and ad − be > 0 in model (5.1), then there
exists a super-threshold for initial conditions that allow for unlimited proliferation of activated Tconvs, or
equivalently, limt→∞ T (t) =∞.
Proof. In order to show the existence of such super-threshold, we characterize the dynamical behavior of
the model (5.1) in its phase space. This model has two equilibrium points
(I1, T1) = (0, 0), (I2, T2) =
(
b
a
,
bf
ad− be
)
. (5.2)
The parameters of the model are representing biological processes and therefore, they are assumed to
be positive. According to (5.2), the nontrivial equilibrium point (T2, I2) is positive if and only if
ad− be > 0. (5.3)
The linear stability of equilibrium points can be determined from the sign of the real part of the
eigenvalues of linearized model in equilibrium points. An equilibrium point is asymptotically stable if all
eigenvalues of the Jacobian matrix J evaluated at the equilibrium point have negative real parts, and it is
unstable if at least one of the eigenvalues has a positive real part.
General notation: Time-variant states of the model are indicated explicitly with time argument (such
as T (t) and I(t)); states without time argument (such as T and I) indicates to steady state values.
The Jacobian matrix of model (5.1) is
J =
(
aI − b aT
d− eI −eT − f
)
. (5.4)
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From Jacobian matrix, the following characteristic polynomial can be obtained
Q(λ) = det(λIn − J) =
∣∣∣∣λ− aI + b −aT−d+ eI λ+ eT + f
∣∣∣∣
= λ2 + (eT + f + b− aI)λ+ (−afI + beT + bf − adT ). (5.5)
where In is the identity (unit) matrix of size n, and n is the number of states in the model. The eigenvalues
λ1,2 in trivial equilibrium point (I1, T1) are obtained by solving the following characteristic equation, which
is derived by evaluating characteristic polynomial (5.5) in (I1, T1)
Q(λ, I1, T1) = λ2 + (f + b)λ+ bf = 0. (5.6)
From quadratic equation above, λ1λ2 = bf is positive and λ1 +λ2 = −(f + b) is negative. Therefore,
eigenvalues λ1,2 are negative and the trivial equilibrium point (I1, T1) is asymptotically stable.
For checking the stability of nontrivial equilibrium point (I2, T2), the characteristic equation (5.6) is
obtained by evaluation of polynomial (5.5) in (I2, T2)
Q(λ, I2, T2) = λ2 +
(
afd
ad− be
)
λ− bf = 0. (5.7)
If we assume that condition (5.3) is satisfied, the coefficient of λ in (5.7) is positive. The sign of
coefficients in quadratic equation Q(λ, I2, T2) changes only once. According to Routh-Hurwitz stability
Criterion (RHC), only one eigenvalue in (I2, T2) has a positive real part. Therefore, the nontrivial equilib-
rium point (I2, T2) is a saddle point and unstable.
Remark: Equilibrium point x0 of saddle type in a system of differential equations x˙ = f(x), with
x ∈ Rn and the map f : Rn → Rn, has stable and unstable manifolds, denoted by W s(x0) and Wu(x0),
respectively. These manifold are defined as
W s(x0) := {x ∈ Rn| lim
t→∞φ
t(x) = x0}, (5.8)
Wu(x0) := {x ∈ Rn| lim
t→∞φ
−t(x) = x0}, (5.9)
where φt is the flow of the system. Trajectories on the stable (unstable) manifold converge to equilibrium
point x0 forward (backward) in time. Manifolds organize the dynamics on the phase space. For example,
stable manifolds may form boundaries of basins of attraction.
The stable manifold of saddle equilibrium point (I2, T2) imposes a threshold for initial conditions of the
model in which the activated Tconvs proliferate unlimitedly, i.e. limt→∞ T (t) = ∞, which in this model,
corresponds to a major immune response. This can be visualized by the phase portrait of the model as
shown in Figure 5.4. 
In the biological context, condition (5.3) imposes a quality constraint on activated T cell clones which
can enter a highly proliferative state. The condition implies that among T cell clones that are in the
activated state, only T cell clones with a sufficiently high proliferation rate (a) or IL-2 secretion rate (d)
are able to significantly contribute to the major immune response against Ag. Since both, the proliferation
and IL-2 secretion rate of activated T cells depend on the affinity/avidity of their TCR to the presented Ag
[168–170], condition (5.3) implies that the existence of T cell clones with sufficiently high specificity (high
affinity) for the presented Ag is required for induction of a major immune response. Similar implications
can be derived from a model that considers a nonlinear IL-2 dependent proliferation rate of activated T
cells (Model will be given in section 5.2.5).
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Figure 5.4: Qualitative phase portrait of Tconv response model (5.1). Stable equilibrium point (I1, T1)
is shown with black circle, and saddle equilibrium point (I2, T2) is shown in black circle. Arrows with
dashed line show trajectories of the model. In the phase plane, the stable manifold of saddle point
(shown with arrows with solid line) defines a separatrix curve in the phase plane that sharply distinguishes
the sub-threshold initial conditions, i.e. initial conditions that tends to stable equilibrium point as t →
∞, from super-threshold initial conditions that allow for unlimited proliferation of activated Tconvs, i.e.
limt→∞ T (t) =∞ and limt→∞ I(t) =∞. To compute stable manifold numerically, two initial conditions
can be considered that are slightly displaced from two different sides of saddle point along the direction
of the eigenvector with negative eigenvalue; an integration backward in time is an approximation to stable
manifold. For obtaining unstable manifold, two trajectories has to be computed by integration forward in
time. These trajectories start from initial conditions slightly displaced from two different sides of saddle
point along the direction of eigenvector with positive eigenvalue [167].
The major focus of central tolerance in thymus is to eliminate T cells with self-specific TCRs. Therefore,
it is unlikely that highly self-specific T cells escape from central tolerance, as they are more effectively
detected and eliminated in the thymus upon interactions with cognate self-peptides [152, 170]. It is thus
expected that autoreactive T cells in the periphery are less aggressive than the ones that undergo clonal
deletion in the thymus, and may not fulfill condition (5.3).
Remark: model (5.1) can be simplified to a dimensionless system by scaling variables in the following
way
τ = θtt, T̂ (τ) = θTT (t), Î(τ) = θII(t). (5.10)
By assuming the following parametric values for scaling factors
θt = b, θT =
b
e
, θI =
b
a
, (5.11)
model (5.1) is converted to the following simple form
˙̂
T (τ) = Î(τ)T̂ (τ)− T̂ (τ)
˙̂
I(τ) = p1T̂ (τ)− Î(τ)T̂ (τ)− p2I(τ) (5.12)
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where
p1 =
ad
be
, p2 =
f
b
(5.13)
are dimensionless parameters. The simplified model has less number of parameters and therefore, makes the
analysis easier. However, since we add additional mechanisms to model (5.1), the number of parameters
increases unless a new set of scaling factors is determined. Hence, we keep the model of Tconv response
in its initial form given in (5.1).
5.2.2 Homeostatic population and antigen stimulation: initiation of an
immune response requires a minimum homeostatic population of na¨ıve T
cells and antigen stimulation
Continuous thymic production of na¨ıve T cells maintains the peripheral number and diversity of mature na¨ıve
T cells [171], although involvement of other mechanisms such as homeostatic proliferation resulted from
stimulation of T cells with low-affinity self-antigens and IL-7 has been shown [172]. Upon Ag-stimulation
by activated APCs, which express both antigen and costimulation, na¨ıve T cells with high affinity/avidity
to the presented Ag become activated. Here, dynamics of the na¨ıve T cell population (denoted by N(t))
and T cell activation by Ag-stimulation (with rate β) are taken into account. It is assume that na¨ıve T
cells with identical Ag-specificity (one T cell clone) have a homeostatic population in the periphery that is
established by na¨ıve T cell renewal (with rate N0) and natural cell death (with rate g)
N˙(t) = f(N) = N0 − gN(t)− βN(t),
T˙ (t) = aI(t)T (t)− bT (t) + βN(t),
I˙(t) = dT (t)− eI(t)T (t)− fI(t). (5.14)
Note that coupling between added variable N(t) to model (5.1) is via the rate that na¨ıve conventional
T cells are stimulated (βN(t)) and enter to the activated state. In the case of β = 0, no coupling exists
between N(t) and other variables. T cell activation k(t) is defined as
k(t) = βN(t), (5.15)
which indicates to the number of na¨ıve T cells activated by Ag-stimulation (β) per unit of time.
Proposition 5.2 Assume that condition (5.3) is satisfied for model (5.14), and N0 is larger than a critical
T cell activation k−,
N0 > k−, (5.16)
with the following value for k−
k− =
adf
e2
(
1−
√
1− be
ad
)2
. (5.17)
By increasing Ag-stimulation β from β = 0, a critical point β− exists with the following value
β− =
gk−
N0 − k− , (5.18)
after which activated Tconvs proliferate unlimitedly, or equivalently, limt→∞ T (t) =∞.
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Proof. According to (5.18), a biologically meaningful (positive) value for β− that corresponds to k− exists
when N0 > k−. In the case of N0 < k−, no positive β− can be found. Next, we study the steady state
and linear stability of model (5.14) with respect to T cell activation (k), to prove that for k larger than
k− given in (5.17), we have limt→∞ T (t) =∞.
In the followings, we show that model (5.14) has either 2 or no equilibrium points depending on the
steady state value of T cell activation (k), and k− given in (5.17) is the critical point where the number of
equilibrium points in the model changes, such that for k > k− or equivalently, for β > β−, model (5.14)
does not have any positive equilibrium point and therefore, limt→∞ T (t) =∞.
The equilibrium points of model (5.14) with the definition of T cell activation k(t) given in (5.15) can
be obtained from the followings
N = k
β
= N0
g + β , (5.19)
I = dT
eT + f =
bT − k
aT
, (5.20)
(ad− be)T 2 + (ek − bf)T + fk = 0. (5.21)
According to (5.21), by keeping the assumption (5.3), the equilibrium points (T1,2), if exist, are positive
(T1,2 > 0) if the coefficient of T in (5.21) is negative
ek − bf < 0 → k < bf
e
. (5.22)
Otherwise, the equilibrium points T1,2 are negative (T1,2 < 0). According to (5.20), if T > 0, then I > 0.
The equilibrium values for T1,2 can be obtained from equation (5.21)
T1,2 =
−(ek − bf)±√(ek − bf)2 − 4(ad− be)fk
2(ad− be) . (5.23)
where (ad− be) > 0, according to assumption (5.3). Real equilibrium points T1,2 exists if
∆ = (ek − bf)2 − 4(ad− be)fk = (ek + bf)2 − 4adfk ≥ 0. (5.24)
Our aim is to obtain a range for T cell activation (k), in which real equilibrium points T1,2 exists. Therefore,
we have to obtain k+ and k− in which ∆ in (5.24) is zero. We can rewrite ∆ in (5.24) as ∆ = ∆1∆2,
where
∆1 =
(
ek + bf + 2
√
afdk
)
, ∆2 =
(
ek + bf − 2
√
afdk
)
. (5.25)
Since all the parameters are positive, ∆1 > 0. Hence, ∆ = 0 can only be resulted from equation ∆2 = 0,
which has the following roots
k+ =
adf
e2
(
1 +
√
1− be
ad
)2
, k− =
adf
e2
(
1−
√
1− be
ad
)2
. (5.26)
Model (5.14) does not have any equilibrium points for k− < k < k+, and two equilibrium points otherwise.
The number of equilibrium points differs between two sides of critical points k+ and k−, where the
bifurcation in the model occurs. It can be verified that by keeping assumption (5.3), we have
0 < k− <
bf
e
< k+. (5.27)
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Therefore, the existence criterion of equilibrium points (k < k− or k > k+) and the criterion for having
positive equilibrium points, given in (5.22), are combined to the following criterion
0 < k < k− (5.28)
In other words, for 0 < k < k−, condition (5.22) is satisfied and the model has two positive equilibrium
points. Further, for k > k+, condition (5.22) is not satisfied and model has two negative equilibrium points.
As shown, for k > k−, model (5.14) does not have any stable positive equilibrium point and therefore in
this caes, limt→∞ T (t) =∞. 
Next, as we learned that bifurcation occurs in k− and k+, we check the type of bifurcation by evalu-
ating the linear stability of model in equilibrium points. In the first case, consider that model (5.14) has
two different positive equilibrium points (0 < k < k−).
Lemma 5.3 Model (5.14) for 0 < k < k− has two equilibrium points of type stable node and saddle.
Proof. We evaluate the linear stability of the model in equilibrium points. The Jacobian matrix of the
model is
J =
−g − β 0 0β aI − b aT
0 d− eI −eT − f
 (5.29)
from which, the following characteristic equation can be obtained
Q(λ) = det
λ+ g + β 0 0−β λ− aI + b −aT
0 −d+ eI λ+ eT + f
 = Q1(λ)Q2(λ) = 0 (5.30)
where
Q1(λ) = λ+ (g + β), Q2(λ) = (λ− aI + b)(λ+ eT + f) + aT (eI − d). (5.31)
From Q1(λ) = 0, the model has a negative eigenvalue λ = −(g + β) for all equilibrium points. For the
other two remaining eigenvalues, equation Q2(λ) = 0 has to be checked for existence of positive roots.
We rewrite Q2(λ) in the form of Q2(λ) = λ2 + Uλ+ V , where the coefficients U and V are
U = eT + f + b− aI, V = −afI + beT + bf − adT. (5.32)
From (5.20) it can be easily verified that b − aI > 0 and hence, coefficient U is positive. Therefore, the
linear stability depends on the sign of coefficient V . We substitute I = dT/(eT + f), given in (5.20), in
coefficient V
V = − afd
eT + f T − (ad− be)T + bf. (5.33)
In order to determine the sign of V in equilibrium points, we simplify polynomial V by obtaining new
expressions with identical sign and from multiplication of V with positive expressions.
V1 = TV = − afd
eT + f T
2 − [(ad− be)T 2 + (ek − bf)T + fk] + k(eT + f). (5.34)
According to (5.21), the expression in the brackets of equation above is equal to zero. Then, V1 is simplified
to
V1 = − afd
eT + f T
2 + k(eT + f). (5.35)
5.2. MODEL 71
Next, we further simplify V1 like below
V2 =
1
k(eT + f)V1 = −
af
kd
(
dT
eT + f
)2
+ 1. (5.36)
From (5.20), we use I = dT/(eT + f) in V2 to obtain a I-dependent expression
V2 = −af
kd
I2 + 1. (5.37)
According to (5.20) and (5.21), values of equilibrium points I1,2 are:
I1 =
1
2
(
(ek + bf)−√∆
af
)
, I2 =
1
2
(
(ek + bf) +
√
∆
af
)
(5.38)
where I2 > I1 and ∆ is given in (5.24). Next, the sign of V2, which is similar to V1 and V , has to be
checked in the equilibrium points. By substituting the value of I2, given in (5.38), in V2, we have
V2(I2) = − 12fkad
[
∆ + (ek + bf)
√
∆
]
(5.39)
From the existence criterion of equilibrium points, we know that ∆ > 0, and parameters are positive.
Therefore, the expression inside bracket of equation above is positive and V2, V1 and V are negative for I2.
By reminding that coefficient U is positive, this equilibrium point has one positive eigenvalue and hence,
is saddle and unstable. With substituting I1 in V2 and using (5.24), we have
V2(I1) = −
√
∆
2fkad
[√
(ek + bf)2 − 4fkad− (ek + bf)
]
. (5.40)
It can be easily verified that expression inside brackets of equation above is negative, and therefore, V2, V1
and V are positive for I1. Thus, all the eigenvalues in (I1, T1) are negative and hence, it is asymptotically
stable.
From the linear stability analysis presented above, it is shown that by increasing k from k < k−, a
bifurcation occurs at k = k− which results from coalescence of saddle point (I2, T2) and stable node
(I1, T1). This is called a fold or saddle-node bifurcation (described in section 3.2.1.4). 
Lemma 5.4 Model (5.14) for k > k+ has two equilibrium points of type unstable node and saddle.
Proof. We evaluate linear stability of the model in equilibrium points. For this, it is sufficient to obtain
the sign of coefficients U and V in (5.32). Remind that for k > k+, two real equilibrium points exist and
the steady state values of T1,2 are negative. From (5.20), the equilibrium values of I1,2 are positive when
T1,2 < 0. From (5.20), and the fact that T < 0, we have
T = k
b− aI < 0→ b− aI < 0. (5.41)
From (5.20), and the fact that I > 0 and T < 0, we have
I = dT
eT + f > 0→ eT + f < 0. (5.42)
Therefore, coefficient U in (5.32) is negative, and at least one positive eigenvalue exists in both equilibrium
points. Next, we check the sign of coefficient V in equilibrium points. From (5.20), we use T = k/(aI−b)
in V to obtain I-dependent expression below
V = −f(aI − b) + (ad− be) k
aI − b . (5.43)
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We simplify polynomial V by multiplication with positive expressions. From (5.20), we use aI−b = −k/T ,
which is a positive expression since T < 0
V2 = (aI − b)V = −f(aI − b)2 + (ad− be) k = −f k
2
T 2
+ (ad− be) k. (5.44)
V3 =
T 2
fk2
V2 = −1 +
(
ad− be
fk
)
T 2. (5.45)
The sign of V3 in (5.45), which is the same as the sign of V in (5.32), is determined by substituting T1,2
with their equilibrium values given in (5.23)
V3(T2) =
1
4(ad− be)fk [2∆− 2
√
∆(ek − bf)] (5.46)
By referring to our assumption in (5.3), the sign of V3 in (5.46) only depends on the sign of the expression
inside the brackets. Further, we have considered the case k > k+ in Lemma 5.4; therefore, according
to (5.27), (ek − bf) > 0. The fact that we are studying real equilibrium points implies that ∆ given in
(5.24) is positive. By substituting ∆ from (5.24) in (5.46), it is easily verified that V3, or equivalently,
V is positive in (I2, T2). By reminding that the coefficient U in (5.32) is also negative for (I2, T2), this
equilibrium point has only one positive eigenvalue. Hence, (I2, T2) is a saddle and unstable equilibrium
point.
For (T1, I1), we have
V3(T1) =
1
4(ad− be)fk [2∆ + 2
√
∆(ek − bf)] (5.47)
By referring to our assumptions in (5.3), and knowing from k > k+ and (5.27) that (ek − bf) > 0, and
the fact that we have real equilibrium points (∆ > 0), it is easily verified that V3 in (5.47), or equivalently,
V is positive for (I1, T1). By reminding that the coefficient U in (5.32) is negative for (I1, T1), therefore,
the equilibrium point (T1, I1) has two positive eigenvalues and hence, it is unstable node. Note that by
decreasing k from k > k+, a bifurcation occurs at k = k+ which is resulted from the coalescence of a
saddle and an unstable node. 
In summary, model (5.14) has either 2 or no equilibrium points dependent on the steady state value
of T cell activation (k). According to the bifurcation diagram of the model depicted in Figure 5.5, which
is obtained by treating k as bifurcation parameter, model (5.14) has no biologically meaningful (positive)
equilibrium points for k > k−, with k− given in (5.17), which corresponds to the unlimited proliferation
state of activated T cells. Therefore, condition k > k− has to be satisfied for initiation of an immune
response. However, according to (5.19), the steady state value of T cell activation (k) is
k = βN0
g + β (5.48)
which is limited by rates of na¨ıve T cell renewal (N0) and Ag-stimulation (β). Therefore, according to
(5.48) and the requirement of k > k− for initiation of a major immune response, there exists an Ag-
stimulation range β > β−, with β− given in (5.18), in which an immune response is initiated if condition
(5.16) is satisfied. Condition (5.16) implies that the renewal rate of na¨ıve T cells plays a critical role
for the initiation of immune responses. Without a sufficient renewal rate of na¨ıve T cells, the immune
response cannot be initiated by any Ag-stimulation. Instead, Ag-stimulation results in a subcritical immune
response which is interpreted as insufficient for pathogen clearance. By increasing the proliferation rate
or IL-2 secretion of activated T cells or the renewal rate of na¨ıve T cells, the threshold of Ag-stimulation
required for initiation of an immune response is decreased (see equations (5.17) and (5.18)). Therefore,
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Figure 5.5: Bifurcation diagram of T cell activation model (5.14) by treating k as bifurcation parameter.
Stable (node) and unstable (saddle) equilibrium points are shown by black and red lines, respectively. A
fold bifurcation at k = k− occurs which is resulted from coalesce of saddle and stable node. For k > k−, no
stable equilibrium point exists and the immune response enters the regime of unlimited T cell proliferation,
i.e. limt→∞ T (t) = ∞. In the immune system, despite massive T cell proliferation, T cell population is
limited to a high cell number. Such saturation cannot be represented by model (5.14). Numerical result is
obtained with parameters given in table 5.1.
central tolerance in thymus is able to tune the initiation criterion of self reaction not only by limiting the
quality of autoreactive T cells, but additionally by restricting the renewal rate of autoreactive T cells. As
central tolerance does not limit nonself-specific T cells, according to the model, these cells exhibit a lower
threshold of activation by nonself Ag-stimulation.
5.2.3 T cell fratricide: a mechanism to limit but not to suppress immune
responses
The immune response in model (5.14) is characterized by unlimited proliferation of activated T cells which
is physiologically unrealistic. The linear death term that represents natural death of activated T cells in
model (5.14) is not sufficient to limit cell proliferation. Any other linear death term, such as b̂T (t), is
incorporated to natural cell death rate (b)
T˙ (t) = aI(t)T (t)− bT (t)− b̂T (t) + βN(t) = aI(t)T (t)− (b+ b̂)T (t) + βN(t) (5.49)
By defining b¯ = b + b̂, modified model keeps the structure as is in (5.14). By replacing b with b¯ in the
analysis given for model (5.14), it is verified that still a saturated T cell level cannot be achieved. Therefore,
such saturation requires a nonlinear limiting factor.
A potential mechanism of limiting the immune response is activation-induced cell death (AICD) in
activated T cells, known as fratricide [173]. Upon T cell activation, death ligand (FasL) and receptor (Fas)
proteins are expressed on the surface of T cells. Followed by expression of these proteins, T cells eliminate
themselves in a cell contact-dependent manner. A death mechanism based on cell contacts requires a cell
density-dependent death term. If it is assumed that cells are well-mixed in the space and meet randomly,
the rate of cell contacts and consequently, fratricide death rate increases if the number (or density) of cells
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increases. If the number of cells are doubled, the potential encounter for each cell is doubled. Additionally,
the number of cells that can make cell contacts is also doubled. Therefore, the total number of encounters
in the system is quadruples. In general, encounter rate of cells is proportional to T 2(t); assuming a constant
rate (c) of Fas-mediated fratricide for each cell encounter, the overall rate of cell death is represented by
a nonlinear death term cT 2(t) [173]:
N˙(t) = f(N) = N0 − gN(t)− βN(t),
T˙ (t) = aI(t)T (t)− bT (t)− cT 2(t) + βN(t),
I˙(t) = dT (t)− eI(t)T (t)− fI(t). (5.50)
In the following, we obtain a proper range for fratricide-associated death rate c, in which a saturated level
for the population of activated Tconv is obtained.
Proposition 5.5 In model (5.50), assume that condition (5.3) is satisfied and β = 0. There exists a critical
value c− for fratricide-associated death rate, with the following value
c− = f−1(
√
ad−
√
be)2, (5.51)
such that for
0 < c < c− (5.52)
model (5.50) is bistable with two stable nodes. The larger stable node corresponds to a saturated level for
the population of activated Tconv.
Proof. First, we analyze the number and linear stability of equilibrium points of model (5.50) in the case
of β = 0, i.e. no coupling exists between N(t) and the other two variables T (t) and I(t) in (5.50). These
equilibrium points are
I1 = 0, T1 = 0, N1 =
N0
g
, (5.53)
N2,3 =
N0
g
, (5.54)
ceT 2 + (cf + be− ad)T + bf = 0,
 T2 = −
1
2ce (− (cf + be− ad)−
√
∆)
T3 = − 12ce (− (cf + be− ad) +
√
∆)
∆ = (cf + be− ad)2 − 4cfbe
(5.55)
I2,3 =
cT2,3 + b
a
. (5.56)
According to (5.55), equilibrium points T2,3, if exist, are positive only if
cf + be− ad < 0→ c < f−1(ad− be) (5.57)
Model (5.50) has two different real equilibrium points T2,3 when
∆ = (cf + be− ad)2 − 4cebf = f2c2 − 2f(ad+ be)c+ (ad− be)2 > 0. (5.58)
The above condition is equivalent to the following condition
{c < c−} ∪ {c > c+} (5.59)
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where [
c− = f−1
(√
ad−
√
be
)2]
< f−1(ad− be) <
[
c+ = f−1
(√
ad+
√
be
)2]
(5.60)
Therefore, according to (5.57), (5.59) and (5.60), two positive equilibrium points exist only if
0 < c < c−. (5.61)
Next, we assume that the condition (5.61) is satisfied, and we analyze the stability of the equilibrium
points. The Jacobian matrix is
J =
−g − β 0 0β aI − b− 2cT aT
0 d− eI −eT − f
 (5.62)
from which the following characteristic equation is obtained
Q(λ) = det
λ+ g + β 0 0−β λ− aI + b+ 2cT −aT
0 −d+ eI λ+ eT + f

= (λ+ g + β)(λ2 + Uλ+ V ) (5.63)
where
U = eT + f + b− aI + 2cT, V = −afI + 2ceT 2 + beT + bf + 2cfT − adT. (5.64)
All the equilibrium points have a negative real eigenvalue λ = −g − β. For determining the type of other
eigenvalues, the sign of coefficients U and V in (5.64) has to be checked in equilibrium points. These
coefficients are positive for (N1, T1, I1) and therefore, all eigenvalues have negative real values. Hence,
(N1, T1, I1) is asymptotically stable. For stability analysis of other equilibrium points, the sign of U and
V in (5.64) has to be analyzed. We use b− aI = −cT from (5.56) in U
U = eT + f + cT. (5.65)
According to (5.65), coefficient U is positive for positive equilibrium points (T2,3 > 0). Therefore, the
stability depends on the sign of V in (5.64). We use b− aI = −cT from (5.56) in V
V = ceT 2 +
[
ceT 2 + (cf + be− ad)T + bf]− bf = ceT 2 − bf. (5.66)
According to (5.55), the expression inside the brackets of equation above is zero. Then, V is simplified to
V = ceT 2 − bf. (5.67)
We evaluate coefficient V at equilibrium point T3 given in (5.55)
V (T3) =
√
∆
2ce
(√
∆− (cf + be− ad)
)
, (5.68)
where ∆, given in (5.57), is positive since we are considering the case that real equilibrium points exist
by assuming (5.61). According to (5.57), it is verified that V in (5.68) is positive and hence, equilibrium
point (N3, T3, I3) is a stable node. Next, we evaluate the sign of coefficient V for T2
V (T2) =
√
∆
2ce
(√
∆ + (cf + be− ad)
)
(5.69)
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According to (5.57), and by replacing ∆ from (5.55), it is verified that the sign of V for T2 is negative.
By reminding that the sign of coefficient U in (5.63) for (N2, T2, I2) is positive, this equilibrium point has
one eigenvalue with positive real part, and therefore, it is a saddle point and unstable. Note that the value
of stable node T3 is larger that saddle T2. Now that the stability of equilibrium points is revealed, the
bifurcation that occurs at c− by increasing the fratricide death rate c from c < c−, is of type fold which
is resulted from the coalescence of a saddle (T2) and an stable node (T3). Note that since the aim of
introducing fratricide death mechanism is to have a saturated population for activated Tconvs, we have to
assume a fratricide death rate in the range given in (5.52), where the model (5.50) is bistable. 
The equilibrium points of the model with β > 0 and by considering βN(t) = k(t) are obtained by
solving:
−ceT 3 − (cf + be− ad)T 2 + (ek − bf)T + kf = 0, (5.70a)
I = dT
eT + f . (5.70b)
By keeping our assumptions (5.3) and (5.61), the equation (5.70a) has either one positive real equilibrium
point or three positive real equilibrium points depending on the value of k. The stability of equilibrium
points that are obtained from (5.70a) and (5.70b) by varying the value of k is hard to be checked analyt-
ically; instead, it is analyzed numerically by obtaining eigenvalues from characteristic equation (5.63) for
equilibrium points.
In summary, model (5.50) for β = 0 has either 3 or 1 equilibrium points, depending on the value
of fratricide death rate c. The bifurcation diagram of the model (5.50) with respect to c is depicted
in Figure 5.6A for β = 0. When c satisfies (5.52), the stable node (T3) exists that corresponds to a
saturated population of activated Tconv. When the conditions (5.3) and (5.52) are fulfilled, the model
(5.50) exhibits the bifurcation diagram plotted in Figure 5.6B with respect to the steady state value
of T cell activation k. The fratricide mechanism added a large stable node (T3) to the model which
imposes a saturation level to the activated T cell population. The larger the c, the smaller the saturated
population of activated T cells is. Similar to model (5.14), model (5.50) shows an initiation threshold of
the immune response (k > ki). Despite solving the issue of unlimited proliferation of activated T cells
by the fratricide mechanism, model (5.50) bears a hysteresis characteristic so that the immune response
cannot be suppressed when Ag-stimulation (β) is removed.
5.2.4 Dynamic interplay of activated conventional and regulatory T cells
Tregs are essential in maintaining self-tolerance and immune homeostasis by preventing autoimmunity and
limiting chronic inflammation in the periphery. However, they might also limit beneficial responses by
inducing tolerance to pathogens [174,175] or limiting anti-tumor immunity [176,177]. One functional role
of Tregs is to shut down the cell-mediated immune response via cell contact-dependent and inhibitory
cytokine-driven suppression of activated T cells [178]. As an extension for model (5.50) in which immune
response is not suppressed after resolving Ag-stimulation, we add Treg population for immune suppression.
Two different subsets of Tregs were identified. Natural Tregs are the dominant subset of peripheral Tregs
[179] and are selected in the thymus. In our model, we consider only natural Tregs and neglect the
induced Treg subset that differentiates from na¨ıve T cells. Like for na¨ıve T cells, the thymus contributes
to the renewal of resting Treg pool (N̂) by continuously selecting them from self-reactive thymocytes. The
renewal of resting Tregs is assumed to occur with rate N̂0. Our aim is to obtain the size of Treg population
(Treg selection or renewal rate) such that immune activation to foreign and self antigens are allowed, but
is tightly restricted for self antigens. We choose the relative renewal of resting Tregs and na¨ıve T cells as
the parameter of interest. We assume that
N̂0 = λN0. (5.71)
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Figure 5.6: Fratricide mechanism. (A) Bifurcation diagram of model (5.50) with β = 0 using the fratricide
death rate c as bifurcation parameter. A fold bifurcation occurs at c = c−. No immune response exists for
fratricide death rates larger than c− due to extensive activation-induced cell death. The trivial equilibrium
point (T1 = 0) of type stable node is omitted in this figure. (B) Bifurcation diagram of model (5.50) using
k as bifurcation parameter. A fold bifurcation occurs at k = ki. An immune response can be initiated for
large values of k (k > ki). However, due to hysteresis characteristic in this model, the immune response
is not suppressed after decreasing T cell activation (k). Stable and unstable equilibrium points are shown
by black and red lines, respectively. Numerical results are obtained with parameters given in table 5.1.
Tregs remain in the resting state until they are stimulated by Ag (β) and become activated in a TCR-
dependent manner. The dynamic population of the resting Treg compartment is assumed to be the same
as the na¨ıve T cell compartment in (5.14) and (5.50) (dN̂/dt = f(N̂)). Activated Tregs (R) are assumed
to suppress activated T cells (by rate γ). Survival and proliferation of activated Tregs depends strictly
on IL-2, produced by activated non-Tregs [165, 180, 181]. The IL-2 dependent proliferation rate of Tregs
is considered as a linear function of IL-2 (a nonlinear case will be given in section 5.2.5). In contrast to
activated T cells, activated Tregs lack the ability to secrete IL-2 [182]. The relative proliferation rate of
activated Tregs and activated T cells is controlled by the parameter :
N˙(t) = λN0 − gN(t)− βN(t),
˙̂
N(t) = λN0 − gN̂(t)− βN̂(t),
T˙ (t) = aI(t)T (t)− bT (t)− cT (t)2 − γR(t)T (t) + βN(t),
R˙(t) = aI(t)R(t)− bR(t) + βN̂(t),
I˙(t) = dT (t)− eI(t) (T (t) +R(t))− fI(t). (5.72)
The description and values of model parameters are given in Table 5.1 and the model components are
illustrated in Figure 5.3. We define Treg activation k̂(t) as
k̂(t) = βN̂(t) (5.73)
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and indicates to the rate of resting Treg activation by Ag-stimulation (β) per unit of time. According to
(5.48) and (5.71), the steady state value of Treg activation (k̂) is given by
k̂ = λ βN0
g + β = λk. (5.74)
Model (5.72) for βN(t) = k(t) = 0 has five equilibrium points with following values:
(T1, I1, R1, N1) =
(
0, 0, 0, N0
g
)
(5.75)
T2,3 : ceT 22,3 + (cf − ad+ be)T2,3 + bf = 0, I2,3 =
dT2,3
eT2,3 + f
,R2,3 = 0, N2,3 =
N0
g
(5.76)
T4 =
b(eR5 + f)
ad− be , I4 =
b
a
,
R4 =
(
b

)(−(cf + be− ad) + be(− 1)− (ad− be)
cbe+ γ(ad− be)
)
, N4 =
N0
g
(5.77)
T5 = 0, I5 =
b
a
,R5 =
−f
e
,N5 =
N0
g
(5.78)
For resting Treg population, steady state values are N̂i = λNi for i ∈ {1, · · · , 5}. The sign of the
equilibrium point T4 changes by changing the Treg-associated parameters (,γ). T4 is positive if
ad− be > 0, R > −f
e
(5.79)
or
ad− be < 0, R < −f
e
(5.80)
The physiologically relevant regime of the model occurs by satisfying condition (5.79) which means positive
R4 is allowed.
The equilibrium points of model (5.72) for βN(t) = k(t) 6= 0 can be obtained from the following
N = βN0
g + β (5.81)
R = −λk
aI − b (5.82)
T = −I(−eλk + faI − bf)(aI − b)(−d+ eI) (5.83)
P5I
5 + P4I4 + P3I3 + P2I2 + P1I + P0 = 0 (5.84)
where
P5 = a3f2e (5.85)
P4 = −bf2a2e+ cf22a2 − k2a2e2 − a3f2d− 2 a2f be− a2e2λ k (5.86)
P3 = be2λ k a− 2 cf2 ab+ ae2λ kb+ 2 a2f bd+ γ λ kf ae+ ab2fe+ bf2a2d
+ 2 k2a2de− 2 ceλ kf a+ 2 b2f ae+ a2eλ k d+ 2 k abe2 (5.87)
P2 = 2 ceλ kbf − 4 k abde− γ λ kbfe− b2e2λ k − kb2e2 − beλ k ad− b3fe− aeλ kbd+ cb2f2
+ ce2λ2k2 − ab2fd− k2a2d2 − γ λ2k2e2 − 2 b2f ad− γ λ kf ad (5.88)
P1 = γ λ2k2ed+ b2eλ kd+ 2 kb2de+ 2 k abd2 + b3fd+ γ λ kbfd (5.89)
P0 = −kb2d2 (5.90)
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Table 5.1: Parameters of immune activation model.
Parameter Value Description Dimension
a 0.4 Proliferation rate of activated T cells molecule−1time−1
b 0.1 Natural death rate of activated T cells and Tregs time−1
c 10−5 Fratricide death rate of activated T cells cell−1time−1
d 0.01 IL-2 secretion rate by activated T cells moleculecell−1time−1
e 0.01 IL-2 consumption rate by activated T cells and Tregs cell−1time−1
f 1 IL-2 decay rate time−1
g b Natural death rate of na¨ıve T cells and resting Tregs time−1
β [0,∞) Ag-stimulation of na¨ıve T cells and resting Tregs time−1
γ 0.1 Treg-mediated suppression rate cell−1time−1
 0.6 Proliferation rate ratio Treg / Tconv -
N0 4 Renewal rate of na¨ıve T cells cell time−1
λ 0.006 ratio of renewal rate of resting Tregs -
0.02 to na¨ıve T cells N̂0/N0
N̂0 λN0 Renewal rate of resting Tregs cell time−1
Parameters are chosen arbitrarily according to conditions given in (5.3), (5.52) and (5.79). Any other
parameters choice that satisfies these conditions results in similar qualitative behaviors shown for the
proposed models.
By incorporating the Treg compartment to model (5.50), two additional equilibrium points (T4 and
T5) emerged for β = 0. The equilibrium point of interest (T4), which depends on the Treg-associated
parameters (,γ), has an impact on the topology of the phase portrait under variations of bifurcation
parameter k. The value of  and γ are assumed to be in a range where the model does not inherit the
hysteresis characteristics of immune responses from model (5.50) in which the immune response is not
suppressed after resolving Ag-stimulation (β). Then, the bifurcation diagrams of model (5.72) for two
different values of λ are obtained by treating k as the bifurcation parameter (Figure 5.7). Depending on
the value of k, the model has either 5 or 3 equilibrium points (positive and negative).
By varying the relative renewal rates of resting Tregs and na¨ıve T cells (λ in (5.71)) a λth can be
found, such that for λ > λth, no immune response can be initiated for any value of k (Figure 5.7A).
For λ < λth (Figure 5.7B), there exists a T cell activation threshold (ki) such that for k > ki the
major immune response can be initiated. However, in contrast to model (5.50), the immune response is
completely suppressed by activated Tregs if k decreases to a lower value than ki (grey region in Figure
5.7B). For persistent Ag-stimulation with k > ki, two scenarios are possible. An oscillating immune
response is induced when k remains in the range of ki < k < ks (red region in Figure 5.7B). For k > ks
the immune response is suppressed after its initiation to a minor immune response, with an activated T cell
population T4, due to over-suppression of activated T cells by over-activation of Tregs (magenta region
in Figure 5.7B). In the latter case (k > ks), despite proper T cell stimulation, only a minor immune
response is induced (and antigen is not cleared). Instead a chronic co-existence of antigen and inefficient
immune activity is established. Therefore, according to the model, a range of T cell and Treg activation
(ki < k < ks) exists in which an efficient immune response is induced. Outside of this range, the antigen
persists because of under-stimulation of na¨ıve T cells, or over-stimulation of Tregs. According to (5.48), the
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Figure 5.7: Bifurcation diagram of Treg-Tconv model (5.72) using k and λ as the bifurcation parameter
with (A) λ = 0.02 and (B) λ = 0.006. Stable and unstable equilibrium points are drawn by black and
red solid lines, respectively. Dashed black lines represent the stable limit cycles by showing the maximum
and minimum populations of oscillating activated T cells for persistent k. Depending on the values of λ
and k, an immune response is not initiated (grey), is initiated (red) or over-suppressed (magenta). With
parameter values given in Table 5.1, λth = 0.01183. The time-courses of the activated T cell population
T (t) were deduced from a numerical solution (using 4th order explicit Runge-Kutta method) of model
(5.72) with zero initial conditions and persistent β. The unstable negative equilibrium point (T5) is not
shown in the plots. In critical point (1), a bifurcation occurs by coalescence of two saddle points. In point
(2), a fold bifurcation occurs resulting from coalescence of the saddle and stable node. In point (3), an
Andranov-Hopf (subcritical Hopf) bifurcation occurs by which the stable limit cycle disappear by increasing
k. Only in case of λ < λth, a major immune response can potentially arises (ki exists); however, the actual
initiation of major immune response depends on N0, or equivalently, the homeostatic population of na¨ıve T
cells. By choosing different values of N0 for self versus nonself, the Ag-stimulation (β) requires for starting
immune response against self versus nonself can be tuned.
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existence of Ag-stimulation thresholds βi and βs which correspond to the values of ki and ks, respectively,
depends on the renewal rate of na¨ıve T cells (N0); βi exists if N0 > ki and βs exists if N0 > ks. Increasing
the renewal rate of na¨ıve T cells reduces the Ag-stimulation required for initiation(βi)/over-suppression(βs)
of the immune response.
The peak immune response depends on the value of the Treg-associated equilibrium point (T4) which
in turn depends on Treg-associated parameters. However, the fratricide-associated equilibrium point (T3)
is a limiting factor for the maximum population of activated T cells if the fratricide death rate (c) is
sufficiently high.
According to our model, sufficient activated Tregs are required to suppress the proliferative response
of activated T cells. These are supplied by two processes: Treg activation (k̂) which depends on Ag-
stimulation (β), and Treg proliferation which depends on the IL-2 secretion by activated T cells. With
a low Ag-stimulation and insufficient Treg activation (k̂ = βN̂), Treg proliferation has to account for
immune suppression. Since Treg proliferation is dependent on the availability of IL-2, sufficient activated
T cells are required to secrete IL-2 and induce immune suppression. Therefore, activated T cells undergo
the proliferation up to a level that sufficient IL-2 is available for Treg proliferation and subsequent immune
suppression. In contrast, by facilitated Treg activation (k̂), less Treg proliferation is required for suppressing
activated T cells which means that the dependency of immune suppression on proliferation of activated T
cells decreases. Consequently, by increasing Ag-stimulation (β) in the range of βi < β < βs (red region
in Figure 5.7B), Treg activation (k̂) increases as well which results in a reduced maximum population of
activated T cells (Figure 5.7B, dashed black line) and an increased frequency of oscillations. By further
increasing Ag-stimulation to β > βs (magenta region in Figure 5.7B), Treg activation (k̂) completely
prevent oscillating immune response.
In the same way, by increasing the relative homeostatic population of resting Tregs and na¨ıve T cells
(λ > λth), Treg activation increases up to a level that Treg suppression does not depend on the proliferative
response of activated T cells. Thus, activated T cells are not able to enter the massive proliferation for any
Ag-stimulation level, as shown in Figure 5.7A. Similar results can be derived from a model that considers
a nonlinear IL-2 dependent proliferation rate of activated T cells and Tregs, which is presented in the next
section.
5.2.5 Nonlinear proliferation rate of conventional and regulatory T cells
In the models (5.1), (5.14), (5.50), and (5.72) it is assumed that proliferation rate of Tconvs and Tregs is
a linear function of IL-2. In the biological context, IL-2-dependent proliferation of Tconvs and Tregs may
not be linear, and may require a critical IL-2 level for effective proliferation. In previous models, a linear
IL-2-dependent proliferation is assumed in order to allow parametric stability analysis of the model in a
closed form and to find explicitly the dependency between parametric variations and topological changes of
the model. Here, we show that our simplifying assumption does not affect the three regimes of qualitative
immune responses that could be derived from the model. Therefore, the linear IL-2-dependent proliferation
rate is replaced with a nonlinear function of IL-2, named Φ(I) in models (5.1), (5.14) and (5.72)
T˙ (t) = Φ (I(t))T (t)− bT (t) + k(t),
I˙(t) = dT (t)− eI(t)T (t)− fI(t) (5.91)
where Φ (I(t)) is considered as a Hill function of IL-2
Φ (I(t)) = a I
n(t)
hn + In(t) . (5.92)
With choosing proper parameters n and h in (5.92), requiring a critical level of IL-2 for effective proliferation
can be imposed to the model. The models (5.1) and (5.91) are compared by steady state analysis. The
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equilibrium points of the modified model (5.91) (with k = βN0g+β = 0) are
(I1, T1) = (0, 0), (5.93)
(I2, T2) =
(
h
(
b
a− b
) 1
n
,
fI2
d− eI2
)
. (5.94)
The nontrivial equilibrium point (I2, T2) is positive and biologically meaningful only if
(a− b)dn − benhn > 0. (5.95)
The local stability of the equilibrium points can be determined by obtaining the eigenvalues from the
characteristic equation
Q(λ) = det
(
λ− a Inhn+In + b −aT nh
nIn−1
(hn+In)2
−d+ eI λ+ eT + f
)
= λ2 +
[
eT + f − a I
n
hn + In + b
]
λ
+
[(
−a I
n
hn + In + b
)
(eT + f) + aT nh
nIn−1
(hn + In)2 (−d+ eI)
]
= 0 (5.96)
By checking Routh-Hurwitz stability criterion, it can be easily confirmed that the eigenvalues have negative
real parts for trivial equilibrium point since all the coefficients of polynomial Q(λ) are positive, and hence,
the trivial equilibrium point (I1, T1) is asymptotically stable. For checking the stability of the non-trivial
equilibrium point, the characteristic equation (5.96) is evaluated in (I2, T2)
Q(λ, I2, T2) = λ2 + Uλ+ V = 0 (5.97)
where
U = eT2 + f, V = − nbh
nT2
I2(hn + I2n)
(d− eI2). (5.98)
By assuming that condition (5.95) is satisfied, the coefficients U and V in (5.97) are positive and negative
respectively. Therefore, there exists an eigenvalue with positive real part, and consequently, nontrivial
equilibrium point (I2, T2) is a saddle point and unstable.
Similar to the model (5.1), the stable manifold of saddle point in the model (5.91) defines a threshold
for initial conditions that allow for unlimited proliferation of activated T cells. By comparing the conditions
(5.95) and (5.3), the dependencies of these conditions to the model parameters, specifically the proliferation
rate (a) and IL-2 secretion rate (d), are positively correlated. In other words, in both models, only T cell
clones with sufficiently high proliferation rate (a) and/or high IL-2 secretion rate (d) are able to undergo
major T cell proliferation.
For k 6= 0, the equilibrium points of the model (5.91) are obtained from the following equations
T = fI
d− eI , (5.99)
[(a− b)f − ke] In+1 + [kd] In − [hn(bf + ke)] I + kdhn = 0. (5.100)
The stability of equilibrium points is analyzed by evaluating the characteristic equation and is shown in
Figure 5.8 for parameter values given in Table 5.1 and Hill-function parameters n = 2 and h = 0.5.
By comparing the bifurcation diagram in Figure 5.8 and Figure 5.5, the qualitative similarity between
model (5.14) and (5.91) is evident. This qualitative similarity also holds true between model (5.72) and
the following model
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Figure 5.8: Bifurcation diagram of T cell activation model (5.91) with nonlinear proliferation rate. Hill-
function parameters are n = 2 and h = 0.5. k is treated as bifurcation parameter. Stable and unstable
equilibrium points are shown by black and red lines, respectively. For k > k−, the immune response enters
the regime of unlimited proliferation. The unstable negative equilibrium point is omitted in this figure.
T˙ (t) = Φ (I(t))T (t)− bT (t)− cT 2(t)− γR(t)T (t) + k(t),
R˙(t) = Φ (I(t))R(t)− bR(t) + k̂(t),
I˙(t) = dT (t)− eI(t) (T (t) +R(t))− fI(t) (5.101)
where Φ (I(t)) is identical to (5.92).
The equilibrium points of model (5.101) are calculated and their stability is analyzed by deriving the
characteristic equation of the model and obtaining the eigenvalues. By keeping assumption (5.71), the
bifurcation diagrams of model (5.101) for two different values of λ are obtained by treating k = βN0g+β > 0
as the bifurcation parameter (depicted in Figure 5.9). Depending on the value of k, the model has either
8 or 6 equilibrium points (4 or 2 equilibrium points with T > 0, identical to model (5.72)) with parameter
values given in Table 5.1 and Hill-function parameters n = 4 and h = 1. The additional equilibrium points
resulted from considering the Hill-function nonlinearity are all in the negative space of the model variables.
As it can be seen from Figure 5.9, similar to the model (5.72), the three qualitatively different responses
still could be derived from the modified model. It is clear that the value of ki, ks and λth are different
from their corresponding values in the model (5.72).
In summary, imposing the nonlinear IL-2 dependent proliferation rate of cells results in a more restricted
condition for initiation of an immune response in comparison to the linear IL-2 dependent proliferation rate,
namely the requirement of higher T cell avidity (higher a and d), higher Ag-stimulation (increased βi) and
lower Treg/Tconv ratio (lower λth); but three qualitatively different immune reactions depending on the
critical levels of Ag-stimulation could still be derived, very similar to model (5.72).
5.3 Discussion
In this study, a model of the dynamic interplay between effector and regulatory immune responses was
examined to investigate the requirements for the initiation of an immune response by Ag-stimulation. The
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Figure 5.9: Bifurcation diagram of Treg-Tconv model (5.101) with with nonlinear proliferation rate. Hill-
function parameters are n = 4 and h = 1. k and λ are treated as bifurcation parameters with (A)
λ = 0.0016 and (B) λ = 0.0008. Stable and unstable equilibrium points are drawn by black and red solid
lines, respectively. The stable limit cycles are not shown for all value of ki < k < ks except for k = 12.
Depending on the values of λ and k, an immune response is not initiated (grey), is initiated (red) or over-
suppressed (magenta). With parameter values given in Table 5.1 and Hill-function parameters n = 4 and
h = 1, the threshold becomes λth = 0.00111. The time-courses of the activated T cell population T (t)
were deduced from a numerical solution of model (5.101), by using 4th order explicit Runge-Kutta method,
with zero initial conditions and persistent β. The negative equilibrium points which are all unstable are
not shown in the plots.
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model unifies several components developed in previous studies, such as IL-2 dependent proliferation of T
cells [20], fratricide-induce programmed cell death [173], IL-2 competition between activated T cell and
activated Tregs [25], and Treg-mediated immune suppression [25, 27, 161]. Homeostatic division of T cell
compartments was not considered in the present study, such that the main renewal source of T cells in the
absence of Ag-stimulation is the thymus. While the presented model is still simplifying the real situation in
many aspects, the stability analysis revealed a number of reasonable results matching many experimental
findings and allowing for an analysis of reasons for immune failure and autoimmunity.
The model predicts three qualitatively different immune responses depending on the level of antigenic
stimulation. At first, a threshold stimulation βi is required in order to get an immune response at all.
Secondly, in a limited range of Ag-stimulation β ∈ (βi, βs) an efficient immune response is induced. Tregs
limit the duration of the immune response. If the antigen was cleared by the first immune response, further
immune activity would be suppressed by Tregs. However, if the first peak of the immune response fails
to clear the antigen, but keeps the antigen in the stimulation range βi < β < βs, the immune system
attempts to clear the antigen with subsequent immune responses, which corresponds to the oscillatory
solution depicted in Figure 5.7B. If the immune response failed to control the antigen spread, antigenic
stimulation would be further increased to β > βs, leading to the third class of immune responses. Tregs are
over-stimulated and suppress immune activity. In this situation, a chronic persistence of the antigen would
develop. Treg-mediated over-suppression of immune responses in chronic infections is well-established
(reviewed in [183]). According to our model, depletion of resting Tregs restores the immune response by
transiently decreasing λ and by this increasing βs. This notion is consistent with the experimental model
of chronic infections according to which depletion of Tregs results in the restoration of effector immune
response and restriction of antigen spread [184, 185]. A key feature of our model is that the immune
response does not rely on a stable equilibrium point with a dominant population of activated T cells which
is typically derived from existing bistable models. It rather relies on a transient response (or stable limit
cycles in the case of persistent Ag-stimulation) which originates from T-cell-mediated suppression and IL-2
consumption by Tregs. Moreover, the role of Tregs in the chronic state of the immune response is not
represented by available models.
According to our model, the qualitatively different immune responses and their requirements are de-
pendent on the quality and quantity of Tconv and Treg clones responding to the Ag-stimulation. The
proliferation rate of activated T cells, which depends on their avidity to the stimulating antigen determines
the existence of an Ag-stimulation threshold (βi) which is required for the initiation of an immune response.
The absolute renewal rate of na¨ıve T cells (N0) adjusts the Ag-stimulation threshold βi, which exists when
the renewal rate of resting Tregs remains below a threshold value (λ < λth). Further Treg-associated
parameters, namely the proliferation rate of Tregs () and the Treg-mediated suppression rate (γ), also
affect the existence and the level of the Ag-stimulation required for initiation (βi) and over-suppression
(βs) of immune responses. By increasing the proliferative () and suppressive (γ) activity of Tregs, βi
increases, whereas βs decreases up to a level where the initiation of an immune response is completely
impossible for any Ag-stimulation. Interestingly, when proliferation rate of activated Tregs exceeds the one
for activated T cells ( > 1) a massive proliferation of activated T cells is still required for subsequent
immune suppression by Tregs. Thus, IL-2 secretion by sufficiently large numbers of activated T cells is
a strict requirement for immune suppression. Note also that without Tregs, a return to the homeostatic
state is not possible, even when the antigen was cleared.
Considering all aforementioned parameters controlling the initiation of an immune response, is it bene-
ficial for the immune system to completely avoid self reaction, or is there a benefit in allowing self reaction?
Clearly, autoreactive T cells exist in the periphery of healthy individuals as a normal component of the T cell
repertoire [152, 155, 186, 187]. These cells respond to self-tissue destruction even in the presence of Tregs
and without genetic predisposition to autoimmunity [154]. Although the activation of autoreactive T cells
has been shown to be involved in autoimmunity [152], several lines of evidences indicate that these cells are
required for limiting self-destruction by supporting self-regenerative processes [188–190]. In addition, the
86 CHAPTER 5. IMMUNE ACTIVATION MODEL
anti-tumor immune responses evoked by autoreactive T cells are beneficial [170, 191]. Therefore, it seems
unlikely that autoreactive T cells escaping from the thymus are simply a result of thymic selection error
that can disturb self-tolerance under certain physiological conditions. Instead, these evidences imply that
beneficial self reaction is allowed in the immune system. According to the mathematical model, immune
reactions against self are only possible with a critical homeostatic population of autoreactive T cells (or
sufficient renewal rate N0) which is balanced by a proper number of Tregs (λ < λth) which corresponds to
region (C) in Figure 5.10. Since the T cell repertoire is normally stimulated with an endogenous level of self
antigens in the periphery which does not evoke any self reaction, the Ag-stimulation threshold for initiating
an immune response (βi) should be sufficiently high in comparison to a typical nonself Ag-stimulation.
According to our model, this is achieved by ensuring a low renewal rate (N0) of low-avidity autoreactive T
cells and a high, but balanced renewal rate of Tregs (high λ but lower than λth). In other words, according
to Figure 5.10, by choosing N0 close to ki and higher value of ki which is obtained by higher λ, a large
Ag-stimulation threshold (βi) for the initiation of immunity against self can be achieved.
Figure 5.10: The balance between renewal rate of na¨ıve T cells and resting Tregs. The relative renewal
rate of na¨ıve T cells and resting Tregs (λ = N̂0/N) determines the existence of an immune response. The
initiation of an immune response requires a sufficient renewal rate of na¨ıve T cells (N0). (A) For λ > λth,
the immune response does not exist for any value of N0 and Ag-stimulation (β). (B) For N0 < ki, no
immune response can be initiated for any value of β. (C) For N0 > ki, immune response can be initiated
for β > βi. In this regime, the Ag-stimulation that results in over-suppression of immune response (βs)
does not exist. (D) In this regime, immune response is initiated for β > βi, and is over-suppressed for
β > βs. Note that ki and ks are dependent on the value of λ. For any point in the plane (e.g. blue point),
the values of k∗s and k∗i are obtained by projecting the intersections of the line created by connecting the
point to the origin (slope=λ∗) with the nonlinear curves N0 = ki(λ) and N0 = ks(λ) onto the N0-axis. By
decreasing λ∗, the effective range of T cell activation (k∗s − k∗i ) or equivalently, the effective range of Ag-
stimulation (β∗s − β∗i ) which evoke immune response without over-suppression increases. We hypothesize
that a healthy individual bears the potential to evoke self reaction and therefore its immune system is
located in parametric regime (C); however, higher self Ag-stimulation compared to nonself Ag-stimulation
is required for initiating immune response due to low renewal rate of autoreactive T cells (N0).
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Aging of the immune system, the so-called immunosenescence, is characterized by involution of thymus,
decreased number of thymic output, contraction in T cell diversity and disturbed T cell homeostasis which
all result in attenuated immune function and susceptibility to infectious diseases and cancer in the elderly
[192,193]. By decreasing thymic output, the homeostatic population of some T cell clones diminishes which
leads to the creation of holes in the T cell repertoire [194]. According to our model, a decreased renewal
rate of a na¨ıve T cell clone (N0) per se could prevent an immune response or increase the Ag-stimulation
level required for initiation of an immune response. In addition, as shown in many studies, the frequency of
Tregs increases with age [195,196] which results in a disturbed balance between the population of na¨ıve T
cells and resting Tregs (increased λ). In line with these results, in the mathematical model an increased λ
prevents the initiation of an immune response corresponding to the age-related immune hyporesponsiveness
in infection and cancer.
Based on the reasonable and physiologically realistic results that we could derive from the model, we
dare to speculate about the self versus nonself concept emerging from the model. As mentioned before,
the na¨ıve T cells and resting Tregs are two major components of the immune reaction. The model does
not distinguish self and nonself, but rather derives different responses to self and nonself from quantitative
differences in the nature of Ag-stimulation. According to the model, by adjusting different parameters,
different requirements in terms of Ag-stimulation level are found for the initiation of immune responses to
self versus nonself. If the immune system responds according to a universal set of Ag-stimulation thresholds,
regardless of whether the stimulus arises from self or nonself antigens, a change of systemic parameters can
lead to immune failure or autoimmunity. Self is no more considered as self if it exceeds an Ag-stimulation
threshold determined by the stringency of central and peripheral tolerances. Similarly, nonself is considered
as self if it does not properly stimulate the T cell repertoire. Autoimmunity might occur due to either a
failure in tuning the Ag-stimulation threshold by the thymus that leads to unwanted self reaction in the
periphery, or a chronic self Ag-stimulation in the periphery that leads to an oscillating self reaction and
tissue destruction like in type 1 diabetes [197] and multiple sclerosis [198]. Cancer or chronic infection
would arise as the result of an imbalance in central and peripheral tolerances such as insufficient release
of autoreactive T cells as well as high production or induction of Tregs that results in over-suppression of
immune responses.
An early elegant mathematical modeling study analyzed a series of models to investigate self/nonself
discrimination by T cells without explicitly considering suppressive Tregs [20]. As a result of their critical
assumption that memory cells accumulate in poor stimulatory conditions, the authors suggested that due to
high stimulation by self antigen the lack of memory accumulation for T cell clones with high affinity to self
accounts for self tolerance. Also in our model, a high self Ag-stimulation (β > βs in Figure 5.7B) results
in over-activation of Tregs and by this in over-suppression of self reaction. In both models an increased
stimulation by self antigen would not lead to autoimmunity. The fact that autoreactive T cells do respond
in the presence of Tregs when their stimulatory requirements are provided [154] makes it unlikely that
this is the mechanism of self-tolerance induction. In the framework of our model, the view is supported
that immune tolerance is induced by an increased stimulation threshold for self antigen and keeping self
Ag-stimulation in a subcritical regime (β < βi).
Undoubtedly, other mechanisms besides clonal deletion and Treg selection in the thymus also contribute
to the fine tuning of the Ag-stimulation threshold required for initiation of immune reactions to self and
nonself, such as anergy in the periphery [199] or activation threshold tuning in the thymus [84, 200].
However, our simple model emphasizes the subtle balance between the generation of Tregs and autoreactive
T cells which are both needed for beneficial autoimmunity. The model supports the view according to which
self and nonself do not differ on a qualitative level. It is rather quantitative differences of the immune
status and Ag-stimulation level that determine which molecule is treated as self or nonself.
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5.4 Summary
The adaptive immune system reacts against pathogenic nonself, whereas it normally remains tolerant to
self. The initiation of an immune response requires a critical antigen(Ag)-stimulation and a critical number
of Ag-specific T cells. Autoreactive T cells are not completely deleted by thymic selection and partially
present in the periphery of healthy individuals that respond in certain physiological conditions. A number
of experimental and theoretical models are based on the concept that structural differences discriminate
self from nonself.
In this chapter, we presented a series of mathematical models for immune activation in which self and
nonself are not distinguished. The most complete model considers the dynamic interplay of conventional T
cells, regulatory T cells (Tregs) and IL-2 molecules and shows that the renewal rate ratio of resting Tregs
to na¨ıve T cells as well as the proliferation rate of activated T cells determine the probability of immune
stimulation. The actual initiation of an immune response, however, relies on the absolute renewal rate
of na¨ıve T cells. This result suggests that thymic selection reduces the probability of autoimmunity by
increasing the Ag-stimulation threshold of self reaction which is established by selection of a low number
of low-avidity autoreactive T cells balanced with a proper number of Tregs.
The stability analysis of the ordinary differential equation model reveals three different possible immune
reactions depending on critical levels of Ag-stimulation: A subcritical stimulation, a threshold stimulation
inducing a proper immune response, and an overcritical stimulation leading to chronic co-existence of Ag
and immune activity. The model exhibits oscillatory solutions in the case of persistent but moderate Ag-
stimulation, while the system returns to the homeostatic state upon Ag clearance. In this unifying concept,
self and nonself appear as a result of shifted Ag-stimulation thresholds which delineate these three regimes
of immune activation.
Chapter 6
Regulation of immune stimulation
In Chapters 4 and 5, induction of central tolerance by removing self-antigen specific cells and peripheral
tolerance by antigen-specific activation and regulatory function of regulatory T cells (Treg) were discussed.
However, antigen-nonspecific mechanisms for maintaining immune tolerance exist in the immune system.
One mechanism by which the immune system is able to maintain a balance between immune activation and
inhibition is to use different antigen-nonspecific receptors for different cellular outcomes. In this chapter,
one of the most important inhibitory receptors of the immune system, Cytotoxic T lymphocyte antigen 4
(CTLA4), is discussed.
6.1 Background
Activation of T cells requires close contacts with antigen presenting cells (APCs). This cell-cell contact
forms immunological synapses that allow membrane receptors of one cell to effectively interact with their
ligands on the surface of opposing cell [201, 202]. ”Two-signal” activation model of T cells is the widely
accepted model of how T cells become activated. This model states that optimal T-cell activation requires
two signals: antigen-specific and antigen non-specific signals. First signal is induced by interaction of TCRs
expressed by T cells with major histocompatibility complex (MHC)-bound peptides presented by APCs.
Second signal is induced by interaction of CD28 receptors expressed by T cells with costimulatory molecules
(CD80 and CD86 molecules) expressed by APCs [203, 204] (see Figure 2.5). It is generally believed that
costimulatory molecules increase the sensitivity of T cells to antigen-specific signals, and allowing them to
become activated by few high-affinity antigens presented by APCs.
Providing abundant costimulation to T cells may lead to uncontrolled T cell activation and clonal
expansion which may damage healthy tissues. Especially, abundant costimulation may lead to T cell
activation against self-peptides that is normally expressed by APCs. CTLA4 is an inhibitory receptor
expressed by T cells that controls the outcome of costimulatory signals. CTLA4 binds to the same ligands
for CD28, which are CD80 and CD86. CD28 molecules are expressed on the surface of resting and
activated conventional T cells. In contrast, CTLA4 is only expressed approximately 2 days after activation
of conventional T cells in mice [205] and humans [206]. CTLA4 is expressed by both CD4+ and CD8+
T cells, but the its expression on CD4+ may be more important, since the unbalance immune regulation
can be avoided in CTLA4-deficient animals by eliminating CD4+ T cells [207]. Unlike conventional T
cells, CTLA4 is expressed by Tregs in resting state [208–210]. This expression is upregulated after Treg
activation [211].
CTLA4 is a receptor that binds to its specific ligands on the cell surface (it is a transmembrane protein).
However, the cellular distribution of CTLA4 molecules contrasts with its function; CTLA4 is mostly located
inside the cell (in cytoplasm). This unusual distribution for a transmembrane protein raises questions about
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the functionality of CTLA4. For example, it is not clear whether a small amount of CTLA4 on the plasma
membrane (cell surface) under steady-state condition (without inflammation) is sufficient for the inhibitory
effects of CTLA4. A possible answer for this question would be that higher affinity interactions of CTLA4
with CD80/CD86 molecules should be limited in order to allow stimulation of lower affinity interactions
of CD28 with the same costimulatory molecules. Another question is whether the distribution of CTLA4
molecules corresponds to a static behavior of CTLA4 molecules, or rather it is resulted from a dynamic
trafficking process. In each case, there should be an explanations about what the immune system gains if
CTLA4 is located stably, or highly traffics between plasma membrane and cytoplasm.
It is generally believed that CTLA4 molecules impact on the cell that express them. This is generally
referred as cell-intrinsic pathway of immune inhibition. Such a cell-intrinsic mechanism would predict
that if CTLA4 is removed from the immune system (in a CTLA4-deficient mouse model), T cells undergo
uncontrolled activation from which autoimmunity arises. Indeed, this prediction is validated by experimental
observations. However, cell-intrinsic inhibition idea would predict that if a mixture of CTLA4-deficient and
CTLA4-sufficient T cells exists in an individual (a chimeric experiment), CTLA4-deficient T cells become
activated. In contrast to this prediction, it has been shown (in chimeric experiment) that all T cells remain
in their quiescent state. Recently, a new function of CTLA4 has been discovered which is compatible
with observations in chimeric experiments. It has been shown that CTLA4 molecules on T cells are able
to detach and internalize costimulatory molecules from the surface of APCs, a process known as trans-
endocytosis (Figure 6.1). Trans-endocytosis is an unusual mechanism for regulating molecule expression
in the immune system. Trans-endocytosis allows CTLA4-expressing T cells to regulate the expression of
CD80/CD86 molecules by APCs, and by that, regulate the activation of other interacting T cells. In such
a cell-extrinsic inhibitory mechanism, the dynamics of CTLA4 trafficking is critical. In contrast to a fast
trafficking CTLA4 machinery, static model of CTLA4 expression would not allow an efficient removal of
costimulatory molecules. In this chapter, a series of experiments and their corresponding mathematical
models are employed to quantify sub-processes involved in CTLA4 trafficking. Once the trafficking rates
are obtained, they can be used to predict the contribution of trans-endocytosis mechanism in immune
regulation.
6.2 Modeling
Cells express a variety of proteins in cytoplasm (CP) and on plasma membrane (PM). These proteins are
usually maintained in homeostatic numbers by multiple trafficking sub-processes. These sub-processes are
regulated depending on different environmental stimuli which leads to the changes of protein distributions.
Typical trafficking sub-processes are protein synthesis, secretion of proteins to PM (exocytosis), internal-
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Figure 6.1: Trans-endocytosis, a T cell extrinsic function of CTLA4 [13]. CTLA4-expressing cell removes
costimulatory molecules (CD80/86) from surface of antigen presenting cell (APC). This removal mechanism
deprive other interacting T cells from costimulatory signals from APC.
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ization of proteins from PM to CP (endocytosis), protein degradation and protein diffusion on plasma
membrane which is the process of protein movements from one location to another. The rates of traf-
ficking sub-processes differ among different proteins. For example, CD28 molecules are stably present on
the plasma membrane, which resulted from low endocytosis and exocytosis rates. In order to identify the
trafficking rates for CTLA4 molecules without any priori knowledge, the model has to be constructed by all
the aforementioned sub-processes and associated rates. Then, by using experimental measurements, the
contribution of each process can be quantified.
Experimental data obtained from CTLA4-labeling experiments given in [212] and [213] are used. In
these experiments, CTLA4 molecules were expressed in Chinese Hamster Ovary (CHO) cells. These cell
are widely used for production of various proteins. The modeling starts with a general model for CTLA4
trafficking. Since various experimental protocols have been used to observe CTLA4 molecules, such as
using labeling antibodies, the general model is modified to often more complex models to represent these
experimental protocols.
6.2.1 Model 1: ligand-independent trafficking model of CTLA4 receptors
First, we consider CTLA4 molecules without cell interactions. General model is constructed by consider-
ing fundamental processes in protein trafficking, namely protein synthesis, recycling, internalization and
degradation (Figure 6.2). General model relies on the following assumptions:
• CTLA4 molecules are synthesized at a constant rate σi with dimension of molecule number (#) per
minute. Protein synthesis results in the maintenance of homeostatic number of CTLA4 molecules
in the plasma membrane (Rip with dimension #) and subsequently in the cytoplasm (Ric with
dimension #) after internalization. This assumes that newly synthesized CTLA4 molecules are not
directly undergo the degradation pathway that exists in the cytoplasm, but only after exocytosis
to plasma membrane and subsequent internalization to cytoplasm. The subscript i is taken from
inhibition as an indication to inhibitory role of CTLA4 molecules. Letter R is taken from Receptor
and will be used for number of CTLA4 molecule. L (taken from Ligand) will be used for co-
stimulatory (CD80/CD86) or labeling molecules. The subscripts c and p indicate to the location of
molecules (taken from Cytoplasm and Plasma membrane, respectively).
• The cytoplasmic CTLA4 molecules are degraded in a lysosomal-dependent manner with a constant
rate δil (with dimension of min−1). To quantify the degradation of CTLA4 in non-lysosomal-
dependent manner, we assume that CTLA4 molecules also degrade with a constant rate δin (with
dimension of min−1). Total cytoplasmic degradation rate is δic = δil + δin.
• The intracellular CTLA4 molecules (Ric) are exocytosed (recycled) to the plasma membrane by a
constant rate kir (with dimension of min−1).
• The surface CTLA4 molecules (Rip) are internalized with a constant rate kii (with dimension of
min−1) and are added to the cytoplasmic CTLA4 molecules (Ric).
The general model, depicted in Figure 6.2, can be written as the following nonhomogeneous linear
system of ordinary differential equations (ODE):(
R˙ic(t)
R˙ip(t)
)
=
(
−(kir + δic) kii
kir −kii
)(
Ric(t)
Rip(t)
)
+
(
0
σi
)
(6.1)
where δic = δil + δin. Steady state values of model (6.1) are the followings:
Ric =
σi
δic
,
Rip =
kir + δic
kii
Ric =
σi(kir + δic)
kiiδic
. (6.2)
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Figure 6.2: General model: Ligand-independent model of CTLA4 trafficking.
Before starting each experiment, the number of CTLA4 moleculse are assumed to be at their steady state
values given in (6.2).
6.2.2 Model 2: ratio of plasma membrane to internalized receptors
In the first ligand-independent experiments, CTLA4-expressing CHO cells are pulsed at 37 ◦C for 30 minutes
with an unlabeled anti-CTLA4. Unlabeled anti-CTLA4 is a primary antibody without any color and binds to
CTLA4 molecules. This primary antibody can also bind to secondary antibodies with different colors, once
they are provided in the medium. In 37 ◦C, CTLA4 molecules undergo a natural trafficking. Therefore,
once CTLA4 molecules appear on the plasma membrane (newly synthesized or recycled molecules), they
can bind to unlabeled anti-CTLA4 molecules. We refer to this compound as marked CTLA4. After being
marked, CTLA4 molecules can be subsequently internalized or recycled again.
Next, by putting cells on ice, the CTLA4 trafficking was blocked. Then, by using a fluorescently
labeled secondary antibody (red), marked CTLA4 molecules (without color) on the plasma membrane were
labeled by red color. Subsequently, the cells were permeabilized and stained with an alternate secondary
antibody (green). Note that with permeabilization, secondary antibodies can diffuse to cytoplasm and bind
to intracellular marked CTLA4 molecules. Since the CTLA4 molecules were labeled with the red labels,
they cannot be labeled with green antibody. Finally, CHO cells were analyzed by confocal microscopy and
the ratio of red mean fluorescent intensity (MFI) to green MFI was obtained (see Figure 6.3). Confocal
microscope is capable of showing a plane of focus from within a sample and eliminating out of focus
objects.
Model of this experiment, depicted in Figure 6.4A schematically, is representing the labeling process
during the natural trafficking of CTLA4 molecules. It is assumed that free CTLA4 molecules on the
plasma membrane Rip(t) can bind to primary labeling molecules (unlabeled anti-CTLA4 molecules Lp),
which has no color in this particular experiment, and make marked CTLA4 compounds R∗ip(t) on the
plasma membrane in CTLA4+Lp  CTLA4∗ reaction. This reaction has a constant binding rate kL and
unbinding rate k̂L. Free CTLA4 molecules and marked CTLA4 compounds on the cell surface (Rip(t)
and R∗ip(t), respectively) are internalized with a constant rates kii and k∗ii, respectively. Once the marked
CTLA4 molecules are in cytoplasm (R∗ic(t)), free primary labeling molecules Lc(t) appear in cytoplasm
due to the unbinding of the marked CTLA4 to its reactants (CTLA4∗  CTLA4 + Lc), which further
can bind to free cytoplasmic CTLA4 molecules Ric(t). Note that internalization is the only pathway that
primary labeling molecules can enter cytoplasm from extracellular environment. With these aforementioned
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assumptions, model of labeling experiment is the following
R˙ic(t) = − (δic + kir + kLLc(t))Ric(t) + kiiRip(t) + k̂LR∗ic(t) (6.3)
R˙ip(t) = kirRic(t)− (kLLp + kii)Rip(t) + k̂LR∗ip(t) + σi (6.4)
R˙∗ip(t) = kLLpRip(t)−
(
k̂L + k∗ii
)
R∗ip(t) + k∗irR∗ic(t) (6.5)
R˙∗ic(t) = kLLc(t)Ric(t) + k∗iiR∗ip(t)−
(
k̂L + k∗ir + δ∗ic
)
R∗ic(t) (6.6)
L˙c(t) = −kLLc(t)Ric(t) + k̂LR∗ic(t)− δLLc(t) (6.7)
where R∗ip(t) and R∗ic(t) are the number of CTLA4 molecules on plasma membrane and in cytoplasm,
respectively, which are marked with binding to the unlabeled anti-CTLA4 (no color). Lp and Lc(t) are the
number of unlabeled anti-CTLA4 molecules in the medium and cytoplasm, respectively. The nonlinearity of
this model arises from forward reaction of CTLA4 labeling (CTLA4 + L → CTLA4∗). In a typical labeling
experiment, the following assumptions are taken in order to interpret the data:
(A) Lp is constant and sufficiently large
(B) kL is sufficiently large in comparison to other reaction rates.
(C) k̂L is smaller than other rates and is approximated to zero.
(D) δ∗ic = δic, k∗ir = kir and k∗ii = kii.
Assumption (A) indicates to the experimental procedure, where sufficient anti-CTLA4 molecules are
provided into the medium, and labeling molecules are not a limiting factor for CTLA4 observation. As-
sumption (B) and (C) imply that labeling molecules bind to CTLA4 with a very high rate and remain bound
during the time of sample observation. This represents the experimental definition of a labeling molecule.
Assumption (D) represents the approximation that trafficking rates of labeled CTLA4 molecules is similar
to free CTLA4 molecules. We apply these assumptions to model equations.
According to the assumptions (A) and (B), we can assume that marking CTLA4 molecules on the
plasma membrane Rip with unconjugated unlabeled anti-CTLA4 is at quasi steady state. By setting
Figure 6.3: Ratio of plasma membrane (PM) to internalized (I) CTLA4 [212]. CHO cells expressing either
wild type (wt), ∆13, or ∆23 CTLA4 were incubated with unlabeled anti-CTLA4 at 37 ◦C for 30 minutes.
∆13 and ∆23 are mutants of CTLA4 molecules, and ∆23 turned out to be a non-endocytic mutant. After
labeling, cells were then cooled to 4 ◦C, and CTLA4 that remained on the cell surface were stained with
a fluorescently labeled secondary antibody (red). Cells were then fixed, permeabilized, and stained with a
different secondary antibody (green) and imaged by confocal microscopy. The ratio of plasma membrane
to internalized CTLA4 fluorescence (PM/I) was calculated and is shown in the right panel.
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Figure 6.4: Model of CTLA4 labeling process. (A) Complete model of PM/I experiment and (B) the
simplified version.
R˙ip(t) = 0 in (6.4), we have
R˙ip(t) = 0→ Rip =
kirRic(t) + k̂LR∗ip(t) + σi
kLLp + kii
(6.8)
Since the cytoplasmic unconjugated unlabeled anti-CTLA4 Lc(t) appears during the unbinding process
of internalized marked CTLA4 compound (R∗ic), its initial value (Lc,0) at starting time of the labeling
process is zero. By employing assumption (C), we evaluate (6.7) by k̂L = 0,
L˙c(t) = −(kLRic(t) + δL)Lc(t), (6.9)
with initial condition Lc,0 = Lc(0) = 0. Since (kLRic(t) + δL) in (6.9) is positive for every t, then
Lc(t) = 0. (6.10)
Next, we employ (6.8) and (6.10) in (6.3),
R˙ic(t) = −(δic + kir)Ric(t) + kiikir
kLLp + kii
Ric(t) +
kiik̂L
kLLp + kii
R∗ip(t) +
σikii
kLLp + kii
. (6.11)
According to assumptions (A) and (B), we extract kLLp  kiikir, kLLp  kiik̂L and kLLp  σikii.
Therefore, ratios in (6.11) are approximated to zero and the equation is simplified to
R˙ic(t) = −(δic + kir)Ric(t). (6.12)
Next, we evaluate (6.5) according to (6.8), (6.10) and assumptions (C) and (D).
R˙∗ip(t) =
kLLp
kLLp + kii
(kirRic(t) + σi)− kiiR∗ip(t) + kirR∗ic(t) (6.13)
From assumptions (A) and (B), we extract kLLp  kii. Therefore, kLLp/(kLLp + kii) ≈ 1, and above
equation is simplified to
R˙∗ip(t) = kirRic(t) + σi − kiiR∗ip(t) + kirR∗ic(t). (6.14)
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Finally, we evaluate (6.6) according to (6.8), (6.10) and assumptions (C) and (D).
R˙∗ic(t) = kiiR∗ip(t)− (kir + δic)R∗ic(t). (6.15)
As the result of biologically relevant assumptions, the nonlinear model of labeling process is simplified
to the following nonhomogeneous linear ODE modelR˙ic(t)R˙∗ip(t)
R˙∗ic(t)
 =
−(kir + δic) 0 0kir −kii kir
0 kii −(kir + δic)

Ric(t)R∗ip(t)
R∗ic(t)
+
 0σi
0
 . (6.16)
Model (6.16) is equivalent to the labeling process schematically depicted in Figure 6.4B. According
to the simplified model, all free CTLA4 molecules (Rip(t)) on the plasma membrane are labeled at the
moment of adding labeling molecules into the medium. Hence, the initial value of marked CTLA4 molecules
R∗ip,0 is equal to the steady state number of free CTLA4 molecules on the plasma membrane in general
model (6.1) given in (6.2). Initial number of free cytoplasmic CTLA4 molecules (Ric,0) can be taken from
its steady state value given in (6.2). No marked CTLA4 molecule exists at starting time of the experiment.
In summary, model (6.16) has the following initial condition
Ric,0 =
σi
δic
, R∗ip,0 =
σi(kir + δic)
kiiδic
, R∗ic,0 = 0. (6.17)
Initial conditions are used to obtain the time-varying solution of model (6.16). In Appendix B.1, steps to
obtain the following solutions are given.
Ric(t) =
σi
δic
e−(kir+δic)t, (6.18)
R∗ip(t) = R∗ip,0 =
σi(kir + δic)
kiiδic
, (6.19)
R∗ic(t) =
σi
δic
(
1− e−(kir+δic)t
)
. (6.20)
In (6.19), a constant value for marked CTLA4 molecules on plasma membrane is obtained, which is identical
to its initial value. This is the result of uninterrupted CTLA4 synthesis during the labeling process and
subsequent binding to labeling molecules which is a very fast process. According to (6.18), free CTLA4
molecules in cytoplasm disappear as t→∞. This is resulted from the assumption that all newly synthesized
molecules are directly go to the plasma membrane, and all molecules on the plasma membrane are marked
with labeling molecules. Consequently, no free CTLA4 molecule exists on the plasma membrane to be
subsequently internalized and to sustain the pool of free CTLA4 molecules in the cytoplasm.
We are interested in the ratio of marked CTLA4 molecules on the plasma membrane (PM) to marked
CTLA4 molecules in the cytoplasm (I) which are resulted from internalization process. This ratio (PM/I)
can be obtained by using (6.19) and (6.20),
R∗ip(t)
R∗ic(t)
= kir + δic
kii
1
1− e−(kir+δic)t (6.21)
As t→∞, the fraction (6.21) converges to steady state ratio of free CTLA4 molecules on plasma membrane
to free cytoplasmic CTLA4 molecules in the general model (6.1), given in (6.2). Since the labeling process
was only done for 30 minutes, a larger ratio than steady state ratio was obtained.
Note that in confocal microscopy, only a focus plane is visible, meaning that a fraction of total CTLA4
on plasma membrane and in cytoplasm were quantified with confocal microscopy. Therefore, this fraction
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has to be considered in the theoretical value of PM/I ratio. By considering a visible area Avis and a visible
volume Vvis of a spherical cell in confocal microscopy, observed number of molecules are
R∗ip,vis(t) =
Avis
A
R∗ip(t), (6.22)
R∗ic,vis(t) =
Vvis
V
R∗ic(t) (6.23)
where A and V are the area of plasma membrane and volume of cytoplasm of a spherical CHO cell. The
total and visible area and volume of the cell can be obtained from the followings
Avis = 2piRzs,
A = 4piR2,
Vvis =
pizs
6
(
6R2s + z2s
)
,
V = 43piR
3, (6.24)
where R is the radius of spherical cell, Rs is the radius of top focal plane, zs is the thickness of cell slice
that is visible in confocal microscopy (see Figure 6.5). Therefore, the experimentally quantified fraction
of (6.21) is
YPM/I(t) =
R∗ip(t)
R∗ic(t)
= kir + δic
kii
1
1− e−(kir+δic)t
Avis
A
V
Vvis
. (6.25)
Note that CTLA4 molecules on plasma membrane and in cytoplasm are visualized by two different
labeling antibodies, and hence, might show different fluorescent intensities with identical stimulation. This
difference which is directly affecting the quantified PM/I ratio was not quantified in [212]. From observer
(6.25), the rate of CTLA4 synthesis (σi) cannot be observed. By measuring the reaction kinetics of labeling
process CTLA4+LCTLA4∗, and obtaining the number of labeling molecules available in the vicinity of
each CHO cell (Lp), an error that may arise from modeling assumptions (A), (B) and (C) can be extracted.
Thickness of
visible volume
Spherical
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Radius of cell
Bottom focal plane
Radius of top focal plane
Visible plasma membrane (area)
Visible cytoplasm (volume)
Figure 6.5: Visible area and volume of a spherical cell in confocal microscopy
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6.2.3 Model 3: receptor internalization
To determine the rate of internalization, CTLA4-expressing CHO cells were labeled at 4 ◦C with a primary
fluorescently conjugated anti-CTLA4 (primary antibody with a predetermined color). Since in 4 ◦C, natural
trafficking is stopped, only CTLA4 molecules on the plasma membrane were labeled. Then, the cells were
washed, so that no further labeling was allowed. Then, cells are warmed to 37 ◦C for various durations.
Next, the cells were put on ice (4 ◦C) to stop CTLA4 trafficking. Finally, those initially labeled CTLA4
molecules that were still existing on the cell surface (remained on or recycled to plasma membrane) were
detected via a fluorescently conjugated secondary antibody. Note that the secondary antibody could not
bind to free CTLA4 molecules on the plasma membrane, but only to CTLA4 molecules that were initially
labeled with primary antibody. The fraction of the initially labeled CTLA4 molecules that were detected
on plasma membrane by confocal microscopy was obtained at different time points (Figure 6.6A).
In the presented internalization experiment, only the trafficking of an initially labeled CTLA4 molecules
is observed. Therefore, the corresponding model is a simplified version of model (6.16) shown in , without
CTLA4 synthesis and cytoplasmic pool of free (unlabeled) CTLA4 molecules (compare Figure 6.4B and
Figure 6.6B). The model of this experiment can be written as the following homogeneous linear ODE
model (
R˙∗ip(t)
R˙∗ic(t)
)
=
(
−kii kir
kii −(kir + δic)
)(
R∗ip(t)
R∗ic(t)
)
(6.26)
where R∗ip(t) is the subset of CTLA4 molecules which are initially labeled and can be detected on the
plasma membrane, and R∗ic(t) is the cytoplasmic number of labeled CTLA4 molecules. Labeled CTLA4
molecules can only appear in the cytoplasm via internalization process, which is blocked by ice at starting
time of the experiment; therefore, initial value of the cytoplasmic number of labeled CTLA4 molecules
(R∗ic,0) is zero. Note that since we track only a subset of CTLA4 molecules that were initially labeled on
ice, and labeling molecules were no further available in the medium after washing, no newly synthesized
CTLA4 molecules contribute to the pools we observe in later time points. The initial number of labeled
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Figure 6.6: CTLA4 internalization. CTLA4-expressing CHO cells were labeled at 4 ◦C with anti-CTLA4 PE
to label surface CTLA4. Cells were then warmed to 37 ◦C for the time indicated. Then CTLA4 remaining
on the surface was detected on ice with a fluorescently conjugated anti-mouse secondary antibody. (A)
The time course of surface labeling is plotted against initial labeling. Data points are normalized to the
initial data points. The data are reported in [212]. (B) Schematic of the internalization model (6.26).
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CTLA4 molecules on the plasma membrane (R∗ip,0) is equal to the steady state number of free CTLA4
molecules on the plasma membrane obtained from general model (6.1) which is given in (6.2)
R∗ip,0 =
σi(kir + δic)
kiiδic
, (6.27)
R∗ic,0 = 0. (6.28)
The solution of the model with the above initial conditions are (see Appendix B.2):
R∗ip(t) = −
kii + λ2
λ1 − λ2R
∗
ip,0e
λ1t + kii + λ1
λ1 − λ2R
∗
ip,0e
λ2t, (6.29)
R∗ic(t) =
kii
λ1 − λ2R
∗
ip,0e
λ1t − kii
λ1 − λ2R
∗
ip,0e
λ2t, (6.30)
where λ1 and λ2 are the eigenvalues of the model:
λ1 =
1
2
[
−(kii + kir + δic)−
√
(kii + kir + δic)2 − 4kiiδic
]
, (6.31)
λ2 =
1
2
[
−(kii + kir + δic) +
√
(kii + kir + δic)2 − 4kiiδic
]
. (6.32)
The quantified value in experiment is the fraction of initially labeled CTLA4 molecules that remained
on the plasma membrane
R∗ip(t)
R∗ip,0
= 1
λ2 − λ1
(
(kii + λ2)eλ1t − (kii + λ1)eλ2t
)
. (6.33)
Theoretically, the measured fraction in (6.33) at t = 0 is 1. Similarly, the experimental value for this
fraction at t = 0 is 1, because all the data points are normalized to the initial data point at t = 0. By
using normalized data and the fraction given in (6.33), we force a zero estimation error for initial data
point. To avoid this, we introduce a scaling parameter Sint which allows the parameter estimation process
to estimate the initial data point as well. Therefore, we use the following modified theoretical fraction for
parameter estimation:
Yint(t) = Sint
R∗ip(t)
R∗ip,0
= Sint
1
λ2 − λ1
(
(kii + λ2)eλ1t − (kii + λ1)eλ2t
)
(6.34)
With this modified fraction, the estimated initial data point is 1/Sint fold of the measured value. Note
that different antibodies were used to label CTLA4 molecules on the plasma membrane at starting time
of the experiment (at t = 0) and remaining initially labeled CTLA4 molecules on the plasma membrane.
In the theoretical value given in (6.34), it is assumed that antibodies are equally sensitive to visualization.
However, difference in fluorescent intensities resulted from equal stimulation can directly affect the fraction
given in (6.33) and (6.34). From observer (6.34), the rate of protein synthesis (σi) cannot be observed.
6.2.4 Model 4: blocking lysosomal degradation
To quantify the rate of CTLA degradation, two independent experiments were done. In the first experiment,
CTLA4 molecules were labeled by 60 minutes pulse with a labeling antibody (anti-CTLA4 PE) at 37 ◦C.
Since the labeling was performed at 37 ◦C, CTLA4 molecules undergo a normal trafficking. Consequently,
labeled CTLA4 molecules appeared on the plasma membrane and in the cytoplasm. During 60 minutes of
labeling process, only a fraction of total CTLA4 molecules could be labeled. After 60 minutes, cells were
washed, such that no further labeling was allowed. This means that protein synthesis did not contribute
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to the pool of labeled CTLA4 molecules after labeling process was ended. Next, two different samples
with and without addition of Ammonium chloride (NH4Cl) into the medium were prepared. NH4Cl is
known to block lysosomal-degradation pathway. In the presence and absence of NH4Cl, degradation of
labeled CTLA4 molecules were tracked for different time points by flow cytometry, which measures the
fluorescent intensity arising from cellular labeled CTLA4 molecules (summation of CTLA4 molecules on
plasma membrane and in cytoplasm) in a population of cells. Data of this experiment is shown in Figure
6.7A.
In order to construct the model of this experiment, in the first step, we assume that R∗ip,0 and R∗ic,0
number of CTLA4 molecules were labeled after 60 minutes on the plasma membrane and in the cytoplasm,
respectively. Topology of the labeling model is similar to the model given in (6.16). By referring to
equations (6.19) and (6.20), the number of labeled CTLA4 molecules are
R∗ip,0 =
σi(kir + δic)
kiiδic
,
R∗ic,0 =
σi
δic
(
1− e−(kir+δic)t0
)
at t0=60 min, (6.35)
where δic = δil + δin. In the second step, after 60 minutes of labeling, the cells were washed and the
lysosomal degradation of CTLA4 was blocked by NH4Cl, which is equivalent to δil = 0. The second
step of this experiment can be modeled by the following differential equation (depicted in Figure 6.7B
schematically)
(
R˙∗ip(t)
R˙∗ic(t)
)
=
(
−kii kir
kii −(kir + δin)
)(
R∗ip(t)
R∗ic(t)
)
(6.36)
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Figure 6.7: CTLA4 degradation block. (A) CTLA4-expressing CHO cells were labeled with a 1-hour pulse
of anti-CTLA4 PE. Cells were then washed and incubated for various time-points in the presence or absence
of NH4Cl and analyzed for CTLA4 expression by flow cytometry. (B) Schematic of the model for NH4Cl-
dependent lysosomal degradation block with initial labeling, given in (6.36). (C) Schematic of the model
for control experiment with initial labeling.
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with initial conditions given in (6.35). The complete solution of this model is (see Apendix B.3):
R∗ip(t) = C1eλ1t + C2eλ2t, (6.37)
R∗ic(t) = C1
kii + λ1
kir
eλ1t + C2
kii + λ2
kir
eλ2t, (6.38)
where
λ1 =
1
2
[
−(kii + kir + δin)−
√
(kii + kir + δin)2 − 4kiiδin
]
, (6.39)
λ2 =
1
2
[
−(kii + kir + δin) +
√
(kii + kir + δin)2 − 4kiiδin
]
(6.40)
are the eigenvalues of the model and
C1 = −R∗ic,0
kir
λ2 − λ1 +R
∗
ip,0
kii + λ2
λ2 − λ1 , (6.41)
C2 = R∗ic,0
kir
λ2 − λ1 −R
∗
ip,0
kii + λ1
λ2 − λ1 (6.42)
are the constant coefficients. The experimentally quantified value (observer) which is reported in Figure
6.7A-NH4Cl, is equivalent to the following theoretical value
YNH4Cl,1(t) = R∗ip(t) +R∗ic(t). (6.43)
In the same experiment where NH4Cl was missing in the medium, the similar model as (6.36) can be
used by replacing δin with δic = δil + δin (see Figure 6.7C). The theoretical value below is equivalent to
experimentally quantified values shown in Figure 6.7A-Control
YCTR(t) = R∗ip,CTR(t) +R∗ic,CTR(t), (6.44)
where R∗ip,CTR(t) and R∗ic,CTR(t) have the following form
R∗ip,CTR(t) = C1eλ1,CTRt + C2eλ2,CTRt, (6.45)
R∗ic,CTR(t) = C1
kii + λ1,CTR
kir
eλ1,CTRt + C2
kii + λ2,CTR
kir
eλ2,CTRt (6.46)
where
λCTR,1 =
1
2
[
−(kii + kir + δic)−
√
(kii + kir + δic)2 − 4kiiδic
]
, (6.47)
λCTR,2 =
1
2
[
−(kii + kir + δic) +
√
(kii + kir + δic)2 − 4kiiδic
]
(6.48)
are the eigenvalues of the model with δic = δil + δin and
C1 = −R∗ic,0
kir
λCTR,2 − λCTR,1 +R
∗
ip,0
kii + λCTR,2
λCTR,2 − λCTR,1 , (6.49)
C2 = R∗ic,0
kir
λCTR,2 − λCTR,1 −R
∗
ip,0
kii + λCTR,1
λCTR,2 − λCTR,1 (6.50)
are the constant coefficients.
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In another experiment, CHO cells were treated with or without NH4Cl for 3 hours. Then, total cellular
CTLA4 molecules were quantified by flow cytometry using anti-CTLA4 PE, a fluorescently labeled antibody.
Data of this experiment is shown in Figure 6.8. This experiment can be represented by the following model(
R˙ip(t)
R˙ic(t)
)
=
(
−kii kir
kii −(kir + δin)
)(
Rip(t)
Ric(t)
)
+
(
σi
0
)
(6.51)
where degradation in cytoplasm only includes non-lysosomal degradation pathway (with rate δin). Model
(6.51) has the following initial conditions which is similar to steady state values of general model (6.1)
given in (6.2) with δic = δil + δin
Rip,0 =
σi(kir + δil + δin)
kii(δil + δin)
, (6.52)
Ric,0 =
σi
δil + δin
. (6.53)
Note that the total cellular CTLA4 before adding NH4Cl is equal to:
Rip,0 +Ric,0 =
σi(kii + kir + δil + δin)
kii(δil + δin)
. (6.54)
The exact solution of the model is as follows (see Appendix B.4.1)
Rip(t) = −σi(λ1 + λ2 + kii)
λ1λ2
+ C1eλ1t + C2eλ2t, (6.55)
Ric(t) = − σi
kir
(kii + λ1)(kii + λ2)
λ1λ2
+ C1
kii + λ1
kir
eλ1t + C2
kii + λ2
kir
eλ2t (6.56)
where
λ1 =
1
2
[
−(kii + kir + δin)−
√
(kii + kir + δin)2 − 4kiiδin
]
, (6.57)
λ2 =
1
2
[
−(kii + kir + δin) +
√
(kii + kir + δin)2 − 4kiiδin
]
, (6.58)
C1 = −Ric,0 kir
λ2 − λ1 +Rip,0
kii + λ2
λ2 − λ1 +
σi(kii + λ2)
λ1(λ2 − λ1) , (6.59)
C2 = Ric,0
kir
λ2 − λ1 −Rip,0
kii + λ1
λ2 − λ1 −
σi(kii + λ1)
λ2(λ2 − λ1) . (6.60)
λ1,2 are the eigenvalues of the model (6.51). During parameter estimation by differential evolution, random
generation of parameters may set extremely low values for δin, which results in one approximately zero
eigenvalue in the model. In the special case of δin = 0, the solution of the model is as follows (see
Appendix B.4.2)
Rip(t) =
σi
λ2
[
(kii + λ2)t+
kii
λ2
]
+ C1 + C2eλ2t, (6.61)
Ric(t) =
σikii(kii + λ2)
kirλ2
[
t+ 1
λ2
]
+ C1
kii
kir
+ C2
kii + λ2
kir
eλ2t (6.62)
where
λ1 = −(kii + kir), (6.63)
λ2 = 0 (6.64)
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Figure 6.8: CTLA4 degradation and synthesis block. (A) CHO cells expressing CTLA4 were treated as
shown for 3 hours followed by fixation and staining for total cellular CTLA4 using anti-CTLA4 PE. Cells
were analyzed by flow cytometry, and the relative fluorescence was plotted. Data are reported in [212].
(B) Schematic of the model for NH4Cl-dependent block of lysosomal degradation, given in (6.51). In this
experiment δil = 0. All CTLA4 molecules could be observed in this experiment, in contrast to model
(6.36) where only an initially labeled subset of CTLA4 molecules were observed. (C) Schematic of the
model for CHX-dependent CTLA4 synthesis block, given in (6.68). In this model, σi = 0, and total CTLA4
molecules were counted experimentally.
are the eigenvalues of the model and
C1 =
(
1 + kii
λ2
)
Rip,0 − kir
λ2
Ric,0, (6.65)
C2 =
kir
λ2
Ric,0 − kii
λ2
Rip,0 − σikii
λ22
(6.66)
are the constant coefficients. The quantified value shown in Figure 6.8 is
YNH4Cl,2(t) =
Rip(t) +Ric(t)
Rip,0 +Ric,0
(6.67)
where Rip,0 + Ric,0 is given in (6.54). Note that in observer (6.67), the rate of protein synthesis (σi)
cannot be observed.
6.2.5 Model 5: blocking receptor synthesis
To observe the contribution of CTLA4 synthesis in CTLA4 homeostatic numbers, CTLA4-expressing CHO
cells were treated with Cycloheximide (CHX) which is known to block protein synthesis. The data in
Figure 6.8 indicates 3 hours of CTLA4 trafficking without protein synthesis (σi = 0). This experiment
can be modeled by the following equations (shown schematically in Figure 6.8C), with initial CTLA4
values obtained from steady state values of the general model (6.1), which has the protein synthesis(
R˙ip(t)
R˙ic(t)
)
=
(
−kii kir
kii −(kir + δic)
)(
Rip(t)
Ric(t)
)
. (6.68)
6.2. MODELING 103
At t = 0 the CTLA4 values are as follows (which indicates the CTLA4 values before adding CHX)
Rip,0 =
σi(kir + δic)
kiiδic
,
Ric,0 =
σi
δic
. (6.69)
Total number of cellular CTLA4 molecules before adding CHX is
Rip,0 +Ric,0 =
σi(kii + kir + δic)
kiiδic
= −σi(λ1 + λ2)
λ1λ2
(6.70)
where λ1 and λ2 are the eigenvalues of the model (6.68):
λ1 =
1
2
[
−(kii + kir + δic)−
√
(kii + kir + δic)2 − 4kiiδic
]
, (6.71)
λ2 =
1
2
[
−(kii + kir + δic) +
√
(kii + kir + δic)2 − 4kiiδic
]
. (6.72)
The CTLA4 levels in CHO cells by treating with CHX are varying according to the following functions (see
Appendix B.5):
Rip(t) = C1eλ1t + C2eλ2t, (6.73)
Ric(t) = C1
kii + λ1
kir
eλ1t + C2
kii + λ2
kir
eλ2t (6.74)
where
C1 =
σi[λ1λ2 + (kir + δic)λ2]
λ1λ2(λ2 − λ1) , (6.75)
C2 = −σi[λ1λ2 + (kir + δic)λ1]
λ1λ2(λ2 − λ1) (6.76)
are the constant coefficients. The data in Figure 6.8 indicates the ratio of the number of CTLA4 molecules
at t = 180 minutes without protein synthesis and the control. The number of CTLA4 molecules in control
cells is equal to the initial values. Control and synthesis-blocked cells are equivalent at t = 0. The observer
of this experiment is as follows
YCHX(t) =
Rip(t) +Ric(t)
Rip,0 +Ric,0
. (6.77)
Note that in (6.77), the rate of protein synthesis (σi) cannot be observed.
6.2.6 Model 6: receptor recycling
Kinetics of CTLA4 recycling was carried out by confocal microscopy. CTLA4-expressing CHO cells were
incubated with Alexa488-conjugated anti-CTLA4 (a green antibody) for 60 min at 37 ◦C. During this step,
a subset of CTLA4 molecules were labeled via cell surface and subsequently internalized or further recycled
to the plasma membrane. Assume that the labeled CTLA4 on the plasma membrane and in cytoplasm are
represented by Rgip and R
g
ic, respectively. Schematic of a model that can represent this labeling step is
shown in Figure 6.9A. This model has the following formR˙ic(t)R˙gip(t)
R˙gic(t)
 =
−(kir + δic) 0 0kir −kii kir
0 kii −(kir + δic)

Ric(t)Rgip(t)
Rgic(t)
+
 0σi
0
 (6.78)
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with the following initial conditions
Rgip,0 =
σi(kir + δic)
kiiδic
(6.79)
Ric,0 =
σi
δic
(6.80)
Rgic,0 = 0 (6.81)
Model (6.78) is equivalent to model (6.16) representing the labeling process. Therefore, according to
solutions given in (6.20), the following amount of CTLA4 are greed-labeled after t0 = 60 minutes:
Ric,t0 =
σi
δic
e−(kir+δic)t0 (6.82)
Rgip,t0 = R
g
ip,0 =
σi(kir + δic)
kiiδic
(6.83)
Rgic,t0 =
σi
δic
(
1− e−(kir+δic)t0
)
(6.84)
Cells were then washed, and surface CTLA4 molecules were blocked on ice with unconjugated anti-
human IgG, an antibody without color. Let’s assume that this blocking antibody bound to all green-labeled
CTLA4 molecules on plasma membrane (represented by RgBip ). Once the trafficking is allowed, these green
and blocked CTLA4 molecules can be internalized to the cytoplasm (represented by RgBic ). Since the
blocking process was on ice, no green and blocked CTLA4 molecules was internalized. Therefore, the
values of of green-blocked CTLA molecules on plasma mebrane and in cytoplasm are:
RgBip,t0 = R
g
ip,t0
= σi(kir + δic)
kiiδic
(6.85)
RgBic,t0 = 0 (6.86)
Next, cells were washed (no further CTLA4 blocking was possible) and incubated with Alexa555-
conjugated anti-human IgG (a red antibody) at 37 ◦C. This antibody is able to bind to green-labeled
CTLA4 molecules that are not blocked. Therefore, this allows to detect green-labeled CTLA4 molecules
that are recycling to plasma membrane from cytoplasm. The red labeled CTLA4 molecules on plasma
membrane and cytoplasm are represented by Rgrip and R
gr
ic , respectively. During the second labeling process
states of the model follow equations below:R˙gBip (t)
R˙gBic (t)
 = (−kii kir
kii −(kir + δic)
)(
RgBip (t)
RgBic (t)
)
(6.87)
R˙
g
ic(t)
R˙grip (t)
R˙gric (t)
 =
−(kir + δic) 0 0kir −kii kir
0 kii −(kir + δic)

R
g
ic(t)
Rgrip (t)
Rgric (t)
 (6.88)
with the initial conditions given in (6.84), (6.85), (6.86) and the followings:
Rgrip,t0 = 0 (6.89)
Rgric,t0 = 0 (6.90)
Submodel (6.87) is equivalent to internalization model (6.26), and submodel (6.88) is equivalent to
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Figure 6.9: CTLA4 recycling model. Similar to PM/I experiment (Figure 6.4), nonlinear labeling model
can be simplified to a linear ODE model. Only the simplified models are shown here. Recycling model is
developed for two experimental steps: submodel (A) corresponds to first labeling process with Alexa488-
conjugated anti-CTLA4 (green) and submodel (B) corresponds to second labeling step with Alexa555-
conjugated anti-human IgG (red), during which the recycling of green-labeled CTLA4 molecules occurs
after initially blocking the green-labeled CTLA4 molecules on plasma membrane (on ice). Note that the
number of green-labeled CTLA4 molecules after 1 hour in submodel (A) is used as initial conditions for
submodel (B).
homogeneous version of labeling model in (6.16). The following solutions can be obtained (see Appendix
B.6):
RgBip (t) = −
kii + λ3
λ2 − λ3R
gB
ip,0e
λ2t + kii + λ2
λ2 − λ3R
gB
ip,0e
λ3t, (6.91)
RgBic (t) =
kii
λ2 − λ3R
gB
ip,0e
λ2t − kii
λ2 − λ3R
gB
ip,0e
λ3t, (6.92)
Rgic(t) = R
g
ic,t0
eλ1t, (6.93)
Rgrip (t) = −Rgic,t0
kir
λ3 − λ2 e
λ2t +Rgic,t0
kir
λ3 − λ2 e
λ3t, (6.94)
Rgrip (t) = −Rgic,t0eλ1t −Rgic,t0
kii + λ2
λ3 − λ2 e
λ2t +Rgic,t0
kii + λ3
λ3 − λ2 e
λ3t, (6.95)
where
λ1 = −(kir + δic), (6.96)
λ2 =
1
2
[
−(kii + kir + δic)−
√
(kii + kir + δic)2 − 4kiiδic
]
, (6.97)
λ3 =
1
2
[
−(kii + kir + δic) +
√
(kii + kir + δic)2 − 4kiiδic
]
(6.98)
are the eigenvalues of the model, Rgic,t0 and R
gB
ip,0 are given in (6.84) and (6.85), respectively. In notation
of variables, the superscript gr is taken from “green-red” which means that these molecules is labeled with
both labeling antibody, gB is taken from “green-blocked” and g is taken from “green”.
All the green and red labeled CTLA4 molecules were quantified by confocal microscopy. Experimental
data are shown in Figure 6.10. Green and red fluorescent intensities are assumed to be proportional to the
theoretical values, G(t) and R(t), respectively. Note that experimental values were measured by confocal
microscopy, and therefore, only fractions of CTLA4 molecules on plasma membrane and in cytoplasm were
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Figure 6.10: CTLA4 recycling data [212]. (A) Live-cell confocal imaging of recycling receptors was carried
out using CTLA4-expressing CHO cells. Cells were incubated with Alexa488-conjugated anti-CTLA4 (green
antibody) for 60 minutes at 37 ◦C. Cells were then washed, and surface CTLA4 receptors were blocked with
unconjugated anti-human IgG at 4 ◦C (secondary antibody without any color). Cells were then incubated
with Alexa555-conjugated anti-human IgG (secondary antibody with red color) to detect recycling receptors.
Confocal Z-stacks were then acquired at the time points shown. Panel (B) shows quantification of mean
fluorescent intensities from (A).
observed (see equation (6.24) and Figure 6.5). These values are
G(t) = Vvis
V
[
RgBic (t) +R
g
ic(t) +R
gr
ic (t)
]
+ Avis
A
[
RgBip (t) +R
gr
ip (t)
]
(6.99)
R(t) = Vvis
V
Rgric (t) +
Avis
A
Rgrip (t) (6.100)
from which the normalized values can be obtained:
G¯(t) = G(t)G(t = 0) (6.101)
Yrc,R(t) = R¯(t) =
R(t)
max(R(t)) (6.102)
Note that in (6.101), the theoretical and experimental values for t = 0 are equal to 1. Therefore,
normalization forces zero estimation error for first data point in green fluorescence. To avoid this, we
define a scaling parameter Src which allows the identification procedure to estimate the initial data point
as well. Further, nonzero value of red fluorescent intensity in Figure 6.10A-B at t = 0 indicates to a delay
between the starting time of recycling process and measurement. We define a forward shifting time (∆trc)
for experimental measurements as a parameter to take into account such delay. By this definition, we use
the following modified theoretical value for green fluorescent measurement in parameter estimation:
Yrc,G(t) = G¯(t) = Src
G(t)
G(∆trc)
(6.103)
Note that since we considered the time shift in experimental values, and red fluorescent measurements are
normalized to maximum value but not to initial data point, theoretical value (6.101) does not need any
modification and is suitable for parameter estimation. From observers (6.103) and (6.102), the rate of
protein synthesis (σi) cannot be observed.
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6.2.7 Model 7: trans-endocytosis
It has been shown that CTLA4 can capture CD80/CD86 ligands from opposing cells by a process of trans-
endocytosis [213]. This ligand capturing is followed by degradation inside CTLA4-expressing cells. Such
an observation was performed in CHO-cell lines by live-cell imaging of CTLA4+ CHO cells interacting with
CHO cells expressing CD86 molecules. In this experiment, a CHO cell line used in which CD86 molecules
tagged with green fluorescent protein (GFP). In a mixture sample of CD86- and CTLA4-expressing CHO
cells, the kinetics of CD86 removal was observed by confocal microscopy (shown in Figure 6.11). Herein,
the aim is to use such confocal microscopy data in order to estimated the rate of CD86 removal and its
subsequent fates, such as degradation.
The trans-endocytosis model (depicted in Figure 6.12) is composed of essential CTLA4 trafficking
sub-processes that considered in previous ligand-independent models (compare Figure 6.12 with Figure
6.2), in addition to CD86-trafficking components in CD86-expressing cells and molecular reactions (CTLA4
+ CD86 CTLA4:CD86) in cells contact surface (Acs). The underlying assumptions of trans-endocytosis
model are the followings:
• Rates of CTLA4 molecule synthesis (σi), internalization (kii), recycling (kir), degradation (δic, δil
and δin) are identical to ligand-independent model (depicted in Figure 6.2).
• CD86 synthesis (with rate σ86) results in the maintenance of a homeostatic number of CD86
molecules on the plasma membrane (L86p) and subsequently in the cytoplasm (L86c) after internal-
ization (with k86i). This assumes that newly synthesized CD86 molecules are not directly undergo
the degradation pathway that exists in the cytoplasm, but only after exocytosis to plasma membrane
and subsequent internalization to cytoplasm.
• The cytoplasmic CD86 molecules are degraded with a constant rate δ86c.
• Exocytosis (recycling) of intracellular CD86 molecules (L86c) is assumed to be negligible.
• Upon interaction with CTLA4+ cells, CD86 molecules on the plasma membrane of CD86+ cells
(L86p) bind to CTLA4 molecules on the plasma membrane of opposing cell (Rip) with constant
binding rate (ki:86) and form CTLA4:CD86 complex (Ri:86p). This complex can unbind with a
constant rate (k̂i:86).
• CTLA4:CD86 complex on interaction surface (Ri:86p) can be internalized by CTLA4-expressing cell
(with rate kt86). These internalized complexes (Ri:86c) are directly degraded (with rate δi:86c), or
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Figure 6.11: Trans-endocytosis data [213]. (A) Time-lapse (0-80 minutes) confocal micrographs of GFP-
tagged CD86 (green) transfer into CTLA4 expressing cells which are stained red by pulsing anti-CTLA4
APC. White images show CD86 alone. (B) Quantitation of CD86 GFP mean fluorescence intensity of the
cells shown in (A). Substantial depletion of GFP fluorescence from the plasma membrane of the CD86
donor cell and a corresponding increase in GFP inside the CTLA4+ recipient cell is evident.
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are dissociated (with rate krc86).
• CTLA4 molecules resulted from dissociation of CTLA4:CD86 complexes are recovered and added
to cytoplasmic CTLA4 molecules (Ric).
• Rate of CD86 degradation in CD86-expressing and CTLA4-expressing cells are identical.
Based on the above assumptions, trans-endocytosis model can be represented by the following nonlinear
ODE-based model:
R˙ic(t) = kiiRip(t)− (kir + δic)Ric(t) + krc86Ri:86c(t), (6.104)
R˙ip(t) = σi + kirRic(t)− kiiRip(t)− ki:86Rip(t)
A
L86p(t)
A
Acs + k̂i:86Ri:86p(t), (6.105)
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Figure 6.12: Schematic of trans-endocytosis model.
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R˙i:86p(t) = ki:86
Rip(t)
A
L86p(t)
A
Acs − (kt86 + k̂i:86)Ri:86p(t), (6.106)
R˙i:86c(t) = kt86Ri:86p(t)− krc86Ri:86c(t)− δi:86cRi:86c(t), (6.107)
˙̂
L86c(t) = krc86Ri:86c(t)− δ86cL̂86c(t), (6.108)
L˙86p(t) = σ86 − k86iL86p(t)− ki:86Rip(t)
A
L86p(t)
A
Acs + k̂i:86Ri:86p(t), (6.109)
L˙86c(t) = k86iL86p(t)− δ86cL86c(t). (6.110)
where Acs is the total area of cell-cell contact surface with radius r and Acs,vis is the visible area of contact
surface in confocal microscopy (see Figure 6.13). Note that the nonlinearity of the model arises from the
forward reaction of receptor-ligand binding (CTLA4 + CD86 → CTLA4:CD86).
The observers in this experiment are the mean fluorescent intensities acquired from CD86 donor cell
and recipient cell. It is assumed that these intensities are proportional to theoretical values Gd(t) and
Gr(t) for donor and recipient cells respectively
Gd(t) =
Vvis
V
L86c(t) +
Avis
A
L86p(t) +
1
2
Acs,vis
Acs
Ri:86p(t) (6.111)
Gr(t) =
Vvis
V
Ri:86c(t) +
Vvis
V
L̂86c(t) +
1
2
Acs,vis
Acs
Ri:86p(t) (6.112)
It is assumed that 50% of intensity arising from total CTLA4:CD86 complexes in contact surface was
counted for each interacting cell.
We normalize data in Figure 6.11B to initial data point of CD86+ cell. To avoid zero error of
estimation for this data point, we define a scaling factor Strans, in the same way it was defined in (6.34)
and (6.103).
As it is evident from Figure 6.11A-B, CD86 removal started before observing the samples in confocal
microscopy. In order to incorporate this delay, an unknown forward shift ∆ttrans is considered in data which
will be estimated by parameter estimation algorithm. Hence, the following observes are used for parameter
Thickness of
visible volume
Cell-cell contact surface
with radius     and area
Visible contact surface (area =            )
r
CHO Cell
Radius of cell
Radius of top focal plane
Bottom focal plane
Visible plasma membrane (area)
Visible cytoplasm (volume)
Cell contact surface
Figure 6.13: Visible area and volume of cell contacts in confocal microscopy.
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estimation:
Ytrans,d(t) = Strans
Gd(t)
Gd(∆ttrans)
(6.113)
Ytrans,r(t) = Strans
Gr(t)
Gd(∆ttrans)
(6.114)
6.3 Results
The parameter estimation is divided into two steps. First, the parameters of ligand-independent model
(shown in Figure 6.2) is acquired. Then, the parameters are used for ligand-dependent model in order to
estimate remaining parameters.
6.3.1 Parameter estimation of ligand-independent model of CTLA4 trafficking
Summary of experimental and corresponding theoretical observations are given in Table 6.1.
Ligand-independent CTLA4 trafficking model in its simplest form (6.1) has 5 unknown parameters.
There are 3 additional parameters that are concerned with the types of data reported in the literature and
aimed to improve estimation quality. These parameters and associated dimensions are listed in Table 6.2.
The following cost (objective) function E(θ) is minimized by differential evolution algorithm for parameter
estimation:
E(θ) = 1m∑
k=1
dk
m∑
k=1
dk∑
l=1
(
Ŷkl − Yk(θ, tl)
Ŷk,max
)2
(6.115)
where Ŷkl is observed value from k-th experiment at time t = tl and Yk(θ, tl) is corresponding theoretical
value (observer) obtained from model with parameter set θ, dk is the number of data points in k-th
experiment, Ŷk,max is the maximum observed experimental value in k-th experiment, and m is the number
of independent experiments (m ∈ {1, · · · , 7}). A differential evolution (DE) algorithm is performed,
according to pseudo-code 1 in chapter 3, with 1000 initial solutions with randomly generated parameters
in range [0,5], CR = 0.5 and F = 0.5. Maximum number of generations Gmax = 1000 is considered as
termination criterion of DE.
Table 6.1: Summary of ligand-independent experiments
Exp. No. (m) Experiment description Observer Equation # points Max time
1 PM/I ratio YPM/I (6.25) 1 30 min
2 Internalization Yint (6.34) 5 30 min
Lysosomal degradation block3 of initially labeled CTLA4 YNH4Cl,1 (6.43) 3 360 min
4 Control experiment YCTR (6.44) 3 360 min
Lysosomal degradation block5 without initial labeling YNH4Cl,2 (6.67) 1 180 min
6 Synthesis block YCHX (6.77) 1 180 min
7G Red fluorescent Yrc,R (6.102) 20
7R Recycling Green fluorescent Yrc,G (6.103) 20
95 min
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First, an optimal parameter set (θ∗t ) is obtained by considering all the experiments. Next, improvement
in the value of cost function with exclusion of each independent experiment, irrespective of obtained optimal
parameter values, is evaluated by following formula
∆Em =
1
dm
E(θ∗t )− E(θ∗m)
E(θ∗t )
(6.116)
where E(θ∗m) is the cost function evaluated by optimal parameter set θ∗m obtained by exclusion of m-th
experiment, dm is the number of data points in experiment m and m ∈ {1, · · · , 7}. ∆Em is a measure for
improvement in the value of cost function per excluded data point, and an index to show which experiment
is the major impediment in decreasing the value of cost function. Experiment exclusion results are given
in Table 6.3.
It turned out that exclusion of PM/I experiment, where the ratio of the number of CTLA4 molecules on
the plasma membrane to internalized CTLA4 molecules was obtained after an initial labeling (see section
6.2.2), leads to a large improvement (≈ 67% decrease) in the value of cost function. The main uncertainty
in PM/I experiment is the difference in fluorescent intensity of two different labeling antibodies that were
employed. Another round of experiment exclusion by evaluating ∆E1,m,m ∈ {2, · · · , 7}, which is the
evaluation of (6.116) after excluding PM/I experiment (m = 1), reveals a decrease of ≈ 30% in the value
of cost function by removing data of lysosomal-degradation block (experiment m = 5), despite a minor
change in obtained parameter values (not shown). In Table 6.2, the values of parameters are given with
exclusion of experiments m = 1 and m = 5. The model simulations are shown in Figure 6.14.
Table 6.2: Ligand-independent CTLA4 trafficking parameters
Parameter Description Dimension Estimated value
σi CTLA4 synthesis rate # min−1 Not identified
kii Internalization rate min−1 0.5192
kir Recycling rate min−1 0.02
δin non-lysosomal degradation min−1 0.0005
δil Lysosomal degradation min−1 0.0036
δic Cytoplasmic degradation rate min−1 δil + δin
Sint Scaling factor in internalization model; (6.34) - 0.9641
Src Scaling factor in recycling model; (6.103) - 0.9819
∆trc Shifting time in recycling data; (6.103) min 6.77
Table 6.3: Experiment exclusion results
Exp. No. (m) Experiment description # points ∆Em ∆E1,m
1 PM/I ratio 1 67.29 -
2 Internalization 5 15.08 -238.85
3 Lysosomal degradation block 3 0.78 6.92of initially labelled CTLA4
4 Control experiment 3 1.93 10.4
5 Lysosomal degradation block 1 8.66 30.09without initial labeling
6 Synthesis block 1 -0.08 4.28
7G Recycling Green fluorescent 20 -1.18 0.117R Red fluorescent 20
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Figure 6.14: Parameter identification of ligand-independent model of CTLA4 trafficking. Parameters
are given in Table 6.2. Experiments are summarized in Table 6.1. Rate of CTLA4 synthesis can only be
estimated from degradation block and control experiments (m=3,4) shown in panel (B), where the absolute
mean fluorescent intensities are provided (σi = 2.69 fluroscent intensity per minute). However, estimated
rate has a dimension of fluorescent intensity per minute, but not the number of molecules (#) per minute.
Observed quantities in other ligand-independent experiments are independent of CTLA4 synthesis rate,
as can be seen from theoretical values, mainly because of data normalization. Mean squared error of
estimation for ligand-independent experiments m=1,· · · ,7 are MSE1 = 0.738,MSE2 = 0.008,MSE3 =
0.0036,MSE4 = 0.006,MSE5 = 0.052,MSE6 = 0.008,MSE7 = 0.0003. Note that experiments m=1,5
are not considered for parameter estimation.
6.3.2 Parameter estimation of trans-endocytosis
Trans-endocytosis model (Figure 6.11) has 14 parameters. 4 parameters (kii, kir, δil, δin) are estimated
from ligand-independent models. Considering a CTLA4-independent model of CD86 trafficking (in the
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absence of trans-endocytosis process):
L˙86p(t) = σ86 − k86iL86p(t), (6.117)
L˙86c(t) = k86iL86p(t)− δ86cL86p(t). (6.118)
Equilibrium points for model above are the followings:
L86p =
σ86
k86i
, L86c =
σ86
δ86c
. (6.119)
By considering that X% of total CD86 molecules are expressed on cell surface, we have:
δ86c =
X
1−Xk86i. (6.120)
The value of X is large since CD86 is mostly expressed on cell surface. We take X = 98% suggested by
the authors of [213] (personal communication).
The affinity of reaction between CTLA4 and CD86 and formation of CTLA4:CD86 complex (CTLA4 +
CD86  CTLA4:CD86) is usually given in units of three-dimension, since they are obtained from soluble
forms of reactants [14]. However, model contains a two-dimensional version of complex formation from
membrane-bound reactants. Two-dimensional reactions have larger binding rates than three-dimensional
reactions, since diffusion of membrane-bound reactants are more restricted. It is experimentally difficult to
estimate two-dimensional binding rate, and therefore, commonly converted from three-dimensional rate con-
stants by analytic approximations. We use approximated two-dimensional rate constants reported in [214].
Note that binding rate in the model has a dimension of #−1µm2s−1, where # is the number of molecules.
Experimental data shown in Figure 6.11 report mean fluorescent intensity as an indicator of molecu-
lar number and consequently, binding rate should have a dimension of [Fluorescent Intensity]−1µm2s−1.
Similar data normalization in both data and model, given in (6.113) and (6.114), allows to remove this dis-
crepancy between dimensions. By using equation (6.120), and fixing binding constant rates (ki:86, k̂i:86),
7 unknown parameters remain unknown. We employ differential evolution algorithm to obtain optimal
parameter set (θ∗), given observers in (6.113) and (6.114) and experimental data in Figure 6.11. The
following cost function is minimized:
E(θ) = 1
p
 p1∑
l=1
(
Ŷd,l
Ŷd,1
− Ytrans,d(θ, tl)
)2
+ ω2
p2∑
l=1
(
Ŷr,l
Ŷd,1
− Ytrans,r(θ, tl)
)2 (6.121)
where Ŷd,l is l-th experimental data point of CD86-donor cell (CD86-expressing cell), Ŷr,l is l-th exper-
imental data of CD86-recipient cell (CTLA4-expressing cell), p = 60 is total number of data points,
p1 = p2 = 30 is number of data points for each curve, and ω2 is a weighting factor, defined as
ω2 =
(
Ŷd,1
Ŷr,max
)2
(6.122)
Since the MFI curve for CD86-recipient cell (Ŷr) has lower values than for CD86-donor cell (Ŷd), the
weighting factor ω2 is introduced in order to increase the contribution of estimation error of the MFI curve
for CD86-recipient cell. In general, one can normalize each curve, independent of other curves, to its
maximum value; however, two curves in our experiment are dependent, and different data scale in these
curves has an information that should not be neglected via data normalization. Instead, we use a weighting
factor, rather than independent normalization, to make a fair contribution of the two curves in our cost
function. This is the main reason why the cost function (6.121) differs from conventional cost functions
in (6.115) or (3.39). Estimated parameters are reported in Table 6.4, and model prediction for the value
of observers are shown in Figure 6.15.
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Table 6.4: Parameters of trans-endocytosis model
Parameter Description Dimension Value
σi Rate of CTLA4 synthesis # min−1 875
σ86i Rate of CD86 synthesis # min−1 227
ki:86 Two-dimensional binding rate of CTLA4 and
CD86
#−1 µm2 sec−1 1.09; fixed
k̂i:86 Unbinding rate of CTLA4:CD86 complex sec−1 5.1; fixed
kt86 Trans-endocytosis rate of CTLA4:CD86 com-
plex
min−1 0.7341
krc86 Rate of CTLA4 recovery min−1 0.47307
δi:86c Rate of CTLA4:CD86 degradation min−1 0.0647148
k86i Rate of CD86 internalization min−1 0.0006
δ86c Rate of CD86 degradation min−1 49k86i = 0.0294
Strans Scaling factor in trans-endocytosis model;
(6.113) and (6.114)
- 0.957
∆ttrans Shifting time in trans-endocytosis data;
(6.113) and (6.114)
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N
or
m
al
iz
ed
 v
al
ue
time (min)
Trans-endocytosis experiment
0 50 100 150 200 250 300
0
0.2
0.4
0.6
0.8
1 Model: CD86+cell
Model: CTLA4+cell
Experiment: CD86+cell
Experiment: CTLA4+cell
Figure 6.15: Parameter estimation of trans-endocytosis model. Parameters are given in Table 6.4. Mean
squared error (MSE) of curves are MSECTLA4+ = 0.0107,MSECD86+ = 0.0585.
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6.4 Summary
CTLA4 is an essential negative regulator of T cell immune responses and is a receptor that interacts
with cell surface transmembrane ligands. Endocytosis of CTLA4 is continuous and rapid with subsequent
recycling and degradation. Furthermore, upon ligation with co-stimulatory molecules, CTLA4 can remove
the ligands from opposing cells by trans-endocytosis. In order to determine the impact of this cell-extrinsic
mechanism of CTLA-4 in the regulation of T cell immune response, we proposed a CTLA4 trafficking model
and quantify synthesis, internalization, recycling, and degradation rates of CTLA4. First, a general model
is constructed by assuming all the basic mechanisms exist in CTLA-4 trafficking. Thereafter, according to
the protocols used in the experiments, the general model is adapted in a way to capture the experiment-
specific observations. These attempts lead to the identification of all CTLA4 trafficking parameters. The
resulting and experimentally validated model can be used to develop new hypothesis of how the particular
mechanism of ligands CD80/86 removal may impact onto the stimulatory potential of antigen presenting
cells and, by this, onto the control of immune stimulation versus suppression.

Chapter 7
Summary, conclusions and outlook
In this thesis, a theoretical framework is presented for analysis of immunological processes involved in
immune tolerance induction, maintenance and breaking in T cell repertoire. By using a simplistic view of
immunological components and processes, a series of qualitative and quantitative mathematical models
are constructed and analyzed to study one of the fundamental challenges of the field of immunology which
is to explain how immune tolerance is induced or should be induced. Mathematical models of immune
processes are constructed for three interdependent stages, with respect to location and time, which are
summarized in the following sections.
7.1 Thymic selection
The construction phase of T cell repertoire in thymus is studied by agent-based modeling approach. The
interest was to explain how regulatory (suppressor) T cells and conventional (effector) T cells are extracted
from a pool of T precursor cells (thymocytes) with randomly generated antigen recognition receptor (T cell
receptor, TCR). Agent-based modeling approach allows us to consider heterogeneity in generation of T cell
receptor (TCR) sequences, and observe the consequences of such heterogeneity in thymic selection, which
is not fully achievable in experiments. We are particularly able to track the signaling dynamics of each agent
(cell) with changing the environmental factors (such as the number of peptides and antigen presenting cells),
which is not fully achievable experimentally in single cell level. Different experimental protocols existing
in the immunological literature are translated into different corresponding agent-based simulations. These
simulations allowed the validation of the agent-based model with experimental evidences. Upon model
validation, the presented agent-based model is used for predictions.
By using the agent-based model, a TCR-mediated signal integration hypothesis for thymic selection is
studied. This hypothesis suggests a novel mechanism by which cells would be able to extract information
about the specificity of their TCRs. By tracking the signaling behavior of cells, it is shown in silico that by
relying on the strength and dynamics of integrated TCR signal, thymocytes are able to extract the affinity
of their TCR to host’s MHC molecules, the molecules that present antigens derived from both host’s
tissues and foreign microorganisms to T cells. This suggestion is based on correlation analysis between
TCR signaling components and different affinity-based indices.
It is shown in silico that by selecting thymocytes that sustain their integrated TCR signal in a sufficiently
high level, a T cell repertoire is constructed with cells that have sufficiently high MHC affinity. It is shown
that high MHC affinity allows T cells to recognize a large subset of antigens, a property known as cross-
reactivity. A T cell repertoire with cross-reactive T cells would cover antigenic space with a low and
physiologically affordable number of T cells.
117
118 CHAPTER 7. SUMMARY, CONCLUSIONS AND OUTLOOK
As the result of TCR signal-based selection, highly self-reactive thymocytes that differentiate to regu-
latory T cells are more cross-reactive than conventional T cells. This allows a low number of regulatory T
cells to cover antigenic space, including both self and nonself. Self and nonself-specific regulatory T cells
have been observed experimentally, but the extent of cross-reactivity in regulatory T cell repertoire has not
been investigated experimentally.
According to the model, a thymic negative selection based on strong transient peaks of integrated
TCR signal eliminates a large number of thymocytes with autoreactive TCRs. We found that the escaped
autoreactive thymocytes express low MHC affinity TCRs. This property would restrict their activation in
the periphery; they would require a high frequency of interaction with their specific self-antigens com-
pared to high MHC affinity T cells. Additionally, modeling results show that some regulatory T cells are
always activated along with conventional T cells in identical stimulatory condition. This would assure that
upon activation of escaped self-reactive T cells, a suppressing immune response exists to regulate effector
functions.
In this study, a binary representation of proteins are used as a simplification for protein structures.
Theoretically, amino-acid sequences can be used to study thymic selection with a particular subset of
self-antigens with known sequences. Further, affinity of protein interactions could be approximated by
calculating their binding free energies. In practice, however, this demands a high computational power,
even in the scale of a single interaction of proteins, and might not be applicable for simulating a large
number of interactions.
Presented model is not a spatial model for thymic selection. Evidently, peptides are not distributed
uniformly in thymic microenvironments [7]. Depending on the type of peptides, they are presented in
different locations by different antigen presenting cells. It is of interest to investigate how adding space
into thymic selection would limit positive and negative selections with respect to a particular self-peptide.
The proposed signal integration model is a proof of concept of how TCR-mediated integrated signal
can be translated into fate decisions in thymus. A few biological data are used to fit parameters of the
model, such as ratio of different repertoires or density of presentation for a particular peptide. Therefore,
proposed model is a qualitative model of thymic selection. This model can be used for predicting the
outcome of different manipulations in thymic selection; however, the predictions should be interpreted in a
qualitative fashion, and no quantitative predication should be expected. Further investigations are required
to identify biologically relevant TCR-mediated signals and required intracellular components that would
allow translation of signaling dynamics into fate decisions.
7.2 Immune activation
After selection of T cell repertoire, activation and interplay of conventional T cells and regulatory T cells
is studied by a series of models based on ODEs. In our study, autoimmunity is considered as a natural
phenomenon, with autoimmune T cells being present in healthy individuals. Autoimmune responses are
usually generated in the process of mounting an immune response to foreign antigens, but autoimmune
disease may arise when autoimmunity is poorly regulated [215]. In this study, a parametric regime of the
immune system is found such that a beneficial and tightly restricted autoimmune response is allowed.
Hierarchical models are constructed with considering essential components in immune activation and
suppression. Complexities are added incrementally to an initially considered simple model, up to a degree
that a qualitatively validated model for immune response is obtained. By taking hierarchical modeling
approach, contribution of each added complexity is investigated, and the parametric regime of the model
with biologically relevant behavior is extracted. In the presented models, no quantitative data is used;
however, models are studied purely analytically, such that different behaviors of the model for different
possible values of parameters are extracted. These are mainly achieved via parametric linear stability and
bifurcation analysis.
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By using the simplest model, it is shown that whether an immune response can be initiated is dependent
on the quality of T cell clones (rate of cell proliferation and growth-factor secretion) that are stimulated by
antigen. This criterion imposes a positive saddle equilibrium point in the model, which divides the space of
initial conditions to sub- and super-thresholds, such that a minor and a major proliferative immune response
can be obtained, respectively. The same saddle point results in a saddle-node bifurcation by increasing
Ag-stimulation. The critical point where saddle-node bifurcation occurs defines a minimum requirement of
Ag-stimulation for T cells in order to enter to the substantial proliferation phase of the immune response.
In the most complex model, the minimum Ag-stimulation threshold depends on the absolute number and
ratio of regulatory to conventional T cells, which is controlled by renewal rate of resting regulatory and
na¨ıve conventional T cells.
In the context of autoreactive T cells, renewal rate is tightly restricted by central tolerance in which
thymocytes with high affinity TCRs to self-peptides are eliminated. This restriction does not largely
affect thymic production of foreign-specific T cells. For natural regulatory T cells, renewal rate is tightly
regulated by thymic selection of regulatory T cells, which dominantly induces peripheral tolerance. Other
mechanisms in addition to thymic production contribute to the homeostatic number of regulatory and
conventional T cells, which are not considered in the immune activation model presented here. A more
complex ODE-based modeling of T cell homeostasis is proposed elsewhere [6] (model is introduced in
section 3.1.2 and Figure 3.3), which relies on high resolution kinetic data of regulatory and conventional
T cells population. This model considers other mechanisms, in addition to thymic export, for T cell
homeostasis. In particular, conversion of conventional T cells to regulatory T cells is explicitly considered
and quantified. As an extension, via coupling of the immune activation model and the homeostasis model
given in [6], dependency of immune activation to T cell homeostatic mechanisms other than thymic export
can be studied. However, the major obstacle of coupling these two models is that the immune activation
model is a qualitative model of monoclonal T cell activation, whereas the model presented in [6] is a
data-driven polyclonal model of T cell homeostasis. A scaling parameter would be needed to connect these
two models.
Normally, immune response arises from activation and proliferation of multiple clones of regulatory and
conventional T cells that cross-react to presented antigens. A possible modification for the model would be
to consider polyclonal T cells that cross-react to identical antigen stimulation. Experimental mice models
for immune responses against foreign and self antigens are well established. By employing experimental
data to the immune activation model, the quantitative differences of parameters between self and nonself
reactions can be revealed.
By using hierarchical models, it is shown that regulatory T cells are the necessary component for
terminating the immune response after a major peak in population of effector T cells. Model suggests that
a major immune response is only allowed for a limited time-window (depends on the parameters associated
with regulatory T cells) after which the immune response is suppressed completely when antigen stimulation
is resolved, or subsequently enter to oscillation phases when the antigen stimulation persists. Chronic state
of the immune response which is arises from over activation of regulatory T cells is another interesting
property that is observed from the immune activation model, and should be validated by experiments. An
interplay between effector immune response and viral dynamics has not been considered, which is left for
further investigations. Model suggests that low proliferating antigens (low rate of antigen stimulation) and
highly proliferating antigens (high rate of antigen stimulation) are the challenging antigens for the immune
system, since both of these two types of antigens cannot elicit a major immune response.
7.3 Regulation of immune stimulation
In addition to suppression of effector activities of conventional T cells, regulatory T cells control the
stimulatory capacity of antigen presenting cells (APC). T cells require both antigen specific and non-specific
stimulation by APCs. Antigen-nonspecific signal is induced via ligation of CD28 molecules expressed on
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T cells with CD80/CD86 molecules expressed on APCs. In the immune activation model presented in
chapter 5, only antigen-specific stimulation is considered. By augmenting antigen-nonspecific stimulation
(costimulation) into the model, one has to take into account the negative feedback of regulatory T cells
on APCs. This negative feedback is particularly resulted from newly discovered mechanism of CD80/CD86
removal (trans-endocytosis) by CTLA4 molecules expressed by regulatory T cells. As the first step to
determine the contribution of trans-endocytosis mechanism in the immune suppression, one has to identify
the unusual trafficking machinery of CTLA4 molecules that leads to efficient ligand removal.
In this study, a general trafficking model is constructed by taking into account the essential sub-
processes involved in the trafficking of proteins. However, since different experimental protocols are used to
observe kinetics of CTLA4 molecules, a modified version of the model is constructed for each experiment in
order to use experimental data. These models are solved analytically. In each model, obtaining the analytic
equivalent of observed variables revealed which parameters can or cannot be observed by corresponding
experiment. It is shown that the rate of protein synthesis cannot be observed by most of experiments,
due to data normalization. Further, obtaining the analytic solutions of presented models allows a low
computational cost for parameter estimation. This is due to replacement of numerical integrations with
algebraic equations. Optimal parameters set is obtained by differential evolution algorithm.
By estimation of parameters, it is shown that endocytosis of CTLA4 is rapid with subsequent recycling
and degradation. A large ratio of internalization to recycling rates (≈ 26) explains the unusual distri-
bution of CTLA4 molecules, with higher fraction of total CTLA4 molecules being located in cytoplasm.
Furthermore, it is shown that upon ligation with costimulatory molecules, CTLA4 molecule can remove
CD86 ligands from opposing cells by a rate in the order of CTLA4 internalization rate (≈ 1.4-fold). To
the best of our knowledge, this is the first theoretical work for quantifying the rates of CTLA4 trafficking
and associated trans-endocytosis.
In the presented model, only CD86 costimulatory molecules are considered. The same models can be
applied with similar experimental protocols for CD80 molecules. Differences in removal rates of CD80 versus
CD86 could be of interest as these two molecules are different in their expression regime in steady state and
inflammation. CD80 expression is poor on professional APCs, but increases several days after interaction
with T cells. In contrast, CD86 is constitutively expressed on professional APCs, which increases rapidly
after antigen presentation to T cells [9]. It is not clear why two costimulatory molecules with identical
functions but different expression regimes are used by the immune system.
Reaction between CD80/CD86 and CTLA4 molecules results in the formation of multivalent complexes,
which is not considered in the trans-endocytosis model. As a modification, multivalent complex formation
can be considered as sequential reactions on the cell-cell contact surface. However, it would be challenging
to identify different ligand removal rates at different stages of sequential reactions. Such differences cannot
be identified from the data given in [213].
The CTLA4-mediated regulation of T cell activation is the basis of some clinical therapies by using anti-
CTLA4 antibodies or CTLA4 Immunoglobulin (Ig) fusion proteins. A strong CTLA4-mediated inhibition of
T cell activation in cancer is treated with anti-CTLA4 molecules, which results in enhancement of effector
functions of the immune system. In allergy or autoimmunity, CTLA4 Ig fusion proteins are used to block
costimulatory molecules and inhibit costimulation via ligation of CD28 with CD80/CD86 molecules. These
therapies are designed without considering special trafficking of CTLA4 molecules and associated trans-
endocytosis mechanism. It would be of interest to investigate the efficiency, optimize, or even revise such
therapies by considering the trans-endocytosis mechanism.
In summary, we presented mathematical models for three different stages of the immune system. These
stages are interdependent, but they are usually studied experimentally as isolated components in vitro. For
example, thymic selections that are studied in vitro in organ-cultured thymuses, are not affected by any
feedback from peripheral cells or mechanisms. A recent study has shown that activated regulatory T cells
recirculate to the thymus and suppress the selection of new regulatory T cells [216]. Further, immune
activation is directly dependent on the type and properties of T cells that are daily exported by thymus
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to periphery. Quantification of such feedback loops between different organs of the immune system is
challenging, and cannot be investigated only by experiments. Mathematical modeling is a promising
approach to investigate multi-stage mechanisms, such as immune tolerance presented in this study. The
theoretical multi-stage studies are potentially able to use enormous but isolated experimental data to
provide an overall picture of important mechanisms in the immune system, such as immune regulation.
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Appendix A
Abbreviations
Ag Antigen
APC Antigen presenting cell
CHO Chinese Hamster Ovary
CP Cytoplasm
CTLA4 Cytotoxic T-lymphocyte-associated protein 4
IL-2 Interleukin-2
iTreg Induced regulatory T cell
LN Lymph node
MFI Mean fluorescent intensity
nTreg Natural regulatory T cell
ODE Ordinary differential equation
PDE Partial differential equation
PM Plasma membrane
RHC Routh-Hurwitz stability Criterion
Tconv Conventional T cell
Treg Regulatory T cell
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Appendix B
Analytic solutions of CTLA4
trafficking models
B.1 Ratio of plasma membrane (PM) to internalized (I) CTLA4
Herein, the aim is to obtain solution of model (6.16), given the initial conditions (6.17). Model (6.16)
can be considered in the form of x˙(t) = Ax(t) + g, where x(t) is an n × 1 vector of CTLA4-associated
functions and x˙(t) is the vector of first derivatives of these functions, and A is an n× n matrix, of which
all elements are constants, and g is an n × 1 vector with constant elements. The following characteristic
equation can be obtained from squared matrix A:
Q(λ) = det(λIn −A) =
∣∣∣∣∣∣
λ+ (kir + δic) 0 0
−kir λ+ kii −kir
0 −kii λ+ (kir + δic)
∣∣∣∣∣∣
= [λ+ (kir + δic)][λ2 + (kii + kir + δic)λ+ kiiδic] = 0. (B.1)
where In is the identity (unit) matrix of size n. Eigenvalues of the model are
λ1 = −(kir + δic) (B.2)
λ2 =
1
2
[
−(kii + kir + δic)−
√
(kii + kir + δic)2 − 4kiiδic
]
(B.3)
λ3 =
1
2
[
−(kii + kir + δic) +
√
(kii + kir + δic)2 − 4kiiδic
]
. (B.4)
Let vi be an eigenvector of A associated to λi. We must have
Avi = λivi or (A− λiIn)vi = 0. (B.5)
The following eigenvectors from associated eigenvalue can be constructed
v1 =
 10
−1
 , v2 =
 0(kir+δic)+λ2
kii
1
 , v3 =
 0(kir+δic)+λ3
kii
1
 . (B.6)
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By using eigenvectors given above, fundamental matrix (defined in 3.4) can be obtained
Φ(t) =
 e
λ1t 0 0
0 (kir+δic)+λ2kii e
λ2t (kir+δic)+λ3
kii
eλ3t
−eλ1t eλ2t eλ3t
 . (B.7)
Next, we obtain the solution of the model by using the method of variation of parameters, presented in
section (3.2.1.1.2). The solution of the nonhomogeneous linear system x˙(t) = Ax(t)+g is x(t) = Φ(t)u(t),
where Φ(t)u˙(t) = g is the following e
λ1t 0 0
0 (kir+δic)+λ2kii e
λ2t (kir+δic)+λ3
kii
eλ3t
−eλ1t eλ2t eλ3t

u˙1(t)u˙2(t)
u˙3(t)
 =
 0σi
0
 (B.8)
Therefore, u(t) can be obtained from the following differential equations.
eλ1tu˙1(t) = 0⇒ u˙1(t) = 0⇒ u1(t) = C1, (B.9)
(kir + δic) + λ2
kii
eλ2tu˙2(t) +
(kir + δic) + λ3
kii
eλ3tu˙3(t) = σi, (B.10)
−eλ1tu˙1(t) + eλ2tu˙2(t) + eλ3tu˙3(t) = 0 (B.11)
By using (B.9) in (B.11),
u˙2(t) = −eλ3−λ2 u˙3(t). (B.12)
By employing (B.2) and (B.12) in (B.10), we obtain u˙3(t) and subsequently, u3(t).
λ2 − λ1
kii
eλ2tu˙2(t) +
λ3 − λ1
kii
eλ3tu˙3(t) = σi ⇒ u˙3(t) = σikii
λ3 − λ2 e
−λ3t, (B.13)
⇒ u3(t) = −σikii
λ3(λ3 − λ2)e
−λ3t + C3. (B.14)
Next, u˙2(t) and subsequently, u2(t) is obtained by using (B.13) in (B.12).
u˙2(t) = −e(λ3−λ2)t σikii
λ3 − λ2 e
−λ3t = − σikii
λ3 − λ2 e
−λ2t ⇒ u2(t) = σikii
λ2(λ3 − λ2)e
−λ2t + C2. (B.15)
Next, by employing u(t) in x(t) = Φ(t)u(t), solutions can be found.
x(t) =
Ric(t)R∗ip(t)
R∗ic(t)
 = Φ(t)u(t) =
 e
λ1t 0 0
0 λ2−λ1kii e
λ2t λ3−λ1
kii
eλ3t
−eλ1t eλ2t eλ3t

u1(t)u2(t)
u3(t)
 , (B.16)
Ric(t) = C1eλ1t, (B.17)
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R∗ip(t) =
λ2 − λ1
kii
eλ2t
[
σikii
λ2(λ3 − λ2)e
−λ2t + C2
]
+ λ3 − λ1
kii
eλ3t
[ −σikii
λ3(λ3 − λ2)e
−λ3t + C3
]
⇒ R∗ip(t) =
λ2 − λ1
λ2(λ3 − λ2)σi −
λ3 − λ1
λ3(λ3 − λ2)σi +
C2
kii
(λ2 − λ1)eλ2t + C3
kii
(λ3 − λ1)eλ3t, (B.18)
R∗ip(t) = −
λ1
λ2λ3
σi +
C2(λ2 − λ1)
kii
eλ2t + C3(λ3 − λ1)
kii
eλ3t, (B.19)
R∗ic(t) = −C1eλ1t + eλ2t
[
σikii
λ2(λ3 − λ2)e
−λ2t + C2
]
+ eλ3t
[ −σikii
λ3(λ3 − λ2)e
−λ3t + C3
]
(B.20)
= −C1eλ1t + σikii
λ2(λ3 − λ2) −
σikii
λ3(λ3 − λ2) + C2e
λ2t + C3eλ3t, (B.21)
R∗ic(t) =
σikii
λ2λ3
− C1eλ1t + C2eλ2t + C3eλ3t. (B.22)
Model has the following initial conditions
Ric,0 =
σi
δic
(B.23)
R∗ip,0 =
σi(kir + δic)
kiiδic
(B.24)
R∗ic,0 = 0 (B.25)
Constant coefficient vector C is determined by using the initial values of states. For obtaining C1, we use
(B.23) in (B.17) for t = 0,
Ric(0) = C1 = Ric,0. (B.26)
With using (B.24) in (B.19) for t = 0, we have
R∗ip(0) =
−λ1
λ2λ3
σi +
C2(λ2 − λ1)
kii
+ C3(λ3 − λ1)
kii
= σi(kir + δic)
kiiδic
. (B.27)
By knowing from (B.1) that λ2λ3 = kiiδic, and by using (B.2) in (B.27), we obtain the following relation
between C2 and C3
C2 =
λ1 − λ3
λ2 − λ1C3. (B.28)
By using (B.25) in (B.22) for t = 0,
R∗ic(0) =
σikii
λ2λ3
− C1 + C2 + C3 = 0⇒ λ2 − λ3
λ2 − λ1C3 = 0.⇒ C3 = 0 (B.29)
By using (B.29) in (B.28), we have C2 = 0. By substituting constant coefficient vector C, the following
complete solutions can be obtained
Ric(t) =
σi
δic
eλ1t, R∗ip(t) =
σi(kir + δic)
kiiδic
, R∗ic(t) =
σi
δic
(
1− eλ1t) (B.30)
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B.2 Receptors internalization
Herein, the aim is to obtain solution of the internalization model (6.26), given the initial conditions (6.28).
The following characteristic equation can be obtained from (6.26)
Q(λ) = det
(
λ+ kii −kir
−kii λ+ (kir + δic)
)
= λ2 + (kii + kir + δic)λ+ kiiδic = 0 (B.31)
The eigenvalues of the model and associated eigenvectors are
λ1 =
1
2
[
−(kii + kir + δic)−
√
(kii + kir + δic)2 − 4kiiδic
]
, v1 =
(
1
kii+λ1
kir
)
, (B.32)
λ2 =
1
2
[
−(kii + kir + δic) +
√
(kii + kir + δic)2 − 4kiiδic
]
, v2 =
(
1
kii+λ2
kir
)
(B.33)
By using eigenvectors given above, fundamental matrix can be obtained
Φ(t) =
(
eλ1t eλ2t
kii+λ1
kir
eλ1t kii+λ2kir e
λ2t
)
. (B.34)
General solution is in the form of x(t) = Φ(t)C
R∗ip(t) = C1eλ1t + C2eλ2t, (B.35)
R∗ic(t) = C1
kii + λ1
kir
eλ1t + C2
kii + λ2
kir
eλ2t. (B.36)
Initial conditions of the model are
R∗ip,0 =
σi(kir + δic)
kiiδic
, (B.37)
R∗ic,0 = 0. (B.38)
By using the initial condition, the constant coefficient C can be obtained. From (B.38) and (B.36) for
t = 0, we have
R∗ic,0 = C1
kii + λ1
kir
+ C2
kii + λ2
kir
= 0⇒ C1 = −C2 kii + λ2
kii + λ1
(B.39)
C2 and subsequently C1 can be obtained from (B.37) and (B.35) for t = 0 and (B.39)
R∗ip,0 = C1 + C2 = −C2
kii + λ2
kii + λ1
+ C2 ⇒ C2 = kii + λ1
λ1 − λ2R
∗
ip,0 (B.40)
⇒ C1 = −kii + λ2
λ1 − λ2R
∗
ip,0. (B.41)
By substituting the constant coefficient vector C, the exact solution with given initial conditions is obtained
R∗ip(t) = −
kii + λ2
λ1 − λ2R
∗
ip,0e
λ1t + kii + λ1
λ1 − λ2R
∗
ip,0e
λ2t, (B.42)
R∗ic(t) =
kii
λ1 − λ2R
∗
ip,0e
λ1t − kii
λ1 − λ2R
∗
ip,0e
λ2t. (B.43)
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B.3 Lysosomal degradation block of initially labeled CTLA4
Herein, the aim is to obtain solution of the model for degradation block experiment, given in (6.36), with
initial conditions given in (6.35). Model (6.36) has the following characteristic equation
Q(λ) = det
(
λ+ kii −kir
−kii λ+ kir + δin
)
= λ2 + (kii + kir + δin)λ+ kiiδin = 0. (B.44)
The eigenvalues and associated eigenvectors are:
λ1 =
1
2
[
−(kii + kir + δin)−
√
(kii + kir + δin)2 − 4kiiδin
]
, v1 =
(
1
kii+λ1
kir
)
, (B.45)
λ2 =
1
2
[
−(kii + kir + δin) +
√
(kii + kir + δin)2 − 4kiiδin
]
, v2 =
(
1
kii+λ2
kir
)
. (B.46)
By using eigenvectors, we construct the following fundamental matrix
Φ(t) =
(
eλ1t eλ2t
kii+λ1
kir
eλ1t kii+λ2kir e
λ2t
)
(B.47)
from which, we can obtain the general solution(
R∗ip(t)
R∗ic(t)
)
=
(
eλ1t eλ2t
kii+λ1
kir
eλ1t kii+λ2kir e
λ2t
)(
C1
C2
)
. (B.48)
The general solutions has the following form
R∗ip(t) = C1eλ1t + C2eλ2t, (B.49)
R∗ic(t) = C1
kii + λ1
kir
eλ1t + C2
kii + λ2
kir
eλ2t. (B.50)
Constant coefficient vector C can be obtain by using initial conditions R∗ip,0 and R∗ic,0. From (B.49) for
t = 0, we have
R∗ip,0 = Rip(0) = C1 + C2 ⇒ C1 = R∗ip,0 − C2. (B.51)
By using (B.50) for t = 0 and (B.51), we have
R∗ic,0 = Ric(0) = C1
kii + λ1
kir
+ C2
kii + λ2
kir
= R∗ip,0
kii + λ1
kir
+ C2
λ2 − λ1
kir
(B.52)
⇒ C2 = kir
λ2 − λ1
[
R∗ic,0 −R∗ip,0
kii + λ1
kir
]
⇒ C2 = R∗ic,0
kir
λ2 − λ1 −R
∗
ip,0
kii + λ1
λ2 − λ1 . (B.53)
By using (B.51) and (B.53), C1 can be obtained
C1 = −R∗ic,0
kir
λ2 − λ1 +R
∗
ip,0
kii + λ2
λ2 − λ1 . (B.54)
In the case of δin = 0, the eigenvalues are simplified to
λ1 = 0, λ2 = −(kii + kir). (B.55)
Solutions can be obtained from the case where δin 6= 0 by substituting λ1 = 0.
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B.4 Lysosomal degradation block without initial labeling
B.4.1 Case 1: δin 6= 0
Herein, the aim is to obtain solution of the model for degradation block experiment without initial labeling,
given in (6.51), with initial conditions given in (6.53). Characteristic equation of model (6.51) is the
following
Q(λ) = det
(
λ+ kii −kir
−kii λ+ kir + δin
)
= λ2 + (kii + kir + δin)λ+ kiiδin = 0. (B.56)
Eigenvalues of the model and associated eigenvectors are
λ1 =
1
2
[
−(kii + kir + δin)−
√
(kii + kir + δin)2 − 4kiiδin
]
, v1 =
(
1
kii+λ1
kir
)
, (B.57)
λ2 =
1
2
[
−(kii + kir + δin) +
√
(kii + kir + δin)2 − 4kiiδin
]
, v2 =
(
1
kii+λ2
kir
)
. (B.58)
By using the above eigenvectors, we construct the following fundamental matrix
Φ(t) =
(
eλ1t eλ2t
kii+λ1
kir
eλ1t kii+λ2kir e
λ2t
)
. (B.59)
Next, we obtain the solution of the model by using variation of parameters method.
Φ(t)u˙(t) =
(
σi
0
)
⇒
(
eλ1t eλ2t
kii+λ1
kir
eλ1t kii+λ2kir e
λ2t
)(
u˙1(t)
u˙2(t)
)
=
(
σi
0
)
. (B.60)
u(t) can be obtained from the following differential equations
eλ1tu˙1(t) + eλ2tu˙2(t) = σi (B.61)
kii + λ1
kir
eλ1tu˙1(t) +
kii + λ2
kir
eλ2tu˙2(t) = 0⇒ u˙1(t) = −kii + λ2
kii + λ1
e(λ2−λ1)tu˙2(t) (B.62)
By using (B.62) in (B.61), we have
e(λ2−λ1)teλ1t
(
−kii + λ2
kii + λ1
)
u˙2(t) + eλ2tu˙2(t) = σi ⇒ u˙2(t) = kii + λ1
λ1 − λ2 σie
−λ2t (B.63)
⇒ u2(t) = −σi(kii + λ1)
λ2(λ1 − λ2)e
−λ2t + C2 (B.64)
By using (B.63) in (B.62), we have:
u˙1(t) = −kii + λ2
λ1 − λ2 σie
−λ1t ⇒ u1(t) = σi(kii + λ2)
λ1(λ1 − λ2)e
−λ1t + C1 (B.65)
Next, we obtain general solution of the model(
Rip(t)
Ric(t)
)
= Φ(t)u(t) =
(
eλ1t eλ2t
kii+λ1
kir
eλ1t kii+λ2kir e
λ2t
)( σi(kii+λ2)
λ1(λ1−λ2) e
−λ1t + C1
−σi(kii+λ1)λ2(λ1−λ2) e−λ2t + C2
)
(B.66)
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From above, we expand general solutions
Rip(t) =
σi(kii + λ2)
λ1(λ1 − λ2) + C1e
λ1t − σi(kii + λ1)
λ2(λ1 − λ2) + C2e
λ2t
⇒ Rip(t) = −σi(λ1 + λ2 + kii)
λ1λ2
+ C1eλ1t + C2eλ2t (B.67)
Ric(t) =
kii + λ1
kir
σi(kii + λ2)
λ1(λ1 − λ2) + C1
kii + λ1
kir
eλ1t − kii + λ2
kir
σi(kii + λ1)
λ2(λ1 − λ2) + C2
kii + λ2
kir
eλ2t
⇒ Ric(t) = − σi
kir
(kii + λ1)(kii + λ2)
λ1λ2
+ C1
kii + λ1
kir
eλ1t + C2
kii + λ2
kir
eλ2t (B.68)
Let Rip,0 and Ric,0 be the initial conditions of model states. Next, we obtain constant coefficients C1 and
C2. From (B.67) for t = 0, we have
Rip(0) =
σi(kii + λ2)
λ1(λ1 − λ2) + C1 −
σi(kii + λ1)
λ2(λ1 − λ2) + C2 =
σi [(kii + λ2)λ2 − (kii + λ1)λ1]
λ1λ2(λ1 − λ2) + C1 + C2
= σi [kii(λ2 − λ1) + (λ2 − λ1)(λ2 + λ1)]
λ1λ2(λ1 − λ2) + C1 + C2 = −
σi(λ1 + λ2 + kii)
λ1λ2
+ C1 + C2 = Rip,0
⇒ C1 = Rip,0 − C2 + σi(λ1 + λ2 + kii)
λ1λ2
(B.69)
From (B.68) for t = 0, we have
Ric(0) =
kii + λ1
kir
σi(kii + λ2)
λ1(λ1 − λ2) + C1
kii + λ1
kir
− kii + λ2
kir
σi(kii + λ1)
λ2(λ1 − λ2) + C2
kii + λ2
kir
= σi
λ2(kii + λ1)(kii + λ2)− λ1(kii + λ1)(kii + λ2)
kirλ1λ2(λ1 − λ2) + C1
kii + λ1
kir
+ C2
kii + λ2
kir
= −σi (kii + λ1)(kii + λ2)
kirλ1λ2
+ C1
kii + λ1
kir
+ C2
kii + λ2
kir
= Ric,0 (B.70)
Next, by substituting C1 from (B.69) in (B.70), we obtain C2
Ric,0 = −σi (kii + λ1)(kii + λ2)
kirλ1λ2
+
[
Rip,0 − C2 + σi(λ1 + λ2 + kii)
λ1λ2
]
kii + λ1
kir
+ C2
kii + λ2
kir
= Rip,0
kii + λ1
kir
+ λ2 − λ1
kir
C2 +
σi(kii + λ1)
kirλ2
= Ric,0
⇒ C2 = Ric,0 kir
λ2 − λ1 −Rip,0
kii + λ1
λ2 − λ1 −
σi(kii + λ1)
λ2(λ2 − λ1) (B.71)
Next, by substituting C2 from (B.71) in (B.69), C1 can be obtained
C1 = Rip,0 −
[
Ric,0
kir
λ2 − λ1 −Rip,0
kii + λ1
λ2 − λ1 −
σi(kii + λ1)
λ2(λ2 − λ1)
]
+ σi(λ1 + λ2 + kii)
λ1λ2
= −Ric,0 kir
λ2 − λ1 +Rip,0
kii + λ2
λ2 − λ1 +
σi(kii + λ1)
λ2(λ2 − λ1) +
σi(λ1 + λ2 + kii)
λ1λ2
⇒ C1 = −Ric,0 kir
λ2 − λ1 +Rip,0
kii + λ2
λ2 − λ1 +
σi(kii + λ2)
λ1(λ2 − λ1) (B.72)
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B.4.2 Case 2: δin = 0
Now, consider model (6.51) with δin = 0 The characteristic equation in (B.56) is changed to the following
Q(λ) = λ2 + (kii + kir)λ = 0. (B.73)
From above, the eigenvalues and associated eigenvectors can be obtained
λ1 = 0, v1 =
(
1
kii
kir
)
, (B.74)
λ2 = −(kii + kir), v2 =
(
1
kii+λ2
kir
)
. (B.75)
By using eigenvectors v1,2, the following fundamental matrix can be constructed
Φ(t) =
(
1 eλ2t
kii
kir
kii+λ2
kir
eλ2t
)
. (B.76)
We obtain solutions of the system by using the method of variation of parameters. The aim is to find u(t)
from the following equation
Φ(t)u˙(t) =
(
σi
0
)
⇒
(
1 eλ2t
kii
kir
kii+λ2
kir
eλ2t
)(
u˙1(t)
u˙2(t)
)
=
(
σi
0
)
, (B.77)
or equivalently, we want to obtain u1,2(t) from the following differential equations
u˙1(t) + eλ2tu˙2(t) = σi (B.78)
kii
kir
u˙1(t) +
kii + λ2
kir
eλ2tu˙2(t) = 0⇒ u˙1(t) = −kii + λ2
kii
eλ2tu˙2(t). (B.79)
By using (B.79) in (B.78), we have[
1− kii + λ2
kii
]
eλ2tu˙2(t) = σi ⇒ u˙2(t) = −σikii
λ2
e−λ2t ⇒ u2(t) = σikii
λ22
e−λ2t + C2. (B.80)
Next, by substituting u˙2 from (B.80) in (B.78), we have
u˙1(t) = −kii + λ2
kii
eλ2t
[
−σikii
λ2
e−λ2t
]
= σi(kii + λ2)
λ2
⇒ u1(t) = σi(kii + λ2)
λ2
t+ C1. (B.81)
Next, we construct the general solutions(
Rip(t)
Ric(t)
)
= Φ(t)u(t) =
(
1 eλ2t
kii
kir
kii+λ2
kir
eλ2t
)(σi(kii+λ2)
λ2
t+ C1
σikii
λ22
e−λ2t + C2
)
, (B.82)
or equivalently,
Rip(t) =
σi
λ2
[
(kii + λ2)t+
kii
λ2
]
+ C1 + C2eλ2t, (B.83)
Ric(t) =
σikii(kii + λ2)
kirλ2
[
t+ 1
λ2
]
+ C1
kii
kir
+ C2
kii + λ2
kir
eλ2t. (B.84)
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We denote Rip,0 and Ric,0 as initial conditions of the model. We can obtain constant coefficients C1,2 as
functions of the initial conditions. From (B.83) for t = 0, we have
Rip,0 = Rip(0) =
σikii
λ22
+ C1 + C2 ⇒ C1 = Rip,0 − σikii
λ22
− C2. (B.85)
By using (B.85) in (B.84) for t = 0, C2 can be obtained
Ric,0 = Ric(0) = C1
kii
kir
+ σikii(kii + λ2)
kirλ22
+ C2
kii + λ2
kir
= kii
kir
Rip,0 − σik
2
ii
kirλ22
− kii
kir
C2 +
σikii(kii + λ2)
kirλ22
+ C2
kii + λ2
kir
= kii
kir
Rip,0 + C2
λ2
kir
+ σikii
kirλ2
⇒ C2 = kir
λ2
[
Ric,0 − kii
kir
Rip,0 − σikii
kirλ2
]
⇒ C2 = kir
λ2
Ric,0 − kii
λ2
Rip,0 − σikii
λ22
. (B.86)
C1 can be found by using (B.86) in (B.85)
C1 = Rip,0 − σikii
λ22
− kir
λ2
Ric,0 +
kii
λ2
Rip,0 +
σikii
λ22
⇒ C1 =
(
1 + kii
λ2
)
Rip,0 − kir
λ2
Ric,0. (B.87)
B.5 Blocking protein synthesis
Herein, we obtain solution of model (6.68) for the experiment of blocking protein synthesis, with initial
conditions given in (6.69). Characteristic equation of the model is the following
Q(λ) = det
[
λ+ kii −kir
−kii λ+ (kir + δic)
]
= λ2 + (kii + kir + δic)λ+ kiiδic = 0. (B.88)
Eigenvalues of the model and associated eigenvectors are
λ1 =
1
2
[
−(kii + kir + δic)−
√
(kii + kir + δic)2 − 4kiiδic
]
, v1 =
(
1
kii+λ1
kir
)
, (B.89)
λ2 =
1
2
[
−(kii + kir + δic) +
√
(kii + kir + δic)2 − 4kiiδic
]
, v2 =
(
1
kii+λ2
kir
)
. (B.90)
By using eigenvectors v1,2 given above, the following fundamental matrix can be constructed
Φ(t) =
(
eλ1t eλ2t
kii+λ1
kir
eλ1t kii+λ2kir e
λ2t
)
. (B.91)
By using the fundamental matrix, the following general solutions are obtained(
Rip(t)
Ric(t)
)
= Φ(t)C,
Rip(t) = C1eλ1t + C2eλ2t (B.92)
Ric(t) = C1
kii + λ1
kir
eλ1t + C2
kii + λ2
kir
eλ2t (B.93)
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Model has the following initial conditions
Rip,0 =
σi(kir + δic)
kiiδic
= σi(kir + δic)
λ1λ2
, (B.94)
Ric,0 =
σi
δic
= σikii
λ1λ2
. (B.95)
To obtain constant coefficients C1,2, we evaluate (B.92) and (B.93) at t = 0 by using (B.94) and (B.95)
Rip,0 = Rip(0) = C1 + C2 =
σi(kir + δic)
λ1λ2
⇒ C1 = −C2 + σi(kir + δic)
λ1λ2
. (B.96)
By using (B.96) in (B.93) for t = 0
Ric,0 = Ric(0) = C1
kii + λ1
kir
+ C2
kii + λ2
kir
= σikii
λ1λ2
⇒
[
−C2 + σi(kir + δic)
λ1λ2
]
kii + λ1
kir
+ C2
kii + λ2
kir
= C2
[
−kii + λ1
kir
+ kii + λ2
kir
]
+ σi(kir + δic)(kii + λ1)
λ1λ2kir
= C2
λ2 − λ1
kir
+ σi(kir + δic)(kii + λ1)
λ1λ2kir
= σikii
λ1λ2
⇒ C2(λ2 − λ1) = σikiikir
λ1λ2
− σi(kir + δic)(kii + λ1)
λ1λ2
= σi[−kiiδic − (kir + δic)λ1]
λ1λ2
(B.97)
From quadratic equation (B.88) we extract λ1λ2 = kiiδic and use it in equation above to obtain simpler
form of C2
C2 = −σi[λ1λ2 + (kir + δic)λ1]
λ1λ2(λ2 − λ1) . (B.98)
By using (B.98) in (B.96), C1 can be obtained
C1 =
σi[λ1λ2 + (kir + δic)λ1]
λ1λ2(λ2 − λ1) +
σi(kir + δic)
λ1λ2
⇒ C1 = σi[λ1λ2 + (kir + δic)λ2]
λ1λ2(λ2 − λ1) (B.99)
B.6 Protein recycling
Herein, we obtain solution of recycling submodel (6.88). The following characteristic equation can be
obtained from (6.88)
Q(λ) = det
λ+ (kir + δic) 0 0−kir λ+ kii −kir
0 −kii λ+ (kir + δic)
 (B.100)
= [λ+ (kir + δic)][λ2 + (kii + kir + δic)λ+ kiiδic] = 0. (B.101)
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The eigenvalues of the model and associated eigenvectors are
λ1 = −(kir + δic), v1 =
 10
−1
 , (B.102)
λ2 =
1
2
[
−(kii + kir + δic)−
√
(kii + kir + δic)2 − 4kiiδic
]
, v2 =
 01
kii+λ2
kir
 , (B.103)
λ3 =
1
2
[
−(kii + kir + δic) +
√
(kii + kir + δic)2 − 4kiiδic
]
, v3 =
 01
kii+λ3
kir
 . (B.104)
By using the eigenvectors given above, the following fundamental matrix can be constructed
Φ(t) =
 e
λ1t 0 0
0 eλ2t eλ3t
−eλ1t kii+λ2kir eλ2t kii+λ3kir eλ3t
 . (B.105)
from which the general solution can be obtained
Rgic(t) = C1eλ1t, (B.106)
Rgrip (t) = C2eλ2t + C3eλ3t, (B.107)
Rgrip (t) = −C1eλ1t + C2
kii + λ2
kir
eλ2t + C3
kii + λ3
kir
eλ3t. (B.108)
Model has the following initial conditions
Rgic(0) = R
g
ic,t0
, Rgrip (0) = 0, R
gr
ic (0) = 0. (B.109)
By using initial conditions above in general solutions for t = 0, constant coefficients C1,2,3 can be obtained
C1 = Rgic,t0 , C2 = −
kir
λ3 − λ2C1, C3 =
kir
λ3 − λ2C1. (B.110)

